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ABSTRACT 
Background: Despite the existence of effective interventions such as prophylactic antiretroviral 
medicines, mother-to-child transmission (MTCT) of HIV is still a major reason for HIV 
transmission in sub-Saharan Africa. Antenatal care (ANC) facilities are the main location for 
implementing prevention of MTCT (PMTCT) programmes and HIV testing is the first step in 
PMTCT.  
Aim: The overall aim was to determine access to PMTCT services and to identify barriers and 
facilitators for accessing these services in rural Uganda.   
Methods: Four studies (I-IV) were carried out 2008-2010 in, or neighbouring, the 
Iganga/Mayuge Health and Demographic Surveillance Site (HDSS) covering 12,000 
households in Iganga and Mayuge districts in eastern Uganda. Semi-structured interviews were 
conducted with pregnant women to explore their views on HIV testing during ANC (I). Men’s 
views on being HIV tested together with their spouse were explored through in-depth interviews 
and focus group discussions (II). Questionnaire-based interviews and ANC record reviews were 
employed to quantify the HIV testing uptake and to determine risk factors (adjusted relative 
risks; aRR) for not being tested for HIV among 881 pregnant women (III). Population-based 
data from Study III, known MTCT rates, and health facility- and semi-structured interview data 
on dropouts from the PMTCT programme were used to estimate the number of HIV-infected 
children with base-case PMTCT coverage, and for scenarios with an assumed increase in 
coverage of PMTCT programme components (IV).  
Results: ANC attendance was 96% but even with existing policies for opt-out and couple HIV 
testing only 64% of the women were tested for HIV and only 4% had been tested together with 
their spouse (III). The quality of HIV counselling was generally poor, few attending facilities 
that lacked HIV testing services received any counselling (I, III), even fewer (6%) were tested 
elsewhere (III). Living more than 3 kilometres from a health facility with HIV testing services 
increased the risk for not being tested among the poorest and among the least poor (aRR 1.44 
and 1.72), adjusting for age. Women found recruiting their spouses for couple testing (I) to be 
very challenging (I, II), and men were very negative towards it (II). The estimated MTCT rate 
with base-case PMTCT coverage was 13% at birth (IV). Increasing HIV testing uptake to 100% 
would be the single most effective intervention to reduce MTCT, but only combination 
interventions with perfect adherence would reduce MTCT rates to the target below 5%.  
Conclusions: Despite near to universal ANC attendance and opt-out HIV testing and couple 
HIV testing policies in place, less than two-thirds of women were HIV tested and very few 
tested together with their spouse leading to missed opportunities for PMTCT. The main barriers 
to PMTCT are health systems-related: lack of HIV testing and referral, poor counselling, and 
gender-related power dynamics both at the household level and at the point of health service 
delivery.  
Keywords: HIV, prevention of mother-to-child transmission (PMTCT), HIV testing, access, 
Uganda, Health and Demographic Surveillance Site (HDSS) 
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LIST OF ABBREVIATIONS 
3TC Lamivudine 
ANC Antenatal care 
ART Antiretroviral therapy 
ARVMAC Effects of Antiretrovirals for HIV on African health systems, 
Maternal and Child Health 
ARVs Antiretroviral medicines 
AZT Zidovudine 
FGD Focus group discussion 
HC Health centre 
HDSS Health and Demographic Surveillance Site 
HIV Human immunodeficiency virus 
IDI In-depth interview  
MDG Millennium development goals 
MTCT Mother-to-child transmission 
PEPFAR The U.S. President's Emergency Plan for AIDS Relief  
PMTCT Prevention of mother-to-child transmission for HIV 
SES Socio-economic status 
sd-NVP Single dose nevirapine 
SSA Sub-Saharan Africa 
VCT Voluntary counselling and testing for HIV 
UNAIDS The Joint United Nations Programme on HIV/AIDS 
WHO The World Health Organization 
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OPERATIONAL DEFINITIONS 
Access to health care is defined in this thesis as a concept composed of three dimensions; 
availability, affordability and acceptability. Access is seen as dependent on the interplay 
between the three dimensions, as well as the interaction between the 
individual/household/community and the health system for each of these dimensions. 
Universal coverage is defined as securing access to a certain service or intervention at an 
affordable cost. Incorporates two complementary dimensions in addition to financial protection, 
e.g. who is covered and the extent of health service coverage, which is covered. (Carrin, G., I. 
Mathauer, K. Xu, and D.B. Evans, Universal coverage of health services: tailoring its implementation. Bull World Health Organ, 2008. 86(11): 
p. 857-63.) 
Coverage and Uptake will be used interchangeably in this thesis. They are defined as the 
percentage of the population reached by a certain service or intervention.  
Health facility with onsite HIV testing refers to a health facility that has been accredited by the 
Ugandan Ministry of Health to carry out HIV testing. 
Health facility without onsite HIV testing refers to health facilities that have not been accredited 
by the Ugandan Ministry of Health to carry out HIV testing. 
Couple HIV counselling and testing/ couple HIV testing/ couple testing all these terms are used 
with the same meaning in this thesis: a woman and a man in a relationship that are counselled 
and tested for HIV together. Usually this takes place during antenatal care. 
Provider initiated HIV counselling and testing or Opt-out HIV testing, means that HIV testing 
should be a standard part of medical care for all patients attending health facilities with 
simplified pre-test information. All patients should be tested as long as they do not actively opt-
out.  
Counselling is in this thesis is defined in a broad sense, including information and 
communication regarding health topics. 
Efficacy the ability to cause an effect, or the effect an intervention shows in a research setting.   
Effectiveness, the impact an intervention achieves in the real world, under resource constraints, 
in the entire population, or sub-population. (Aral, S.O. and T.A. Peterman. Do we know the effectiveness of behavioural 
interventions? Lancet, 1998. 351 Suppl 3: p. 33-6.) 
Low-income country GNI per capita of US$1,005 or less (defined by the World Bank (WB)). 
Middle-income country GNI per capita between US$1,006 and US$3,975 (defined by the WB). 
High-income country GNI above US$12,276 (defined by the WB). 
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PREFACE 
While arriving at a health facility in Iganga, a rural district in Uganda, with the intention of 
interviewing a midwife, we instead ended up bringing a pregnant woman to the hospital for an 
acute Caesarean section. The woman had been in labour for several days at home and when she 
finally made it to the health facility, she found that she could not get the care that she needed 
there. Why didn’t this woman have access to the care that she needed? What made her remain at 
home for so many days? This, to me, illustrated the importance of studying and understanding 
access to health care. 
 
During a half-year break from my pharmacy studies in 2003, I volunteered with an 
environmental project in rural Bushenyi, in Western Uganda. After that time, I decided to focus 
the rest of my pharmacy studies on global and public health. For my Master’s thesis, I returned 
to Uganda and studied three different delivery models for antiretroviral treatment to HIV 
patients at St. Francis Nsambya Hospital in Kampala. This made me realize some of the 
challenges faced by health workers and patients in the provision of HIV care. Later on, during 
an internship at the WHO/Ministry of Health Uganda, I had the opportunity to work with the 
logistics of how antiretroviral medicines were supplied to health facilities, and I understood the 
importance of a well-functioning health system to provide sustainable care and for delivering 
medicines.   
 
During the fieldwork for my PhD research I have spent one year in Uganda, mostly in Iganga. 
In order to try to figure out where the women in my study had sought antenatal care, I visited 
many villages in the district and nearly 50 health facilities, drug-shops and traditional birth 
attendants. The time spent in the community and at the various health facilities gave me 
glimpses of what access to health care can mean in real life. What it means when a rural health 
facility does not have any equipment at all. What it means to travel on rural roads. What it 
means to wait the whole day at the health facility. 
 
I have enjoyed writing this thesis. While writing and thinking again through what I have done, 
and why I have done it, I have realized that many of the things that I have experienced and that 
have taught me the most about global health have not always been the things that were directly 
related to the (planned) research. The opportunities to spend time observing and living in the 
field, and in conversations with colleagues and community members, have provided great depth 
to my experience and have enabled me to understand my research findings and the connections 
between them, in new ways.  
 
 
Stockholm 27 March 2012
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BACKGROUND 
THE HIV EPIDEMIC 
For more than 30 years, HIV has been a major global health problem, and was in 2008 the third 
leading cause of death accounting for almost 8% of all deaths in low-income countries [1]. HIV 
has, since it was first identified, shifted from being an untreatable disease with, at the most 
palliative care available, to today being a chronic disease, at least in high-income settings where 
antiretroviral therapy (ART) is available to the majority of people in need [2].  
 
Worldwide, an estimated 34 million people live with HIV and 3.5 million are children below 15 
years. The majority of all infected people, 23 million live in sub-Saharan Africa (SSA) [2]. The 
HIV prevalence is highest in SSA countries, but important to note is that HIV prevalence 
between SSA countries differs tenfold. 
HIV is transmitted through body fluids and the major routes of transmission are through sexual 
intercourse, contaminated needles, and transmission from an infected mother to her baby.   
 
In SSA, most of the HIV infections are heterosexually transmitted or transmitted through 
mother-to-child transmission (MTCT) [3]. The HIV epidemic in SSA is defined as a 
generalized epidemic, described by the UNAIDS as, 1. “an epidemic that is self-sustaining 
through heterosexual transmission” and 2. where the HIV prevalence usually exceeds 1% 
among pregnant women attending antenatal care (ANC) clinics [4]. In other parts of the world 
the HIV epidemic is defined as a “concentrated epidemic”, i.e. HIV is mostly concentrated to 
sub-populations, i.e. among injecting drug users, with a prevalence of 5% or above in the sub-
populations [4].  HIV is also included in one of the eight United Nations’ Millennium 
Development Goals (MDG) to be reached by 2015. The MGD’s aim is to increase health and 
decrease poverty in resource-poor countries. The HIV related goals include to have halted and 
began to reverse the spread of HIV by 2015 and to reach universal access to ART for all those 
who need it by 2010 [5]. 
 
HIV treatment 
Since the discovery of HIV in the early 1980s, much progress has been made in terms of 
knowledge about the virus and the development of treatment and prevention strategies [6]. In 
the early phase of the epidemic, HIV care and treatment was only available in resource-rich 
countries and these countries were therefore the first to gain experience of treating people living 
with HIV, the first to develop clinical guidelines, and the first to design and implement HIV 
service delivery programmes [7]. In 1996 the combination of three antiretroviral medicines 
(ARVs) into ART was shown to be effective in controlling the HIV infection and shown to have 
a great impact on morbidity and mortality in HIV-infected people [6, 8]. ART was introduced in 
high-income countries soon after its discovery. However, due to the fact that most of the early 
experience of HIV care came from resource-rich settings and the fact that there are huge 
differences between the HIV care that could be provided in resource-rich and resource-poor 
settings, just transferring the way HIV care was organized in high-income settings to low-
income settings was considered impossible.  
Therefore many were pessimistic about the possibility to introduce large scale-ART 
programmes in low-income settings and there was much resistance towards it [7]. However, the 
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scale-up of ART to the large population in low-income countries, especially in SSA started with 
the “3 by 5” initiative, launched by the World Health Organization (WHO), aiming to provide 
ART to three million people by 2005 [9]. Even though this initiative did not reach its target, this 
was the start of the scale-up of ART and today 5 million HIV-infected persons have access to 
ART in SSA, which is nearly 50% of those in need [2].  
 
There has been an unprecedented investment in HIV-care in low- and middle-income 
countries over the years, especially after the establishment of The Global Fund to Fight AIDS, 
Tuberculosis and Malaria in 2002, and The U.S. President's Emergency Plan for AIDS Relief 
(PEPFAR) in 2003 (Figure 1).  
 
Figure 1. Global resources available for HIV programmes in low-and middle-income countries, 
billions of US dollars, 1996-2010 
 
 
Although there has been much progress in terms of financial resources available and in terms of 
access to HIV care, there is still a need for better use of the resources available and in 2010 the 
UNAIDS launched its new HIV treatment platform for treatment and prevention called, 
“Treatment 2.0” [10]. The platform seeks to more efficiently reduce new HIV infections by 
one-third and avert 10 million deaths by 2025 and includes the development of better 
combination treatment regimens, cheaper and simplified diagnostic tools, and a low-cost 
community-led approach to delivery. 
 
HIV prevention 
In addition to the scale up of ART and the considerable focus on HIV treatment, in recent years 
there has been a shift to focusing more on prevention [11]. Prevention efforts are crucial since 
the number of new infections in 2010 (2.7 million), still outweighed the number of people 
initiated on ART (1.7 million) [2]. Combination and multi-level prevention interventions have 
been put forward under the concept “highly active HIV prevention” combining interventions for 
behavioural change, increased access to ART and treatment for other sexually transmitted 
infections, and to biomedical (e.g. microbicides, male circumcision) strategies, as well as 
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increased social justice and human rights to reach more effective preventive measures [11].  
Moreover, the UNAIDS has sought to draw more attention to HIV prevention and the fact that 
there is not one single HIV epidemic but rather various epidemic profiles in different settings 
and the expression “Know your epidemic, know your response” has been coined [12]. In order 
to be effective, the preventive response towards HIV should be tailored to fit the epidemic 
profile in a specific context [13].  
 
Another approach towards preventing HIV is the “test and treat”, or treatment for prevention 
model, i.e. that people should be tested for HIV on a routine basis and if identified as HIV-
infected, receive ART immediately [14]. The justification for the test and treat model is that if 
people are tested early and receive immediate ART, they would be less infectious, and hence it 
would prevent them from transmitting the virus to other people.  
 
HIV testing 
Voluntary counselling and testing (VCT) for HIV, client initiated-opt-in-HIV testing where 
people actively seek to be tested for HIV, has for the last twenty years been part of the HIV 
prevention efforts.  
 
HIV testing is important both to identify HIV-infected people in need of care and to provide 
counselling on how to stay uninfected for persons who are tested negative. However, the client-
initiated testing model left many HIV-infected people in sub-Saharan Africa unaware of their 
HIV status, and many HIV-infected people were often diagnosed and received ART very late, 
with the consequence that many infected died soon after the HIV diagnosis [15].  
 
Consequently, in 2007, the WHO and the UNAIDS launched a new testing strategy; provider-
initiated, opt-out HIV testing [16]. With this model the health care provider should initiate HIV 
testing and counsel all people who seek any type of care, and the strategy has been implemented 
in most countries with a generalized HIV epidemic [2]. Arguments in favour of the opt-out HIV 
testing model suggest that it would increase the availability of testing services and reduce HIV-
related stigma since it would be part of routine care [17, 18]. A potential risk when moving 
from the opt-in- to the opt-out testing model might be that patients feel obliged to test without 
being mentally prepared to receive a positive HIV test result, or even worse, that people would 
be diagnosed but without medicines being available [19-21]. However, provider-initiated testing 
has increased HIV testing rates in many SSA countries [22-24].  
 
There are also other approaches employed to increase the number of people tested for HIV such 
as home-based HIV testing, that has shown testing uptake of 69-94% [25-27] and also resulted 
in persons with HIV being diagnosed earlier as compared to health-facility based testing [28]. 
 
Couple HIV testing is another testing model recommended by the WHO for settings with high 
HIV prevalence [29, 30]. The policy was formulated in 2002 and suggests that couples should 
be HIV counselled and tested together, especially during antenatal care (ANC) [31]. The 
guidelines are based on the assumption that couple testing would help increase spousal support 
for women to use prevention of mother-to-child transmission (PMTCT) services, create 
opportunities for secondary prevention by counselling both men and women about HIV, and 
increase the uptake of testing and identification of HIV-infected persons [31-33]. Studies from 
SSA and Europe have shown an association between male partner involvement in their wives’ 
ANC, couple HIV testing, and the pregnant women’s likelihood of accessing and completing 
PMTCT services [34-39].  However, the uptake of couple HIV testing during ANC in SSA has 
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so far been very low, only 5-12% of pregnant women are HIV tested with their spouses [35, 36, 
40-42].  
 
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV 
In 2010, an estimated 390 000 children became infected with HIV [2]. More than 90% of 
children living with HIV have acquired the infection through MTCT, which can occur during 
pregnancy, labour and delivery and the breastfeeding period. In the absence of any intervention 
the risk of MTCT is 15-26% peripartum [43-47], with an additional transmission rate of 1.57% 
or 0.51% per month of breastfeeding, depending on the woman’s immune status with CD4 cell 
count levels below or above 350/mm3 respectively [48].  However, by using available 
interventions for PMTCT and assuming that the woman completes all the PMTCT components, 
the risk of MTCT in high-income countries is about 1-2%.  
 
The PMTCT components are: provision of triple ARV therapy administered to HIV-infected 
women before, during and after delivery, Caesarean section, and provision of prophylactic 
ARVs to newborns and replacement infant feeding [49, 50]. Most women in SSA can not 
provide safe replacement feeding to their infants and are therefore recommended to employ 
exclusive breastfeeding [49].  
 
Despite the limited access in low-income settings to combination ARV prophylactic regimens 
and the capacity to provide Caesarean section and replacement feeding, the rate of MTCT can 
still be reduced to around 5%, provided that women are tested and enrolled in a PMTCT 
programme [51, 52]. In order to reduce the number of children being infected with HIV, the 
WHO and the UNAIDS have developed a Plan towards the elimination of new HIV infections 
among children by 2015, aiming at a reduction of mother-to-child transmission of HIV globally 
to less than 5% [53].  
 
An overview of ARV prophylactic regimens for PMTCT  
To provide a single dose of the ARV nevirapine (sd-NVP) to pregnant women at the onset of 
labour was in 1999 shown to be effective for PMTCT with a MTCT rate of 19% at six months 
post-partum [54]. Since then the ARV prophylactic regimens recommended for PMTCT has 
changed.  The WHO guidelines for PMTCT in low- and middle-income countries from 2006, as 
described in Table 1 below, stated that pregnant HIV-infected women with a WHO staging of 3 
or 4, or a CD4 cell count of < 200/mm3 should receive ART (for WHO staging see Appendix 
1). Women who were not eligible for ART should receive dual ARV prophylaxis of zidovudine 
(AZT) and lamivudine (3TC), as well as sd-NVP (for description of the ARVs, see Appendix 
2). Although, in case dual prophylaxis was not available, providing only sd-NVP was also 
recommended (Table 1). 
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Table 1. The 2006 WHO recommendations for ARV prophylaxis for PMTCT. 
Prophylactic ARV regimens for pregnant women who do not need ART for their own health 
Mother 
Antepartum AZT starting at 28 weeks of pregnancy or as soon as feasible 
thereafter 
Intrapartum sd-NVP + AZT/3TC 
Postpartum AZT/3TC for 7 days 
Infant 
 Irrespective of mode of infant feeding 
 d-NVP within 72 hours after delivery + AZT for 7 days 
  Reference: The WHO, Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards    
  universal access: recommendations for a public health approach. 2006: Geneva.  
 
In 2010, the WHO updated the PMTCT guidelines to the current recommendation summarized 
in Table 2. The major changes from the 2006 policy were the early initiation of ARV 
prophylaxis (from 14 weeks of gestation), the recommendation to use ARV prophylaxis 
throughout the breastfeeding period and the change in ART eligibility criteria, starting when the 
CD 4 cell countζ350 cells/mm3 [49].  
 
For women not eligible for ART for their own health, the WHO recommendations provide two 
options for ARV prophylaxis: 
Option A. AZT from 14 weeks, sd-NVP at onset of labour and AZT+3TC, 7 days postpartum. 
To breastfeeding infants NVP until one week after exposure to breast milk has ended.  
Option B. Triple ARV prophylaxis to the mother until one week after infant exposure to breast 
milk, infants NVP or AZT until 4-6 weeks.  
 
Table 2. The 2010 WHO recommendations for ARV prophylaxis for PMTCT. 
Two options of prophylactic ARV regimens for pregnant women who do not need ART for 
their own health 
Option A. Maternal AZT + infant ARV 
prophylaxis 
Option B. Maternal triple ARV 
prophylaxis 
Mother Mother  
Antepartum  AZT from 14 weeks of 
gestation and continued during 
pregnancy 
Triple ARV* prophylaxis from 14 weeks of 
gestation or as soon as feasible 
thereafter 
Intrapartum Sd-NVP + AZT/3TC Triple ARV* prophylaxis  
Postpartum AZT/3TC for 7 days Triple ARV* prophylaxis continued until 1 
week after infant exposure to breast milk 
has ended.  
Infant  Infant 
For breastfeeding infants 
Daily NVP for a minimum of 4 to 6 weeks, 
and until 1 week after exposure to breast milk 
has ended. 
 
Infants receiving replacement feeding only 
Daily NVP or sd-NVP + twice-daily AZT until 
4 to 6 weeks of age. 
Irrespective of mode of infant feeding 
Daily NVP or twice daily AZT from birth 
until 4 to 6 weeks of age. 
Reference: The WHO, Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants:  
recommendations for a public health approach, 2010: Geneva. *Recommended regimens include: AZT + 3TC +  
LPV/r or AZT + 3TC + ABC or AZT + 3TC + EFV or TDF + 3TC (or FTC) + EFV 
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The PMTCT services 
In order for the ARVs to realize their effects, they have to be delivered to, used and adhered to 
by the pregnant women. The ARV prophylactic regimens included in the PMTCT guidelines 
described above are based on studies that have shown the ARVs to be effective in prevention of 
MTCT. This has been shown in trial settings i.e. the efficacy of the ARVs has been shown. 
However, the effectiveness of the ARVs refers to the effect of the ARVs in a real-life situation. 
The effectiveness of an intervention is: “the impact an intervention achieves in the real world, 
under resource constraints, in entire population, or sub-population” has been described by Aral 
1998 [55].  
 
PMTCT are sequential interventions that should be implemented to reduce MTCT. First of all, 
it is crucial that all pregnant women receive ANC at health facilities, that they are also being 
HIV tested during ANC (either alone or couple tested), that they receive the test results, and 
thereafter, if identified as HIV-infected, receive ARV prophylaxis and are followed up together 
with the baby until 18 months after delivery. The HIV exposed baby should also receive ARV 
prophylaxis and be tested for HIV repeatedly until 18 months old (Figure 2). 
 
Figure 2. The PMTCT services 
 
Since the PMTCT services should be delivered to pregnant women, the services have been 
integrated with the regular ANC health services. However, there is a big discrepancy between 
the coverage of ANC- and PMTCT services in many low- and middle-income countries [56]. 
HIV testing is the first step in PMTCT, but only 42% of the pregnant women in SSA were 
tested for HIV in 2010 [2]. Although considerable efforts have been made to expand and 
integrate PMTCT programmes into ANC clinics [57], studies have shown that even if PMTCT 
treatment is available in the clinics, the uptake and completion of this intervention is very far 
from 100% [58, 59]. Moreover, the HIV-infected women should be linked to HIV-care and 
monitored regularly in order to receive treatment for other infections and ART when eligible 
[60]. 
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As illustrated in Figure 3, the coverage of ARV prophylaxis for PMTCT i.e. the proportion of 
pregnant women living with HIV who received prophylactic treatment, was 50% (60% if 
including sd-NVP) in low- and middle-income countries and only 42% of the HIV exposed 
infants received ARVs for PMTCT [2].  
 
Figure 3. Coverage of antiretroviral prophylaxis for prevention of mother-to-child transmission 
of HIV and the number of new HIV infections among children, low- and middle-income 
countries, 2003-2010 
 
a Coverage before 2010 includes single-dose nevirapine (sd-NVP), which is no longer recommended by WHO. Coverage in 2010 does not 
include sd-NVP [2] 
 
From Figure 3 it is evident that despite an increase in coverage from 10% to 60% (if including 
sd-NVP) between 2004 and 2009, the decrease in number of children infected with HIV for the 
same period was only from 500 000 to 400 000. The reason for this is the way PMTCT-service 
coverage is reported. Coverage is often overestimated as it is usually stated as the proportion of 
woman/baby-pairs that receive ARV prophylaxis [2]. This way of reporting coverage ignores 
whether the ARVs are taken as prescribed during and after labour and delivery, and whether 
exclusive breastfeeding is practiced (or alternatively, whether continued ARV during 
breastfeeding is practiced and adhered to). Since only the first step in the programme is 
reported, the effectiveness of PMTCT programmes might be significantly lower than reported. 
Also reporting might sometimes be of inadequate quality, for example, one study for Kenya 
further showed that routine PMTCT data was double reported and that women already 
identified as HIV-infected were excluded in the denominator, meaning that the PMTCT 
programme over-reported its coverage [61].  
 
Most research on the uptake of PMTCT services is from health facility based studies, while 
actual access to PMTCT services at population level has rarely been assessed [62, 63]. Health-
facility data on PMTCT uptake, in contrast to population-level data, do not cover all pregnant 
women; they do not include those who do not seek ANC at all or those that seek ANC at health 
facilities without HIV testing services. 
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GENDER AND HIV 
The term gender is often, in feminist theories, defined as a social construct of men and women 
and acknowledges the power-imbalances both on structural and individual levels. Gender 
systems are acted and enacted at all levels of society making it crucial to maintain a pluralistic 
viewpoint when studying gender power relations and their effects. Gender power-relations exist 
between men and women, between men and men and between women and women. Further, 
gender structures intersect with other social inequalities such as class and ethnicity that together 
form a complex web of power-relations that are manifested in structural inequalities in access to 
social, cultural and legal rights, as well as financial and other resources [64]. Gender is further 
socially constructed and re-constructed through people’s behaviour, and often holds certain 
characteristics that are (stereo-) typically associated with being a “man” or “woman”.   
 
Gender has been illustrated as a social determinant of health in a framework by Sen et al. 2010 
[65]. Sen (2010) reveals how factors at the individual and collective levels influence health 
outcomes differently for men and women. This framework also details the manner in which 
inequality is generated by gendered structural determinants and intermediary factors. Gendered 
structural determinants act on a higher level in societies and influence access to health care, for 
example, through access to education and political power. Intermediate factors influencing 
health outcomes are: discriminatory norms and behaviours such as stereotyping, influencing 
men’s or women’s ability or desire, to seek health care; or gender biased health systems that do 
not acknowledge gender when, for example, planning and implementing health services [65].  
Nearly 60% of people living with HIV in SSA are women [2]. In HIV prevention and care it is 
necessary to understand how gender dynamics influence men’s and women’s behaviours and 
their access to health services. Gender inequality and vulnerability to HIV infection are 
connected. For example, women are often unable to negotiate condom use with their male 
partners due to unequal power balance and culturally-prescribed expectations of gendered 
decision-making within the couple [66, 67]. Moreover, masculine ideals of having multiple 
sexual partners [68],  and the sometimes culturally sanctioned polygamous relationships or 
unfaithfulness for men, constitute an increased risk of acquiring HIV both for men themselves 
but also for their sexual partners [69].  
 
Women in SSA are more likely than men to be tested for HIV [2]. In South Africa females 
accounted for 65% of all testing even when HIV testing during pregnancy was excluded [70]. 
Hence, in SSA women are often the first in a couple to be tested for HIV and diagnosed with an 
HIV infection [71]. This means that women risk being perceived as the ones that “bring” HIV 
into the family and the disclosure of a woman’s HIV status to her male partner might lead to 
abandonment, a severe consequence since the man is most often the breadwinner in the family 
[71, 72]. The WHO has produced several publications proposing how gender should be 
acknowledged in HIV programmes and these include taking into account how gender norms 
influence HIV risk behaviours and access to care [73, 74]. Men on the other hand are often 
disadvantaged and excluded in HIV programmes [75]. 
 
HEALTH SYSTEMS AND POLICIES 
The WHO states that: “A health system consists of all organizations, people and actions whose 
primary intent is to promote, restore or maintain health [76]. This includes efforts to influence 
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determinants of health as well as more direct health-improving activities.” A crucial part of 
health systems are the health policies that could be defined in various ways but in this thesis a 
health policy is assumed “to embrace the courses of action that affect the different parts of a 
health system”, as described by Buse 2005 [77]. In addition, Walt suggests that health policy 
development should not only focus on the policy content but also on the actors involved in 
policy reform, the processes required for developing and implementing the policy and the 
context within which a policy is developed [78]. The major challenge for implementing health 
policies and tackling health problems in resource-poor countries is not the lack of effective 
interventions [79].  The reason is rather that services that have shown efficiency are not 
implemented, or made accessible, i.e. delivered through the health system. In fact, the primary 
obstacle to achieving many health goals in low and middle-income countries is fragile and 
fragmented health systems that are unable to deliver the health services [79].  
 
Further, the goal of a health system is to; “improve health and health equity, in ways that are 
responsive, financially fair, and make the best, or most efficient, use of available resources”. 
The building blocks of a health system could be divided into; service delivery, human 
resources, medicines and technologies, governance, information, financing and leadership, 
placing the people in need of the system in the middle (Figure 4) [76].  
 
Figure 4. The six building blocks of a health system, and the people it aims to serve  
 
Source: Systems thinking for Health System Strengthening, WHO 2010. 
 
 
In order to deliver health care in an effective way, policies are needed and have to be 
implemented so that good quality service delivery is ensured, and to achieve that strong global 
and national commitment, adequate financial resources, and intensive technical support are 
needed [80]. As early as 1978 the Alma Ata declaration emphasized the need for strong health 
systems in order to deliver health care for all by 2000 [81].  
Background 
26 
Health systems and HIV in sub-Saharan African 
The large increase in funding for the fight against HIV during the 2000 led to a rapid expansion 
of HIV care in SSA, and due to a weak health system in most of the highly affected countries, 
the HIV programmes often has been introduced parallel to the regular health system, i.e. as 
vertical programmes. A criticism of these vertical programmes has been that they might 
undermine rather than support national health systems by diverting away for example human 
resources from the regular health system [79, 82]. It has been argued that if certain conditions 
are looked at separately and parallel systems are introduced, it would result in, for example, 
higher costs (e.g. medicines delivered twice to the same place) [79], an internal brain drain, the 
recruitment of  health workers away from their regular work at the health facility to better paid, 
disease-specific programmes [83], or extra work for the health workers in terms of separate 
reporting systems for parallel programmes [79]. However, due to weak health systems there is a 
need to design effective programmes that balance a specific-disease focus with system-based 
solutions and there has been a debate as to whether HIV care should be provided through the 
regular health system or delivered vertically to the health system [80].  
 
Based on existing data, the effect of the introduction of HIV care on health systems is not 
entirely clear. One example of the effect on service provision after introducing HIV care is the 
quality of ANC that has in some settings been reported as increased [84], and in others 
decreased, after the PMTCT programmes have been implemented during ANC [85]. Similarly, 
in facilities with ART provision integrated with other health care services, an increase in 
workload has been shown [82].  In the light of the situation where there is a critical shortage of 
health workers in SSA, introducing ART for the millions of people in need requires remarkable 
efforts for the health systems to adapt [86]. The increase in HIV services has been hampered by 
the shortage of physicians and nurses and characterized by health workforce innovations such as 
task shifting, and task sharing [87, 88]. In some countries, for example, nurses and clinical 
officers can now prescribe and/or order new supplies of antiretroviral medication [89].  
 
Using parallel systems in the scale up of ART has been shown to increase fragmentation and 
complexity, affecting many areas of the health system [90]. Especially challenging is the 
governance since many actors, such as external donors are involved and coordination is often 
lacking [90, 91]. Different funding also makes the provision of ART complex at the health 
facilities, as several different ART programmes are sometimes run at the same facility [92]. In 
addition has adherence to treatment been reported to be worse at facilities with several ART 
programmes at the same time [82]. 
 
THE UGANDAN CONTEXT 
Uganda is situated in East Africa and has borders with the Democratic Republic of the Congo, 
Kenya, Rwanda, South Sudan and Tanzania.  
 
The Ugandan population is estimated to 32 million and has, at 3.2%, one of the highest annual 
growth rates in Africa. The total fertility rate in the rural areas is 6.7 children/woman [93].  
 
The majority of the population, 85%, lives in rural areas. Almost half of the population (49%) 
are aged 0-14 years and life expectancy at birth (females and males, years) is 56/55 years [1]. 
Some selected health outcomes in Uganda are presented in Table 3. 
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Table 3. Selected health outcomes in Uganda 
Indicator Measure 
ANC attendance at least once/pregnancya (%) 94 
Giving birth in a health facilityb (%) 
  Rural 
  Urban 
 
52 
90 
Total fertility rateb (number of children born/woman) 
  Rural 
  Urban 
 
6.7 
3.8 
Crude birth ratea  
(number of childbirths per 1000 people per year) 
45 
Exclusive breastfeedingb (%) 
  0-1 months 
  2-3 months 
  4-5 months 
 
82 
67 
39 
HIV prevalencec (%) 
  men  
  women 
 
8 
5 
Maternal mortality ratea (per 100 000 live births) 352 
Infant mortality rateb (per 1000 live births) 54 
Under-five mortality rateb (per 1000 live births) 90 
aUNICEF Levels & Trends in Child Mortality. UN Inter-agency Group for Child Mortality Estimation. Report 2011, 2011: New York b Summary 
of results from Uganda Demographic Health Survey, 2011, Pamela N Kakande, Uganda Bureau of statistics. c Ministry of Health and ORC 
Macro. Uganda HIV/AIDS Sero-behavioural Survey 2004-2005. 2006, Calverton, USA. 
 
The Ugandan Health System 
The provision of health services in Uganda is decentralized and health districts and sub-
districts are central in the delivery and management of health care provision. The District 
Local Governments plan, budget and implement health policies and health sector plans [94].  
The districts manage general hospitals and provide supervision and monitoring of all health 
activities (including those in the private sector) in their area.  
 
The public health services in Uganda are delivered through health centres (HCs), ranging from 
the lowest level HC IIs, to HC IIIs, HC IVs, District Hospitals, Regional Referral Hospitals and 
the National Referral Hospital. The health sub-districts are responsible for the health services at 
lower level health centres (II- IV) (Table 4).  
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Table 4. Organization of health service delivery in Uganda 
Health facility level Number of 
facilities 
Services available Location Catchment 
population 
National Referral 
Hospitals 
2  Comprehensive specialist 
services 
National 30,000,000 
Regional Referral 
Hospitals  
11 Specialist clinical services National 2,000,000 
General Referral 
Hospitals 
98 Maternity, inpatient health 
services, surgery, blood 
transfusion, laboratory 
District 500,000 
Health Centre IV  166 Maternity, in-patient health 
services, surgery, blood 
transfusion, laboratory.  
County  100,000 
Health Centre III  905 Laboratory services for 
diagnosis, maternity care 
and first referral level for 
the sub-county. 
Sub-county 20,000 
Health Centre II  1887 Outpatient care and 
community outreach 
services.  
Parish 5,000 
Health Centre I 
/Village Health 
Team  
Unknown No physical structure, only 
persons that function as a 
link between health 
facilities and the 
community. 
Village 1,000 
Source of data; Health Sector Strategic Plan II:  2005/06 – 2009/2010, 2004: Ministry of Health, Kampala, Uganda, and Health Sector Strategic 
Plan III: 2010/11-2014/15, 2010: Ministry of Health, Kampala, Uganda. 
 
Health-care services should be free of charge in all public health facilities, and user fees were 
abolished in 2001, except for the hospitals’ private wings [94, 95].  
 
ANC should be available at all levels of care and include a physical examination, the provision 
of necessary medicines, health education, and HIV counselling and testing, or HIV testing 
referral.  The Ugandan national guidelines recommend at least four ANC visits per pregnancy 
[96]. 
 
The private sector plays an important role in the delivery of health services in Uganda 
covering about 50%. The private health sector comprises of the Private Not for Profit 
Organisations (PNFPs), Private For Profit Practitioners (PFPs) and the Traditional and 
Complementary Medicine Practitioners (TCMPs).  
 
The PNFP sector is important in Uganda and more structured and mostly present in rural areas 
[95]. The PFP is fast growing and most facilities are concentrated in urban areas. TCMPs are 
present in both at rural and urban areas, even if the services provided vary considerably and 
range from traditional practices in rural areas to imported alternative medicines, mostly in 
urban areas. Although 72% of the households in Uganda live within 5km from a health 
facility (public or PNFP), utilization is limited due to poor infrastructure, lack of medicines 
and other health supplies, shortage of human resource in the public sector, and other factors 
that limit access to quality service delivery [94].The Human Resources for Health Strategic 
Plan estimates that for maintaining or slightly improving the health worker to population ratio 
until 2020, the health workforce will need to grow by 66% [97].  
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HIV and PMTCT in Uganda 
In Uganda HIV was first acknowledged by the Ugandan government in the late 1980s, and large 
information campaigns about HIV and HIV prevention, including HIV testing, have been carried 
out at all levels of the society [98].  The overall HIV prevalence in Uganda is estimated at 6%, 
and the HIV prevalence from the ANC surveillance in 2008/09 was estimated to range from 5-
10% [99, 100]. The HIV prevalence is higher in urban areas, especially in Kampala [100]. The 
epidemic has shifted from the single younger-aged individuals to older individuals aged 30–35 
years who are married or in long-term relationships. Multiple concurrent partnerships, extra-
marital relationships, discordance and non-disclosure are among the key factors driving the 
spread of HIV in Uganda [99]. In 2010, an estimated 47% of the HIV infected people in need 
received ART [2]. 
 
The last figures from Uganda show that 1.2 million people are infected with HIV, and 150,000 
of them are children below 15 years of age [2]. Of the about 90,000 new infections in 2008, 
almost 20,000 of them were in children from MTCT [101].  
 
Further, in the same year, of all new infections, 37% were attributable to multiple sexual 
partnerships including infections of their regular partners. Couples in mutually monogamous 
partnerships account for 35% of new infections and mother-to-child transmission accounts for 
18%. Commercial sex work (including partners of sex, workers, their clients and partners of 
clients) accounts for 9% of new infections. 
 
Despite a very high ANC-attendance rate of 94% in Uganda, only 10% of women who gave 
birth in Uganda were tested for HIV in 2003 [102]. Three years later, in 2006, the number of 
pregnant women receiving HIV counselling (40%) and testing (21%) remained at low levels 
[103]. However, the WHO and UNAIDS report that in 2011 63% of the pregnant women in 
Uganda were tested for HIV[2]. Despite an increase in coverage of HIV testing during 
pregnancy, it remained at rather low levels.  
 
To increase the coverage of HIV testing and PMTCT services, the Ugandan government 
launched two new policies in 2005 and 2006 respectively, moving from a client-initiated, “opt-
in” HIV testing model, to a provider-initiated, “opt-out” model. These policies mean that all 
patients visiting health care facilities in Uganda, and all pregnant women receiving ANC should 
be tested for HIV as long as they do not actively opt-out from it [104]. In the Ugandan PMTCT 
guidelines it is also stated that the pregnant woman’s partner should routinely be offered HIV 
testing during ANC [105]. If HIV testing services are not available at the ANC health facility 
where the woman seeks ANC, the woman and any accompanying spouse, should be referred for 
testing to a nearby health facility with testing equipment [104].  
 
The ARV prophylaxis recommended for PMTCT in Uganda for women not eligible for ART, 
during 2008-2010, was a dual regimen of AZT and 3TC, given to HIV-infected pregnant 
women from 28 weeks and until one week after delivery, plus sd-NVP during delivery. 
However, only sd-NVP was also provided in some cases, especially from the lower level health 
facilities.  The infants born to HIV-infected mothers received either sd-NVP after birth and 
AZT for one week after delivery, or only sd-NVP. Women were considered to be eligible for 
ART if their CD4 cell count was ζ350/mm3 or if they were diagnosed to be in WHO staging 3 
or 4, irrespective of CD4-count [104].  
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The PMTCT guidelines were modified in 2010 to the WHO Option B, as described previously. 
However, since there have been problems with procurement of ART in Uganda, these 
guidelines have not yet been introduced on a large scale (personal communication, PMTCT 
officer, Ministry of Health). The estimated uptake of ARV prophylaxis in Uganda was 42% 
among women (sd-NVP excluded) and 22% among infants [2]. 
 
The Ugandan policy states that all pregnant women should receive ANC at least four times per 
pregnancy. The pregnant women are also encouraged to bring their partner, or a family member 
to at least one visit. The goals of the ANC visits are to conduct a risk assessment, provide health 
education, and monitor the progress of the current pregnancy and plan for delivery. Medical, 
surgical, obstetric and gynaecological history is taken, physical examination and laboratory 
investigations, and health promotion is carried out, including nutrition, hygiene, pregnancy 
danger signs malaria prevention, HIV testing and if testing is positive, PMTCT should be 
offered [96].  
 
ACCESS TO HEALTH SERVICES  
Access to health care can be defined in many different ways and several theoretical models have 
been developed to explain access to health care services. Some of the models focus on the 
behavioural aspect, such as the Health Belief Model [106] while others focus more on physical 
and/or geographical aspects of access. 
 
No particular theoretical model was to guide the design and the development of the studies in 
this thesis instead the work was guided by the research questions and aims. However, during the 
course of this PhD work several theoretical models related to access to health care have been 
reviewed and some will be introduced briefly. One model (McIntyre’s) was found to be 
particularly useful when discussing the results and will be presented more thoroughly.  
 
A summary of some theoretical models related to access to health care 
The Health Belief Model was developed in 1966 to study and promote uptake of health 
services, and focused on the psychological and behavioural aspect of access to services [107]. 
The model explains behaviour and uses two kinds of variables; (i) the psychological state of 
readiness to take a specific action, and (ii) the belief that the action would be beneficial in 
reducing the threat (disease). Readiness to act depends on the individual’s perceived 
susceptibility and perceived seriousness of a disease, and the perceived benefits and barriers of 
taking action. For a person to act there is a need for “cues to action”. Those cues could be 
internal, e.g. the bodily state, or external, e.g. media communication. In terms of access to 
services, this model focuses on the individual perception of taking action and the way that 
individuals could be influenced to take action.  
 
The first Behavioural Model for access to health care was developed by Andersen in 1960 and 
the model focuses on the use of health services and was created to assist the understanding of 
why people seek health services [108]. The model has since then been revised several times by 
Andersen and colleagues. In the model Andersen illustrate how certain population 
characteristics and health care system characteristics, influence the access to, i.e. the use of 
health services.  
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Population characteristics: 1. Predisposing factors- socio-demographic factors, e.g. age; social 
structure, e.g. education; health beliefs, e.g. knowledge about health and health services. 2. 
Enabling resources- e.g. economic resources, 3. Need- self decided, or evaluated, based on 
judgment from medical professionals.  
The health care system characteristics: 1. Policy- available and implemented. 2. Resources- 
funding, health workers, medicines etc. 3. Organization- of the way the care is organized and 
delivered at the health facilities and the organization of care at higher level.  
 
Access model by McIntyre, building on the Penchansky model 
Access to health care has been defined by McIntyre et al. 2009 as; the empowerment of an 
individual to use health services [109]. They emphasize the need to take into account the degree 
of fit, the interaction, between on the one hand the health systems and on the other hand the 
individuals, households and communities. Each of the three dimensions of access that will be 
presented in detail below. This definition of access builds on the Access model described by 
Penchansky et al. 1981 who define access as a concept representing the degree of fit between 
the clients and the system [110]. The dimensions included in Penchansky’s model are: 
availability, affordability, acceptability, accommodation (organization of services e.g. 
appointment system, opening hours and walk-in facilities) and accessibility (the geographical 
location). The McIntyre model combines Penchansky’s definitions of accommodation, 
accessibility and availability, into the broader definition of availability. However, the main 
difference between Penchansky’s model and the McIntyre one is that the latter focuses on the 
inter-relationship between the three dimensions. McIntyre et al. further acknowledge the total 
cost in the dimension affordability and include e.g. transportation cost.   
 
The three dimensions of McIntyre’s model of access and the factors that they build on are: 
1. Availability (physical access): the appropriate heath care providers or services, supplied 
in the right place and at the right time to meet the prevailing needs of the population. 
This dimension includes issues like: the fit between the quality/type/range of health care 
services and the extent of health needs among the individuals; the fit between location of 
health care facilities and the individual’s ability to get to that location to receive care; 
ability/willingness of health care provider to give the services, or the fit between the 
opening hours and the time the population need the services.  
2. Affordability (financial access); the degree of fit between full costs (including “under-
the-counter” fees, transportation costs, income loss due to waiting time etc.) to the 
individual of using the services and the individual’s ability to secure funds from the 
household budget and other demands on that budget. The concept of affordability goes 
beyond “ability to pay”.  
3. Acceptability (cultural access): related to the fit between provider and patient attitudes 
and expectations of each other. The ability to receive care would depend on the health 
care provider’s attitudes towards the individual’s characteristics e.g. gender, age, 
ethnicity, and the individual’s attitudes towards provider characteristics, e.g. type of 
provider, age gender. Beliefs and perceptions, and past experiences are also part of this 
dimension.  
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The definition of access used in this thesis is McIntyre’s presented above. This definition was 
chosen due to the broad definition of access where the interaction between the health system 
and the individuals are emphasized.  
 
RATIONALE FOR THE STUDIES 
Effective interventions are available to prevent children born to HIV-infected women from 
contracting the virus. Moreover, most pregnant women in Uganda, over 90%, attend ANC 
services at least once during pregnancy. Hence, the ANC health facilities provide a great 
opportunity to deliver PMTCT services and an obvious aim should be to reach all women 
attending ANC with PMTCT services.  
 
However as described in the background to this thesis: the aim is a long way from being 
achieved. Further, Uganda has one of the highest fertility rates in the world of almost 7 
children/women in rural areas. Hence, many women do not access PMTCT services and 
consequently avoidable HIV infections among children are occurring and HIV-infected women 
are unidentified and/or untreated.  
 
Very few studies internationally have investigated the actual uptake and completion of PMTCT 
services at population level. National estimates of coverage are usually based on the enrolment 
rate of pregnant women into PMTCT at the health facility level, but whether or not the woman 
completes all steps in the programme is not known [111].  
 
Uganda’s HIV preventive policies have been recognised for speaking openly about sexual risk 
behaviours and for taking action early on in the epidemic. However, many children are still 
being born with HIV in Uganda. Understanding what factors contribute to access and 
completion of PMTCT services at population level is therefore crucial.  
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OBJECTIVES  
GENERAL AIM 
The aim is to determine access to Prevention of Mother-to-Child Transmission (PMTCT) 
services and to identify barriers to and facilitators for accessing these services.   
 
 
SPECIFIC OBJECTIVES 
1. To explore pregnant women’s views on routine opt-out HIV testing during antenatal 
care (Study I) 
 
2. To explore men’s views on couple HIV testing during pregnancy (Study II)  
 
3. To assess the population HIV testing coverage during pregnancy, and examine risk 
factors for not being tested for HIV (Study III) 
 
4. To estimate the number of children infected with HIV with current PMTCT coverage 
(Study IV) 
 
5. To model the effect on HIV infections among children when increasing the coverage of 
individual PMTCT programme components (Study IV) 
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MATERIALS AND METHODS 
OVERVIEW OF STUDIES 
This thesis builds on both qualitative and quantitative research methods, where the method 
chosen for each study was guided by the specific objectives. 
In Study I, semi-structured interviews and sit-in observations were used to get an in-depth 
understanding of the women’s perceptions about opt-out HIV testing during pregnancy.  
 
Study II explored men’s views on couple HIV testing during pregnancy through semi-
structured interviews, and focus group discussions.  
 
In Study III, questionnaire-based interviews were employed, together with health facility 
record review, in order to quantify the HIV testing coverage during pregnancy, and to determine 
risk factors for not being tested for HIV during pregnancy. 
 
Study IV employed the same survey and record review data as in Study III. Thereafter the 
dropout at each step in the PMTCT programme was identified through record reviews and semi-
structured interviews and the number of children infected due to the dropout was estimated. The 
number of HIV-infected children was then estimated for scenarios that assumed an increase in 
coverage of individual PMTCT components.  
 
Figure 5. Summary of objectives, materials and methods 
 
*HDSS: health and demographic surveillance site 
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In addition to the methods described above, field observations during the whole data collection 
period were conducted together with formal and informal key-informant interviews with local 
health officers, HIV programme coordinators, health workers and community members. This 
provided a good understanding of the context in which the studies were conducted and of the 
results.  
 
This thesis as part of the ARVMAC project 
The research for this thesis were conducted within the project; “Effects of Antiretrovirals for 
HIV on African health systems, Maternal and Child Health” (ARVMAC), in part supported 
by the European Community’s FP6 funding 2006-2010. The main objective of the project was 
to assess the effects of the rapid scale-up of ART on resource-limited health systems, maternal 
and child morbidity and mortality. The research was carried out in three Health and 
Demographic Surveillance Sites: Iganga-Mayuge (Uganda), Nouna (Burkina Faso) and Rufiji 
(Tanzania).  Along with the Karolinska Institutet, Sweden, which acted as coordinator, the 
project partners were Makerere University School of Public Health, Uganda, the Swiss Tropical 
and Public Health Institute, Switzerland, the Ifakara Health Institute, Tanzania, the Institute of 
Tropical Medicine, Belgium, University of Heidelberg, Germany, and the Nouna Health 
Research Centre, Burkina Faso [112]. 
 
STUDY SETTING 
Iganga and Mayuge districts  
All studies in this thesis have been carried out in Iganga and Mayuge districts situated in 
Eastern Uganda (Map 1). Both districts are mostly rural, except Iganga Town, which is semi-
urban, and the major source of income is subsistence farming, along with fishing in Mayuge, 
which is located on the shores of Lake Victoria. In 2008, Iganga had a population of about 710 
000 inhabitants and Mayuge 430 000. In the last district ranking on performance in health 
management and service delivery, Iganga ranked 53, and Mayuge 61 out of the 80 districts in 
Uganda [99]. Iganga has 81 health facilities, and Mayuge 38. In Iganga and Mayuge 
respectively, 30% and 23% of pregnant women deliver at a health facility [99]. The HIV 
prevalence for the Basoga, the ethic dominant group in the area, is 5.6% for women 15-49 
years and is lower than the Ugandan average for women of reproductive age (7.5%) [100].   
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Map 1. Uganda with Iganga and Mayuge districts highlighted 
 
 
Iganga/Mayuge Health and Demographic Surveillance Site 
To assess the health in a community in settings where health data are not available is a 
challenge. Cross-sectional assessments could be somewhat useful but they cannot provide a 
longitudinal perspective on the health in the community [113]. Health and demographic 
surveillance sites (HDSS) is a methodology that routinely (several times per year) collect 
detailed data on demography, health, and death, including births and migration in a well-
defined population. HDSSs are useful in resource-poor settings without appropriate 
monitoring of health [114].  
The area of the Iganga/Mayuge HDSS is 155km2, and constitutes a defined area in parts of in 
Iganga and Mayuge districts. The HDSS population is about 70 000 persons living in about 
12000 households in 65 villages. In Iganga/Mayuge HDSS the population is followed up 
regularly two times per year. In addition, special studies are carried out for specific research 
studies. The main source of income in the area is subsistence farming [115].  Malaria is endemic 
in the area.  
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Health system in the study area 
Within the HDSS area there is one district hospital, four government HC IIIs, five government 
HC IIs and three non-governmental organization HC IIs. In addition, there are a number of drug 
shops, small private clinics, and traditional healers operating in the area.  
 
At the time of the studies, ANC was offered at all health facilities, HIV testing services was 
available at one third of the facilities and other PMTCT-, and ART services available at around 
half of the facilities.  
 
The ARV regimen used at lower level health facilities in the two districts was sd-NVP, while 
the hospital provided either sd-NVP or dual ARV regimen, or triple drug ARV for women 
eligible for that for their own health (WHO 2006 guidelines).  
 
STUDY PARTICIPANTS AND DATA COLLECTION  
Qualitative (Study I and II) 
Semi-structured interviews and sit-in observations (I) 
In Study I both open-ended semi-structured interviews [116] and sit-in observations were used 
[117]. Interviews used in qualitative research are usually conducted to get the personal view on 
a phenomenon [117]. A topic guide was used with areas that the interview should cover, and 
probes were often posed to follow up on issues that came up during the interviews (Appendix 
3). The sit-in observations were conducted to observe the group counselling sessions and to 
investigate the issues that came up in the interviews [117]. The interviews aimed to investigate 
pregnant women’s experiences of provider-initiated HIV testing [31],  and data collection took 
place between February and March 2008. In total 18 women were interviewed. To get the views 
of women who sought ANC from different level of care, the respondents were recruited from 
three purposely-selected health facilities: one district hospital (n=10), one HC III (n=6) and one 
HC II (n=2). The hospital and the HC III offered HIV testing services during ANC on-site while 
the HC II was supposed to refer the pregnant women for HIV testing. Purposive sampling was 
performed in order to obtain the views of both first-time pregnant women (n=4) and women 
who had been pregnant before (n=14), as well as women with unknown (n=10) and confirmed 
HIV infection (n=8). The interviews were conducted in a separate room at the health facilities. 
The interviews were carried out in the local language Lusoga by one of two Ugandan female 
sociologists who both had previous experience of qualitative- and HIV research, and lasted for 
about 40 minutes. Interviews were audio-recorded, and thereafter translated and transcribed in 
English. 
 
The sit-in observations during ANC were performed at all three health facilities to observe the 
organization of PMTCT services and the content of the pre-test counselling. I personally, 
together with one interviewer, observed the pre-test counselling sessions during six days, two in 
each facility and was done during the same days as the interviews were performed.  
 
Focus group discussions and in-depth interviews (II) 
In Study II, the study participants were men from both rural and semi-urban locations, who had 
had a child in the past year. Data were collected at two time points: four focus group discussions 
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(FGDs) [31, 117] were conducted in April 2008, and five FGDs and 13 in-depth interviews 
were held in April 2009. This iterative process made it possible to review and carry out 
preliminary analysis from the first phase, before the second phase data collection, and enabled 
us to then explore emerging themes and issues more in detail. FGDs are group discussions that 
aim to explore specific issues, and the participants should discuss and interact with each other, 
not simply answering one by one to questions posed by the moderator. FGDs usually capture 
the norms and behaviours in a certain setting [118]. There were about 10 participants in each 
FGD, and the discussions were homogenous with respect to place of living (rural and semi-
urban), age and number of children (or length of marriage in 2009). Data were collected until 
saturation was achieved, meaning that in relation to the research questions issues and themes 
were repeated. In 2008 and 2009, all FGDs included both men who had, and who had not been 
HIV tested. FGDs were held at times and venues that were considered convenient by the 
participants, usually under a big tree in the middle of the village.  
Study participants were recruited by a Ugandan research assistant together with a local political 
leader (local council chairperson), who went around in the community to find eligible men, for 
example at people’s homes and at places where people normally gather. Recruitment took place 
at different times of the day to get both those who worked outside the home and farmers 
working at home. The study specifics were explained to eligible men and they were invited to 
participate.  
 
The in-depth interviews were conducted after the FGDs in order to explore personal experiences 
around HIV and HIV testing, and to follow up on issues that had been identified during the 
FGDs. Eligible men were those who had had a child within the past year, and men were selected 
from both rural and semi-urban settings, as well as men with different experiences of HIV 
testing:  HIV tested during ANC, HIV tested but not during ANC, and never HIV tested. The 
interviewer, together with persons well known in the communities, recruited eligible men from 
their homes, or work places. The interviews were held at times and places that ensured privacy 
and that were convenient for the respondents, typically at their home or work place. 
 
During both the semi-structured and in-depth- interviews as well as during the FGDs, I was part 
of the recruitment process, and present in the field to support and supervise the interviewers and 
field assistants.  
 
The data collection tools used in interviews and discussions were topic guides modified 
according to each data collection method, as well as to the type of respondents in the interviews 
(Appendix 4). The topic guides comprised key areas such as views and experiences of couple 
HIV testing during ANC and HIV testing in general, experiences and perceptions of ANC 
attendance, and factors hindering or facilitating couple testing and ANC attendance. One male 
and one female sociologist collected data in the local language, Lusoga. FGDs and interviews 
were audio-recorded, and thereafter translated and transcribed in English. A note-taker 
participated in the FGDs to capture the group dynamics, gestures, and emotions of participants.  
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Quantitative (Study III and IV) 
Population-based survey, and record review at health facilities (III and IV) 
Study III and IV are based on data from a population-based cohort of pregnant women recruited 
within the HDSS, and record reviews at health facilities, and determined the population dropout 
from the PMTCT programme (III, IV). In addition, by using the population data combined with 
data from the districts the estimated number of HIV infected children with base-case PMTCT 
coverage was estimated. Further the number of HIV infected children was estimated for 
scenarios that assumed an increase in coverage of individual PMTCT components. (IV).  
 
As part of the regular HDSS data collection, all households were screened for pregnant women 
in May-July 2008, and a list of all (n=881) pregnant women was compiled. The data collection 
tool, a questionnaire [119], was translated into the local language Lusoga, and piloted on eight 
women. Thereafter minor changes were made to clarify some of the questions. Four female 
field-assistants were specifically trained on how to ask questions about pregnancy and HIV, and 
how to use the tool (Appendix 5).  
 
Within 2-6 weeks after the initial HDSS screening, the field assistants followed up all pregnant 
women in their homes. The study particulars were explained to the women, they were asked to 
participate in the study, and all of them agreed to do so. The questions asked included personal 
characteristics, ANC attendance, health facility where ANC was sought, transportation to health 
facility, and care received during ANC.  
 
After the HDSS data collection, the health facilities where the women had reported to seek 
ANC were visited for record review, and data were collected on ANC received, including HIV 
testing. The data were collected my myself and two trained field assistants with experience from 
the ANC records, the women were identified in the records by using HDSS information such as 
names, age, expected time of delivery, home village and name of spouse. The data collected in 
the HDSS and at health facilities were then linked to core HDSS demographic data for each 
respondent. 
 
Semi-structured interviews with HIV-infected women (IV) 
In addition to the HDSS and health facility data, for Study IV home-based, semi-structured 
interviews were conducted with HIV-infected women identified at the health facilities. 
Interviews were carried out 12-20 months after giving birth, using both closed- and open-ended 
questions to explore the dropout and reasons for dropout from the PMTCT programme. A 
Ugandan midwife with long experience from PMTCT carried out the interviews. 
 
Secondary data (IV) 
To estimate the number of HIV infected children, the most recent data on MTCT rates from the 
UNAIDS were used [48].  
 
DATA ANALYSIS 
Qualitative content analysis (I and II) 
The data used in Studies I and II, were analysed using latent content analysis as described by 
Graneheim and Lundman [120]. Content analysis could be of two different kinds, manifest or 
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latent, where the visible and obvious content is referred to manifest content, and what the text 
talks about, or the underlying meaning of the text is named latent content. I used the latter, and 
interpreted the data on a deeper and higher analytical level than the manifest analysis would do 
[120]. This method was employed to understand women’s different experiences and perception 
on provider initiated, opt-out HIV testing during ANC (Study I), and men’s views on couple 
HIV testing during ANC (Study II).  
 
The analysis procedure was the following: it started already in the field when the research team 
discussed each interview/FGD, later all transcripts were first read several times, thereafter so-
called meaning units were identified and labelled with codes [120, 121]. The codes were 
compared for similarities and differences, and grouped into categories on a descriptive level. 
The categories were subsequently interpreted for the latent meaning and organized into themes. 
This type of content analysis also share similarities with what is described by Hsieh as 
“Conventional Content Analysis” [121], since the research was inductive rather than deductive, 
and started with a research question. 
During the data collection, discussions about the content were held and helped to establish when 
saturation had been reached.  
Initial coding was done manually on paper copies of transcripts, and thereafter in Study II, 
handled and organized using Nvivo software 8.0.  
 
Statistical analysis (III) 
The data were double entered in SPSS software [122], merged using STATA software [123], 
and linked to demographic data from the HDSS database using the women’s HDSS identity 
numbers. For data analysis STATA software was used [123]. 
 
Main outcome: Not tested for HIV during current pregnancy 
Based on existing literature, various potential risk factors for not being tested for HIV were 
identified. For the data analysis, the risk factors were preliminarily divided into the groups 
described below, and the variables presented for each of them, and individually examined for 
their relation the outcome. 
 
Risk factors examined: 
x Age was grouped into <21, 21-34, and >34 years, since young and mature-age women 
would have different childbirth experiences. 
 
x Occupation was categorized into ‘farmers versus other’. 
 
x Number of living children was grouped into 0-4 children versus >4, and based on a 
median number of 4 children. 
 
x Spousal support, women’s self-report, the variable was dichotomized into yes or no 
according to whether their partner attended ANC.  
 
x Socioeconomic status (SES) data derived from the HDSS that maintains asset-based SES 
data on each household as wealth quartiles generated from principal components 
analysis [124-126]. The two lowest quartiles were then grouped into “poorest women”, 
and the highest two into “least poor women”, due to similar associations with the main 
outcome for these categories. 
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x Person advising woman to seek ANC; women were asked if anyone advised them to 
seek ANC. This variable was categorised into: own initiative; husband; mother/ mother 
in-law; other.  
 
x Adherence to national guidelines for ANC: the number of ANC visits was used as a 
proxy for this and grouped into 1, 2 or 3 and more times. 
 
x Seeking ANC late was defined as the dichotomous variable attending ANC for the first 
time after the sixth gestational month.  
 
x Type of facility where women sought ANC: this was examined through two variables, (i) 
level of care, and (ii) the dichotomous variable “whether the facility had onsite HIV 
testing services”, yes/no. 
 
x Distance to the facility where woman sought ANC, this distance variable was 
categorized into three equally large groups; 0-1; 2-3, and >3 kilometres.  
 
x Distance to nearest facility with onsite HIV testing, initial categories 0-1 kilometres and 
2-3 kilometres were merged due to their similar associations with the main outcome, 
and the analysis included and the dichotomous variable 0-3 km and >3 km.  
 
The distance from home to the nearest ANC health facility and to the nearest facility with onsite 
HIV testing, was estimated using GPS coordinates of households and health facilities to 
calculate the shortest distance [127]. 
 
During an initial descriptive analysis, chi-square statistics were used to compare the distribution 
of the independent variables for not being tested for HIV. Though we grouped the factors as 
described above, their association with the outcome was independently assessed.  
 
The association between the outcome and independent variables was first assessed by 
calculating bivariate relative risk estimates. Independent variables with a p-value <0.25 in 
bivariate analysis were tested in the multivariable model, using a backward selection procedure.  
 
The multivariable analysis indicated interaction between  SES and  number of living children on 
the outcome “Not being tested for HIV”. Hence, the subsequent analysis was stratified by SES.   
In the final multivariable models variables were considered statistically significant if the 
adjusted p-value was <0.05. 
 
Decision tree analysis (IV) 
Decision tree analysis was carried out to estimate the number of children infected with HIV at 
birth and at six months post-partum in the Iganga and Mayuge districts in 2008. In order to 
estimate these numbers, population-based data derived from the women in the HDSS cohort 
were analysed using frequency tables for the proportion of women covered by each stage of the 
PMTCT programme (Table 5).  
 
The HIV prevalence used was 3.5%, based on the HIV prevalence found in in the HDSS cohort.  
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These data were combined with the most recent UNAIDS estimates of MTCT for different 
ARV prophylactic regimens, as well as different feeding practices, and subsequently entered as 
probabilities in a decision tree analysis created in Microsoft Excel (Table 5) [48].  
 
Table 5. Decision tree analysis input 
Data from the HDSS-cohort (base-case) on probability of coverage 
for individual PMTCT programme components   
Components Probabilities 
ANC attendance 0.96 
Attending ANC at a facility with HIV testing services  0.78 
HIV tested (attending ANC at facility with HIV testing services) 0.85 
HIV tested (attending ANC at facility without HIV testing services) 0.06 
HIV prevalence 0.035 
 HIV-infected women/baby pair receiving any ARV prophylaxis  0.83 
       Mother ARV prophylaxis -sd-NVP 
       Mother ARV prophylaxis -dual prophylaxis AZT and 3TC 
       Mother ARV prophylaxis –ART (for her own health) 
0.33 
0.57 
0.10 
 Women practicing safe infant feeding  0 
HIV mother-to-child transmission ratesa  
Peripartum transmission rates for different ARV regimens
 No ARV prophylaxis 0.22 
sd-NVP 0.12 
Dual prophylaxis of AZT and 3TC 0.04 
ART for her own health  0.02 
Postpartum transmission rates per month of any breastfeedinga (mixed or exclusive) 
Mother’s CD4 cell count ζ350/mm3 0.0157 
Mother’s CD4 cell count >350/mm3 0.0051 
If mother receive ART for her own health  0.002 
a UNAIDS Reference Group on Estimates Modelling and Projections, Working Paper on MTCT transmission rates for use in Spectrum, 2011, 
UNAIDS: Geneva. 
 
The MTCT rates for the different ARV prophylaxis regimens are based on the WHO 2006 
guidelines. The MTCT rate for women receiving ART reflect a situation where the woman 
started ART during pregnancy and would continue ART during the breastfeeding period.      
 
The total population in Iganga and Mayuge districts in 2008 was 1 140 000 individuals [99]. 
Among them an expected 51 300 women were pregnant and 1796 women were HIV-infected 
based on the Ugandan crude birth rate of 45/1000 and the HIV prevalence 3.5% found in the 
HDSS cohort [103].  
 
The estimated number of HIV-infected children at birth and at six months MTCT rates were 
calculated for the base-case, i.e. the number of children estimated to be infected when using the 
uptake of PMTCT services found in the HDSS cohort, presented in Table 5. 
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Scenarios assuming an increased coverage of PMTCT components  
Different scenarios where the uptake of individual or combined PMTCT programme 
components were assumed to be increased as compared to the base-case situation, were 
analysed in a decision tree analysis. 
  
For each scenario the number of HIV-infected children as well as the MTCT rates at birth and at 
six months were estimated. Further, the effect of each scenario was illustrated by comparing it 
to the base-case, and the relative effect on the number of HIV-infected children was estimated.  
 
In addition, the number of HIV infected children for a scenario assuming that no one would 
receive any PMTCT service at all was estimated. This scenario was used to calculate the 
reduced MTCT with the base-case PMTCT coverage.  
 
The effectiveness was estimated for the following scenarios, assuming the base-case PMTCT 
coverage but additionally with:  
x an ANC attendance of 100% 
x an uptake of HIV testing of 100%  
x provision of ART throughout pregnancy and the breastfeeding period to the HIV-
infected women receiving ARV prophylaxis (83%)  
x an Optimal scenario, combining all the above  
x an OptimalPlus scenario where uptake of ART was increased from 83% to 100% 
 
In the above presented scenarios, the coverage of all other PMTCT components were kept at the 
base-case coverage level that was presented in Table 5 previously.  
 
FIELD WORK  
The studies in this thesis were part of the ARVMAC project described previously. Being part of 
the larger consortium during my doctoral education was an advantage and offered collaborative 
work with experienced researchers from various institutions and coordination of research 
activities in the field. A possible disadvantage was that data collection was delayed at one point 
due to coordination with other activities within the project. Nevertheless, I have for the most 
part been able to carry out my studies as planned.  
 
During the course of this PhD work, I have had the opportunity to spend approximately one 
year in Uganda, something that gave me a deeper understanding about the community and 
context where the studies were conducted. It also gave me an opportunity to spend time at the 
School of Public Health at Makerere University and exchange idea and experiences with my co-
supervisor, other researchers and PhD student colleges, as well as participate in local research 
related activities such as conferences. 
 
For all four studies I was responsible for the planning, development of the tools, and 
implementation and I applied for and obtained the ethical clearance.   
Study II was initiated by me, and came about as a result of the findings from Study I. For Study 
I and II, I together with Ugandan research assistants conducted the training of interviewers and 
moderators. Data collection was thereafter conducted in the local language. During the data 
collection period I was present in the field and participated in some of the FGDs, but was not 
part of the interviews. However, I led the meeting that followed up on all 
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interviews/discussions, where the data collection was discussed with the research assistants as 
part of the analysis and evolvement of the studies.   
 
For Study III and IV, I led the development of tools, supervised the training and carried out the 
data collection together with the HDSS staff. I together with research assistants visited all health 
facilities and many drug-shops, traditional births attendants and private clinics in Iganga and 
Mayuge districts in order to conduct the record reviews and learn where pregnant women 
sought ANC. 
 
In addition to the planning and data collection I was also responsible for data analysis, and 
manuscript writing.   
 
ETHICAL CONSIDERATIONS 
The National Council of Science and Technology, Kampala, Uganda approved all studies in 
2008, reference number for the approval is IRB 00011353, protocol 052.  
All participants included in the studies were first informed about the studies and after that gave 
their written or verbal consent to participate in the studies.  
 
In addition to asking for consent to interview the women in the HDSS, the interviewer also 
asked for consent to retrieve additional information from the HDSS database and from the 
health facilities where the women had sought ANC.  
 
The women identified as infected with HIV were home-visited by a specifically trained midwife 
and asked questions about their experiences and views on the PMTCT programme, and if they 
had dropped out from any of the steps within the programme.  
 
The home visits were carefully planned together with experienced staff at the health facilities. 
The midwife who conducted the home visits also visited neighbouring households and informed 
them about child health in general in order not to draw attention to households where the HIV-
infected women lived. This was done to avoid stigma, since visiting only households where the 
HIV-infected women lived might have caused suspicion among the neighbours. All HIV 
infected women who were home visited were encouraged to go to the nearest health facility to 
receive appropriate care.   
During the FGDs and semi-structured- and in-depth interviews, questions about HIV and HIV 
testing came up, and the moderator or interviewer answered all questions after the group 
discussion or interview. 
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RESULTS  
This section presents the crosscutting results on access to PMTCT services combining results 
from all studies (I, II, III, IV), as well as unpublished data.  
 
COVERAGE OF HIV TESTING FOR PREGNANT WOMEN (III) 
The coverage of HIV testing during the current pregnancy in the HDSS cohort was  
64%. Figure 6 below illustrates how women in the cohort dropped-out from ANC- and PMTCT 
services.  
 
Almost all women in the cohort, 96%, sought ANC at least once, and the majority (78%) of the 
women identified in the health facility registers (n=544) had attended a facility with onsite HIV 
testing services.  
 
For the women who attended a facility with HIV testing services, uptake of HIV testing was 
85%. By contrast, only 6% of the women who sought ANC from a health facility without onsite 
testing had followed through on a referral and been tested elsewhere.  
 
Figure 6. Study participants in Study III and IV 
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Coverage of HIV counselling 
Among the women who received ANC from a health facility without testing services, only 20% 
had been counselled about HIV, or counselled and tested, as compared to 96% among women 
attending a facility with testing services (Figure 7). 
 
Figure 7. Percentages of pregnant women being counselled and tested for HIV by type of health 
facility where women sought ANC 
 
* Informal facility: Traditional birth attendant or drug shop reported as facility where women sought ANC 
 
CHALLENGES TO HIV TESTING DURING PREGNANCY (I, III) 
Distance, poverty and pregnancy experience (III) 
Risk factors for not being tested for HIV during pregnancy were assessed among the women in 
the HDSS cohort (III). The bivariate analysis found that the risk factors for not being tested for 
HIV were: being a farmer, being poor, having more than four living children, seeking ANC late 
(first visit later than gestational month six), living more than 3 kilometres from a facility with 
onsite HIV testing (all, p<0.25). 
 
When applied in a multivariable model using a backwards selection procedure, the final 
multivariable model included, age, socio-economic status (SES), number of children and 
distance to a health facility with HIV testing services. However, since a statistically significant 
interaction (effect modification) between the variable “number of children” and SES was 
observed, the analysis were stratified by SES. 
 
The only significantly associated variable for the poorest women was living more than three 
kilometres from a health facility with testing services (aRR 1.44, 95% CI 1.02-2.04). For the 
least poor, the variables significantly associated with the outcome were: having more than four 
children (aRR 1.77, 95% CI 1.00-3.16) and living more than three kilometres from a health 
facility with testing services (aRR 1.72, 95% CI 1.12-2.63)  
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Those women who had not been HIV tested had an average distance of 3.5 kilometres to the 
nearest testing facility, compared to 2.8 kilometres among women who had been tested (t-test, 
p<0.01). Moreover, the poorest women had 3.5 kilometres to a health facility with testing 
services as compared to 2.7 km among the least poor (t-test, p<0.01). This is illustrated in Map 
2 where the women in the HDSS cohort and the health facilities in the HDSS area are plotted 
using GPS-coordinates.  
 
Map 2. The geographical distribution of all pregnant women in the HDSS cohort divided by 
socio-economic status, and health facilities divided into with and without HIV testing services 
onsite 
 
 
 
Inadequate counselling and lack of referral (I) 
Inadequate counselling about HIV testing refers to information given both at the health facilities 
with and without onsite HIV testing services. 
 
Women seeking ANC from health facilities that did not have HIV testing services onsite were 
neither informed about, nor referred for HIV testing. This was observed both during the semi-
structured interviews and during the sit-in observations. On the other hand, few of the women 
who received ANC from facilities that provided HIV testing onsite had fully understood the 
reasons for testing and the majority had little knowledge about PMTCT.  
 
Another example of inadequate counselling was the fact that women who sought ANC from 
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facilities that provided HIV testing perceived HIV testing as mandatory and generally thought 
that they could not receive any other ANC services unless they accepted to be tested for HIV.  
 
I am told that when you come for ANC, they have to take your blood sample 
for testing: if you refuse they will not give you any treatment . . . No one 
(health worker) will care about you when you’re pregnant if you don’t accept 
to be tested for HIV (HIV status unknown, multi-gravida, health facility III). 
 
In addition, the women interviewed described how they would not question the 
recommendations from the health workers or ask questions for clarification since they felt 
inferior in relation to the health workers. 
 What the health worker would decide upon is what I would go with, 
because me I am just a patient/…/ (HIV positive, multi-gravida, 
health facility III).  
 
 
COVERAGE OF COUPLE HIV TESTING (III) 
Although couple HIV testing is part of the PMTCT policy guidelines, male partner involvement 
during ANC was shown to be uncommon in this setting (III). Self-reports from women in the 
HDSS-cohort, revealed that 13% had been accompanied to the ANC by their spouse. The record 
reviews at health facilities showed that the uptake of couple HIV testing was even lower, only 
4% of the women tested had been counselled and tested with their male spouse. 
 
CHALLENGES TO COUPLE HIV TESTING (I, II) 
Gender dynamics influencing uptake of couple testing HIV (I, II)  
The pregnant women were requested by the health workers to recruit their spouses for HIV 
testing, a request that was confirmed by the sit-in observations. Women felt obliged to accept 
the request to try to persuade their partners to come for HIV testing. However, the majority 
described it as a complicated task and a major dilemma to try to recruit their spouses while 
having very limited power to influence their partner’s actions.  
You can tell him but he will refuse to come. He will just tell you that he is not 
coming. He does not give any reason why he won’t come (HIV status 
unknown, multi-gravida, health facility II). 
The men’s freedom of choice, having the possibility to decline an HIV test, was often 
mentioned among the women interviewed. It was seen as unfair that men, as opposed to 
women, could choose to opt-out of testing during ANC. The men confirmed this since they 
portrayed a marriage power structure where men are decision-makers and have the power over 
their wives’ actions. Men resisted women’s efforts to influence them, including when it came to 
HIV testing:  
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We men have a mean heart; a woman will tell 
you to go to the health centre with her, but when you 
get up in the morning you tell her not to disturb you 
claiming that you are going to look for money. In 
that way you avoid her (FGD, men). 
The men had a generally negative view of couple HIV testing and the “promise” of couple HIV 
testing at ANC health facilities actually discouraged men from accompanying their wives on 
antenatal visits.  
 
You know in most cases, we men don’t like to accompany our wives because 
we know about this programme whereby once you go with your wife, then you 
must be tested for HIV. So we are very worried about escorting our wives (IDI 
man). 
 
Both women and men feared that couple HIV testing would reveal that one in the couple had 
had extra-marital affairs, something that they feared could lead to relationship problems and 
separation.  
 
It is because we don’t tell our wives the truth; you lie 
to her that she is the only one yet her friends see you 
with other women. So if we go for testing and find 
out that we are infected she will immediately start 
quarrelling (FGD men). 
 
When discussing male involvement during ANC with men, they described how they were 
excluded from the ANC sessions where their wives were examined, and how they had to wait 
outside without any information about what was happening to their pregnant spouse. Men 
therefore questioned the rationale for their presence during ANC.  
 
Now the problem with the medical staff is, you as a man, they cannot tell you 
what exactly they are doing inside there, instead I can sit on the veranda and 
they get on with whatever check-ups and you only take your spouse back home 
(IDI man). 
 
Men reluctant to HIV testing in general (II) 
The men on the other hand discussed their lack of convincing arguments for why they should go 
ahead and get tested for HIV. When speaking in the abstract about HIV testing, the men 
recognized its importance. However, despite the ability to recite the HIV testing messages 
broadcasted in their communities, they did not see any reason to get tested themselves.  
 
The media, especially the radio, which was the men’s main source of information about HIV, 
had conveyed the message that one should get tested, but the campaigns had apparently failed to 
motivate the men to do so. The men suggested that men who had already tested could serve as 
role models and talk about their experiences. Furthermore, live information campaigns at the 
community level instead of frequent media messages were mentioned as a more effective 
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strategy for getting men to test, in part because it would enable them to ask questions.  
 
These programmes are mostly on radio, but it would be better if you organized 
meetings on the LC level (i.e. in the community), rather than putting 
programmes on the radio/.../then I would come there and I will understand 
everything better (IDI man). 
 
General low confidence in the care provided at health facilities further eroded 
men’s feeling that it was worth their time to go there. In addition, waiting time and 
distance made it inconvenient to actually get the care one needed according to the 
men. The health facilities with HIV testing services were often far away from 
where the men lived, and going there was not only costly, but took time away from 
work and other activities. Men reported having been forced to wait an entire day 
for ANC, a heavy sacrifice for someone who needs to work to support his family: 
 
Even the long line at the hospital (chorus answer 
yes....) women can be there from 08.00 a.m. in the 
morning up to evening, and waste all the time you 
would have spent looking for posho [food] (FGD men). 
 
The men discussed the rude treatment from health workers, experienced both by themselves and 
by their pregnant spouses. Some men had experienced nurses at ANC speaking disrespectfully 
also to them directly: 
 
/…/ So we sometimes feel like not going there because the nurse will be 
rude to us yet it is not we men who are pregnant. They use harsh language, 
the same kind they use with women in labour, so sometimes they want to 
use that same harsh language with us. Yet we men are easily provoked and 
could even become harsher than the nurses, so you rather stay away (many 
participants laugh and give signals of approval) (FGD men). 
 
Another barrier for HIV testing described by the men was the lack of integration between HIV 
care and other health services. By singling out and exposing patients seeking HIV care through 
special clinics or opening hours, men were further discouraged from getting tested. 
 
People start noticing your (HIV) status, because of 
      the specific days you go for check up (FGD men). 
 
 
COVERAGE AND ESTIMATED EFFECTIVENESS OF PMTCT SERVICES (IV) 
Coverage of PMTCT services for HIV-infected women 
The HIV prevalence among the women in the HDSS cohort was found to be 3.5%. The 
coverage of PMTCT services for HIV-infected women in the HDSS cohort was assessed 
through record reviews and semi-structured interviews after childbirth. In Table 6 the coverage 
of PMTCT services is presented. The majority of the women received the dual-ARV 
Results 
53 
prophylactic regimen recommended to them by the time of the study, and all women practised 
breastfeeding. 
 
Table 6. Coverage of PMTCT programme components among pregnant HIV-infected women 
in the HDSS cohort  
Component (%) 
HIV-infected women/baby pair receiving any ARV prophylaxis 83 
   Mother ARV prophylaxis -sd-NVP 
   Mother ARV prophylaxis -dual prophylaxis AZT and 3TC 
   Mother ARV prophylaxis –ART 
33 
57 
10 
Women practicing safe infant feeding 0 
 
 
Estimated effectiveness with base-case coverage of PMTCT services  
To estimate the effectiveness of PMTCT services in 2008, the expected number of HIV-infected 
pregnant women in the two districts was estimated by combining the HIV prevalence of 3.5% 
and the Ugandan crude birth rate (45/1000 population). This calculation gave an expected 
number of 1796 HIV-infected pregnant women (15-49 years old) in Iganga and Mayuge 
districts in 2008.  
 
The uptake of PMTCT service in the HDSS cohort, i.e. the base-case PMTCT coverage and the 
MTCT rates from the UNAIDS, were then combined in a decision tree analysis. The analysis 
showed that the base-case PMTCT coverage gave an estimated MTCT rate of 13% at birth and 
16% at six months, or 240 children HIV-infected at birth and 284 children infected at six 
months.  
 
In a situation without access to any PMTCT services 395 children would have been HIV-
infected at birth, meaning that the base-case PMTCT coverage prevented an estimated 155, or 
39%, HIV infections in children.  
 
 
Estimated effectiveness assuming increased coverage of PMTCT services  
To understand how an increased coverage of one or several PMTCT components would 
influence the effectiveness of PMTCT services, different scenarios were modelled in a decision 
tree analysis. An assumed increase in one or several PMTCT programme components were 
analysed to identify which intervention/s would influence the effectiveness of PMTCT services 
the most. The scenarios are presented in Table 7 and for each scenario; the number of children 
infected and the MTCT rate at birth and at six months of age are presented.  
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Table 7. Scenarios with different coverage of PMTCT components, number of children 
infected with HIV and MTCT rates  
a Uptake of ARV prophylaxis of 83% the base-case scenario b Assumed uptake of ARV prophylaxis 100% 
 
An assumed increase in HIV testing to 100%, keeping all other components at base-case level, 
would give an MTCT rate of 10% at birth. Only a combination intervention, with ARV 
prophylaxis uptake levels of over 83% are needed to reach the UNAIDS target of MTCT rates 
below 5%, i.e. the OptimalPlus scenario. The relative effect of each of the scenarios has been 
compared to the base-case PMTCT coverage and is illustrated in Figures 8.  
 
HIV testing was identified as the major obstacle to PMTCT in Iganga and Mayuge districts, and 
the single most effective intervention would be to increase HIV testing to 100%. This would 
reduce the estimated number of HIV infections among children by 28% at birth and by 24% at 
six months as compared to the base-case PMTCT scenario (Figure 8). Obviously, the smallest 
increase in PMTCT effectiveness was shown for the scenario assuming an increase in ANC 
attendance to 100% since ANC attendance was already high at 96%.  
 
The Optimal scenario including 100% uptake of all PMTCT programme components with an 
uptake level of ARV prophylaxis of 83%, would give a 60% decrease of infections at birth and 
a 57% decrease at six months, as compared to the base-case coverage.  
 
 
Base-case PMTCT coverage At birth At six months 
Number of HIV-
infected children 
MTCT 
rate (%) 
Number of HIV-infected 
children 
MTCT 
rate (%) 
Estimated effectiveness with base-
case coverage of PMTCT services 
240 13 284 16 
Scenarios At birth At six months 
Scenarios assuming different uptake 
of PMTCT services 
Number of HIV-
infected children 
MTCT 
rate (%) 
Number of HIV-infected 
children 
MTCT 
rate (%) 
100% ANC 
Base-case coverage with 100% ANC 
attendance 
234 13 278 16 
100% HIV testing 
Base-case coverage with 100% HIV 
testing  
172 10 217 12 
100% ART 
Base-case coverage with ART provided 
to 100% of women receiving ARV 
prophylaxis 
197 11 227 13 
Optimal scenario a 
A combination of Scenario 2, 3 and 4, 
83% uptake  
97 5 121 7 
OptimalPlus scenario b 
A combination of Scenario 2, 3 and 4, 
100% uptake 
36 2 56 3 
No PMTCT 
No ARV prophylaxis given to HIV-
infected women/babies 
395 22 436 24 
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The OptimalPlus scenario, with 100% ANC attendance, 100% HIV testing, and providing ART 
to all HIV-infected women (uptake level of 100%) naturally gives the best results and would 
translate into an estimated reduction of 85% at birth and 80% at six months.  
Thus, it is obvious that increasing coverage of one single PMTCT component would have 
relatively little effect on the MTCT rates and on the number of HIV-infected children. 
 
Figure 8. Estimated relative effects of an increase in coverage of PMTCT components as 
compared to the base-case PMTCT coverage. Assuming 100% adherence 
a) At birth 
 
 
 
 
b) At six months 
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The impact of adherence on effectiveness of PMTCT services 
Adherence to PMTCT services was studied in the seven semi-structured interviews with HIV-
infected women. Those interviews revealed that even though most of the women lived within 
walking distance of Iganga Hospital, none of them adhered to all the components in the PMTCT 
programme. Most of the women had missed out on more than one of the programme 
components.  
 
The majority of the women who received dual ARV regimen did not complete the regimen 
either because they did not return on time, or at all, for refill of ARVs.  
 
I fear taking tablets. I was given a tin of tablets to take, but I only took 
them for three weeks and then stopped.  
 
Adherence to breastfeeding recommendations was poor and six out of the seven women 
reported mixed feeding. Women were generally aware of the recommendations to practice 
exclusive breastfeeding but unable to follow these recommendations.  
 
I used to give him cow’s milk from 2.5 months. They (the midwives) told 
me about exclusive breastfeeding, and I know everything… But the baby 
refused to breastfeed, that’s when I introduced other feeds (cows milk), 
but I still gave him the breast sometimes. 
 
None of the women who received ARV-prophylaxis had been linked to an ART clinic to 
monitor their HIV infection. Most of the women seemed unaware of the importance of HIV 
monitoring and either planned to delay care seeking until the disease had progressed, attend 
traditional healers or just ignored any AIDS-symptoms.  
 
I have never received any HIV care, I am waiting for the disease to 
progress, then I would go to the hospital for treatment.  
 
Similar to the above, interviews with HIV-infected women revealed that all but one woman 
failed to adhere to infant PCR-HIV testing. Most women were unaware about the importance of 
bringing their children for testing. 
 
I did not take him for PCR-testing because they (the midwives) never 
told me that the baby had to be tested. If they had told me, I would have 
done so. 
 
 
To illustrate how adherence to PMTCT services would influence the effectiveness of the 
PMTCT services, the same scenarios as described in Table 7 (except for the OptimalPlus 
scenario) were analysed for a situation where the uptake of ARV prophylaxis was set to 41.5% 
(i.e. 50% of the uptake for the base-case PMTCT coverage of 83%). These scenarios were also 
compared to the base-case PMTCT coverage and are presented in Figure 9. 
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Figure 9. Estimated relative effects of an increase in coverage of PMTCT components as 
compared to the base-case PMTCT coverage.  Assuming 50% adherence 
a) At birth  
 
 
 
b) At six months
 
 
 
From these graphs it is obvious that to reduce MTCT rates an increased coverage 
of PMTCT services has to be accompanied with ensured adherence to the PMTCT 
services. For example the scenario assuming an increase in HIV testing to 100% 
would only give a 10% MTCT rate reduction at birth with an uptake level of 
41.5%, as compared to 28% with an ARV-uptake level of 83%.
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DISCUSSION 
The results from this thesis show that less than two-thirds of women were HIV tested during 
pregnancy. Moreover, only four percent had been tested together with their spouse.  
 
This is a missed opportunity: this low uptake of HIV testing occurs in a setting with a heavy 
burden of HIV, with nearly universal ANC attendance among pregnant women and with opt-out 
HIV testing as well as couple HIV testing policies in place. This research shows that the 
policies have not achieved their intended outcomes, possibly due to low community acceptance 
of the manner in which the policies have been implemented.  
 
The estimated single most effective intervention to optimize PMCTC would be to increase HIV 
testing coverage to 100% for pregnant women. The main barriers to achieve this are health 
systems related: lack of HIV testing and referral, poor counselling, and gender-related power 
dynamics both at the household level and at the point of health service delivery. 
 
HIV TESTING  
In a setting with almost universal ANC attendance (96%), an opt-out HIV policy and where the 
majority of the people lived only a short distance from a health facility with testing services, 
only 64% of the women had been HIV tested during pregnancy (III). Making HIV testing 
services accessible to pregnant women is the key to improving access to other PMTCT services. 
Furthermore, increasing the uptake of HIV testing to 100% was estimated to be the single most 
effective intervention to reduce MTCT (IV). In health facilities with HIV testing services onsite, 
testing coverage was high at 85% (III). One can conclude that in this type of facilities, with 
respect to uptake of HIV testing, the health system had succeeded fairly well with the opt-out 
testing strategy by making service delivery and equipment available. Similarly, high uptake 
levels of HIV testing during ANC have been found in other settings after implementation of 
opt-out HIV testing [128-131].    
 
Consequently, the most important determinant for not being HIV tested during pregnancy was 
seeking ANC from a facility where HIV testing services were not available (III). Only 6% of 
the pregnant women who sought ANC from this type of facility had carried out referral and 
tested elsewhere, despite the fact that the opt-out policy clearly expresses testing referral (III). 
Correspondingly, a Kenyan study has illustrated the important role the health system has when 
it comes to the uptake of HIV testing. It also showed that significant person-level risk factors for 
not being HIV tested disappeared when adjusting for site, thus demonstrating how health 
system factors override personal level factors [132]. Hence, to increase access to HIV testing 
and other PMTCT services, availability of testing services for pregnant women needs to be 
improved.  
 
The pregnant women in the HDSS cohort generally sought ANC from the health facility closest 
to their homes (III), indicating that they did not actively seek ANC where they could access 
HIV testing, but rather accessed testing as an extra service when the ANC facility happened to 
have testing services. In the McIntyre access framework described in the background section, it 
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is pointed out that the availability of a health service is not only about making the service 
physically available, but also about acknowledging the perceived need for the services in the 
community. Hence availability of a service is the fit between the health system making services 
available and the community’s desire for the service. It is interesting to consider the issue of 
HIV testing availability in this setting since, even though the health facility closest to the 
woman’s home did not have HIV testing services, the average distance to a nearby facility with 
HIV testing was relatively short both for women who were tested (2.8 km) and those who were 
not tested (3.5 km) (III). One could therefore argue that HIV testing services are available to all 
women in this setting. Thus, since almost all women attended ANC facilities at least once and 
since most of them were not tested due to lack of referral: making sure that women carry out 
HIV testing referral to a nearby health facility might be an easy way of increasing access to 
PMTCT and reducing MTCT of HIV. 
 
One very likely explanation for the low uptake of HIV testing among women who sought ANC 
from facilities without onsite testing is a lack of referral and lack of counselling about HIV. 
Only 20% of the women who sought ANC from this type of facility had received any 
counselling about HIV (III), confirmed by the qualitative interviews and the observations in 
Study I which showed that women were not refereed for HIV testing. However, there was no 
clear structure in place for how referral for testing should be organized. Health workers might 
not have received instructions from the management to prioritize referral or tools for how to 
handle referrals. In the light of the tough working conditions for many health workers, another 
possible explanation could be that the health workers consciously omitted HIV counselling to 
prioritize other ANC services. Especially since the attitude in general among the health workers 
was that there was no use of counselling the women about testing referral since they would not 
take action anyway.  This is a missed opportunity and to increase access to HIV testing, the 
health system should establish a structure and organisation for testing referrals. In addition 
should the health workers make sure that the messages about HIV testing and the importance 
and benefits of testing is conveyed to all pregnant women.  
 
In relation to the above discussion, the poorest women had worse access to PMTCT services, as 
compared to the least poor. This is due to the fact that the majority of the poorest women live in 
rural areas where the nearest health facility usually is a HCII without HIV testing services (III). 
Hence, when the health system fail to deliver PMTCT services to the rural areas it affects the 
poorest women the most. Poverty has previously been reported as an important barrier to 
PMTCT services in Uganda [133]. Inequity in access to health care was first reported in the 
1970s, and, even though the situation has greatly improved over the years, it still exists in low-
income settings where the poorest people usually have worse health-care access than the least 
poor [56, 134]. 
 
Other possible interventions to increase access to HIV testing could include providing 
transportation to a facility with HIV testing services, or carrying out outreach HIV testing to 
facilities without testing services. These interventions might be more relevant than expanding 
HIV testing services to the lower level of HC IIs, since poor-quality counselling has been 
reported when expanding PMTCT services to lower levels of care due to insufficient 
counselling or inadequately trained staff [135]. 
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COUNSELLING  
Most of the women who were HIV tested during ANC showed little understanding of why HIV 
testing was being carried out, despite the fact that they had just been tested (I). This is a health 
system failure in the opt-out testing policy implementation since women who just have been 
tested have not received enough counselling to be aware of why testing was done. The pregnant 
women who sought ANC at facilities with HIV testing services further perceived testing as 
compulsory (I), confirming findings from other studies in East-Africa and Vietnam, where opt-
out testing is implemented [136-138]. If testing is perceived as compulsory, it also indicates a 
missed opportunity in providing appropriate counselling, something that might have an effect 
on future risk behaviour. Poor counselling has also been reported to accompany opt-out HIV 
testing in other settings where this testing policy has been implemented [136].  
 
Further, women did not dare to ask questions for clarification when health workers said things 
that they did not understand (I). To address this, the individual examinations taking place after 
the group HIV counselling could be a good opportunity to open up for women’s questions since 
the examinations ensure more privacy than the group sessions. This could be a good strategy 
since another study from the same setting showed that health messages brought up during the 
group counselling are not repeated during the individual examinations [139]. This might 
therefore be a relatively easy but efficient intervention to increase the women’s understanding 
of HIV testing.  
 
The implementation of provider initiated HIV testing has increased the testing uptake in many 
settings and at the same time the number of health facilities providing HIV testing services has 
also significantly increased in SSA [2, 22, 140]. 
 
Despite the fact that high HIV testing uptake has been indicated where opt-out testing has been 
introduced, testing per se is not the final goal, but the first and crucial step to accessing PMTCT 
services, HIV care or counselling on how to remain uninfected. Although the health system has 
managed to increase the number of people tested, if testing is not followed by adequate 
counselling, and referral to appropriate care it might do more harm than good. It is obviously 
also a waste of the scarce resources available in the health systems in resource-poor countries.  
 
The main idea of opt-out HIV testing during ANC is to get more women to test for HIV, but 
one could question the benefits of testing if the accessing of appropriate counselling and care 
does not ensue as a consequence. Concerns like whether opt-out testing would promote relevant 
health services and not simply increase testing with no concrete benefits to the women being 
tested has been raised previously in relation to opt-out HIV testing [141]. Studies from the same 
setting as the research in this thesis have also found poor post-test counselling to be a main 
barrier to pre-ARV care among HIV-infected persons, only 10% of those who tested positive 
came back for pre-ARV care [142, 143]. However, many health workers in SSA experience a 
heavy workload and would not have time for individual counselling. Hence, there might be 
much to win by using the health education sessions during ANC better and tailoring the 
messages that are already brought up during group-counselling sessions. These could be used to 
point out the benefits of identifying an HIV infection and in addition make sure that women’s 
questions were followed up during the individual examinations.  
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EFFECTIVENESS AND ADHERENCE TO PMTCT SERVICES  
The PMTCT interventions implemented in this setting decreased the estimated MTCT rates at 
birth and at six-month post-partum by 39% as compared to a situation without any PMTCT 
services at all (IV). Yet, with the base-case PMTCT coverage the estimated transmission rates at 
population-level were still 13% at birth and 16% at six months. Low uptake of HIV testing was 
estimated to be the major obstacle to achieving higher PMTCT effectiveness in this setting.  
 
Most HIV-infected women (57%) received the dual ARV regimen (IV), which was the 
recommended treatment by the time this research was performed. However, by providing ART 
(as is the recommendation today) to all women who received ARV prophylaxis, the MTCT rate 
could be reduced by 18% as compared to the base-case coverage.  
 
Further, the OptimalPlus scenario with an assumed 100% uptake of ANC, HIV testing and ART 
together with perfect adherence gave estimated MTCT rates of 2% and 3% at birth and at six 
months (IV). If, for the same scenario, using the base-case ARV uptake level of 83% instead, 
the MTCT rates would be 5% at birth and 7% at six months. Hence, perfect adherence to and 
coverage of ART for all HIV-infected women would be required to achieve the UNAIDS 
“virtual elimination targets” of less than 5% MTCT rate. This was also illustrated in a recent 
modelling study that found that adherence levels of 95% to the new WHO recommendations 
would be required to reach a MTCT rate of below 5% [144].  
 
However, to initiate the new PMTCT recommendations for the provision of ART, the health 
system not only needs to finance the more expensive regimen, but health workers also need to 
be trained on the new and more complex regimen to be able to deal with, for example, side-
effects. Furthermore, to make the regimen available, a sustainable supply of medicines 
throughout a much longer period than before is needed since women would now receive ART 
until they stop breastfeeding. This is a big challenge and would require efforts and investments 
to improve the supply of medicines, especially since studies from the same setting have shown 
that there is an inadequate supply of ART to the patients already today enrolled on ART [90].   
 
The semi-structured interviews with HIV-infected women revealed that completion of PMTCT 
programme components was not 100% for anyone, even though most of the HIV-infected women 
lived within walking distance from the hospital where they could access HIV care. The poor 
adherence to PMTCT is also in line with another study that showed an HIV testing uptake of 
nearly 85% but only 54% of the infected women and 4% of their infants received ARV 
prophylaxis [145]. One of the reasons for the poor adherence identified in this thesis was lack of 
continuous support to women who are identified to be HIV-infected while pregnant.  To receive 
positive HIV test results when actually seeking ANC could obviously be tough and women might 
not be prepared for it or ready to at once digest all information and counselling they need to make 
informed decisions.  
 
Hence, with the new and more complex ARV prophylactic regimens, a well-functioning health 
system is even more critical to ensure access to PMTCT, sustainable care and adherence to 
PMTCT throughout the breastfeeding period. By organizing continuous counselling to pregnant 
HIV-infected women, women might be better prepared to adhere to the PMTCT programme 
throughout the breastfeeding period. Peer-support groups for pregnant women, or HIV-infected 
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women who have been pregnant, had previously been organized in this setting and had been 
greatly appreciated by the participants. However, during informal conversations with the 
PMTCT coordinator in Iganga, I came to know that the organization of support groups had been 
dependent on an external donor who had financed the Ministry of Health PMTCT programme 
and when the donor changed, these peer-support activities were stopped. This illustrates a health 
system challenge in delivering sustainable care when activities like this one are donor 
dependant and that circumstances might change from one year to another. Furthermore, it shows 
some of the challenges faced by the local health officials when implementing the PMTCT 
programme. 
 
The estimations of the effectiveness of PMTCT services clearly illustrate how PMTCT 
programmes are not a single intervention, but sequential interventions that need to be delivered 
to meet the goal of a reduced MTCT (IV). In order to successfully implement large-scale 
interventions like the PMTCT programme, a well-functioning health system is crucial, as also 
stressed in the Millennium Development Goal Countdown discussion [56]. In addition to 
strengthening the health system to deliver the services, integrating PMTCT and ART services 
might further improve adherence and continuity of HIV care for women identified to be HIV-
infected during pregnancy. This is supported by studies that have found an increase in 
enrolment from PMTCT to ART care, and from HIV testing clinics to family planning clinics 
after integrating the services [146-148].  
 
COUPLE HIV TESTING 
Only 4% of the pregnant women had carried out couple HIV testing together with their spouse 
(III). The rationale for couple testing stems from SSA studies that have shown an association 
between male partner involvement in their wives’ ANC, couple HIV testing and pregnant 
women’s likelihood of accessing and completing PMTCT services [34-37]. Couple testing 
might be desirable from a public health perspective, since the couple would then in theory 
receive the test results and counselling together and thereafter make informed decisions. This 
might be particularly relevant in Uganda where a large share of new HIV infections occur in 
stable, heterosexual relationships [101]. However, it seems more likely that pre-existing male 
partner involvement is what leads some men to accompany their wives to ANC and to support 
them during PMTCT. One could therefore question whether the few men who accompany their 
wives to ANC are representative of the majority. Other aspects that should be considered in 
relation to couple HIV testing is the fact that far from all pregnant women live with a partner, 
and further that polygamous marriages are widely accepted in Uganda, making the 
recommendation of couple testing more complex.  
 
Another barrier to the acceptance of couple HIV testing articulated by the men was their 
commonly occurring extramarital affairs (II), also confirmed by ethnographic studies from 
Iganga [149]. Hence, the relationships, or lack of relationships, need to be acknowledged when 
implementing couple HIV testing during ANC and health workers therefore need to listen to the 
individual’s wishes and need for couple testing. Perhaps a more reasonable approach would be 
to offer couple HIV testing in the most acceptable way and as much as possible facilitate couple 
HIV testing in cases where the persons could benefit from it. There are evidently advantages of 
identifying sero-discordant couples, something that couple testing ultimately could help to do. 
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Couple testing is also relevant in the light of the discussion of “test-and treat” since a 
multicountry study recently found that initiation of ART at the time of diagnosis significantly 
reduced transmission to spouse [150].  
 
A health system barrier to couple HIV testing was that men did not feel welcome at the ANC 
facilities and they considered ANC to be a female domain (II). However, making couple testing 
services available does not only have to do with services being physically available. Though the 
services were available, the aspect of men's acceptance of the testing services was not taken 
into consideration. The norm that men should not show weakness, for example by seeking 
health care, dictates against men being HIV tested, especially alongside their wives [151]. 
Traditional gender norms in themselves constitute significant barriers to health care seeking 
among men across the world [151]. Much of the focus in HIV prevention and care has been 
targeted to women and men have often been neglected in HIV programmes [75].  
 
This also seems to be the case here where the traditionally “exclusively-female” ANC setting 
suddenly would also like men to attend ANC (I, II). For men to attend ANC the setting needs to 
be adapted to make them feel welcome. The couple HIV testing policy, similar to other policies 
for male involvement in sexual and reproductive health, discusses male involvement to enable 
women to access health care services, rather than for the men’s own good [74, 75, 152-154]. 
Men themselves should also benefit from the programmes rather than just be there to support 
their spouse. Interestingly, even publications regarding the integration of gender in HIV 
programmes only discusses men’s participation in order to increase women’s access to services, 
and say nothing about men’s access for their own health [73]. Gender-sensitive messages 
together with health systems adaptation might help to make HIV testing more acceptable among 
men and to achieve equal access to HIV care, different strategies when targeting men and 
women may be needed [155]. 

The men in this setting were enrolled for couple HIV testing through their pregnant spouses, 
this way of recruiting was perceived as unacceptable by both the men and the women (I, II). 
The men are the breadwinners and the decision-makers in the families, thus making it difficult 
for women to influence their partner’s actions [149].  
 
Couple gender dynamics had seemingly not been acknowledged when introducing the policy 
for couple HIV testing in this setting, even though it is well known how crucial it is to 
understand how gender might influence the effectiveness of a programme [155]. In order to 
increase men’s awareness about the importance of ANC, HIV testing and PMTCT, alternative 
ways are therefore needed. More successful methods to recruit men have been demonstrated, for 
example in a study where men received information about ANC services through an invitation 
letter from the health facility where women sought ANC, a simple intervention that increased 
the male partner ANC attendance and couple HIV testing [156].  
 
Hence, scaling-up couple HIV testing has been a challenge in many different settings. Couple 
HIV testing might in some cases provide support to women to access PMTCT services and 
encourage HIV testing for men. However the bottom-line is seemingly that in the near future 
the significance of universal couple HIV testing both in PMTCT and for increasing the uptake 
of men’s HIV testing seems to be limited.  
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POLICY IMPLEMENTATION  
The Ugandan PMTCT policy guidelines are in line with the provider-initiated HIV testing 
policy recommended by the WHO and aim to integrate HIV testing into standard medical care 
[31, 104]. However, the results from this thesis show that the wanted outcomes from these 
policies, i.e. HIV testing of all pregnant women and as well as couple testing have failed in this 
setting. Furthermore, the way in which the policies have been implemented have not found 
acceptance in the community (I, II).  
 
Hence, for men and women to access services, the services need to be considered as acceptable. 
McIntyre writes, “acceptability problems arise where health care services are organized from 
the perspective of the system and its providers, i.e. a normative perspective under which 
individuals ‘should’ be expected to use services, as opposed to the perspective of individuals or 
patients”. Further, Walt describes policy development and implementation processes as either 
top-down or bottom-up [157]. The top-down approach clearly separates the policy formulation 
from the implementation; the implementation is viewed as a sequential transmission from 
formulation to implementation, whereas the bottom-up approach is a non-linear, interactive 
process, where the implementers are part of the policy formulation.  Walt concludes that a 
successful policy implementation is a bottom-up product, where formulation and 
implementation is in a “continuous loop” [157]. When listening to the men and women in this 
setting (I, II) and looking at the uptake of services (III), the PMTCT policy implementation is 
apparently very much a top down product from the health system and not accepted by the men 
or women. Neither group (I, II) appreciated the way in which the couple HIV testing policy had 
implemented. Not acknowledging the target group’s opinions and ideas when implementing the 
PMTCT policy seems to be a major reason for the failure of testing referral for women and the 
recruitment of men for couple HIV testing (I, II). This further illustrates the challenge of 
implementing already known effective interventions in a real-life setting, i.e. the efficacy vs. the 
effectiveness of an intervention.  
 
Another example of not listening to the community members’ needs was the ongoing 
information campaigns accompanying the implementation of HIV testing services that had 
failed to motivate the men to get tested (II). The men themselves suggested ways to improve 
their understanding about HIV testing such as live information at community level, where they 
could ask questions. This clearly illustrates how the community could contribute to policy 
implementation and make policies more acceptable. Community sensitization campaigns and 
peer-to-peer interventions might be one way forward and has also previously shown to have 
better effect than radio commercials or similar [158-160].  
 
The opt-out HIV testing policy during ANC on the other hand seems to be introduced without 
enough counselling and in a way that do not support women to make informed decisions (I), a 
concern raised previously [141].  Including both the health workers as well as community 
members when implementing the PMTCT policies might have created better acceptance for the 
policy. Walt and Gilson states that when developing health policies a great deal of focus is on 
the content, but they argue that in order for health policy effectiveness, the actors, the context 
and the process also need to be considered during the policy formulation and -implementation 
[78]. Similarly, for incentives to work, people within the health system have to be involved in 
policy implementation, a factor that has been found to be crucial for successful policymaking in 
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Uganda [161]. Further, for a successful policy it is essential for the health system to have a 
broad understanding of the environment in which health services are delivered and health 
outcomes are produced to increase intervention coverage [80].  
 
To summarize, this thesis found that lack of both availability and acceptability of services 
hampered the access to PMTCT services and contributed to the missed opportunities. Major 
reasons identified for the missed opportunities were due to the health system as well as gender 
dynamics.  
 
METHODOLOGICAL CONSIDERATIONS 
Qualitative studies 
Qualitative research methods have become more used in medical research in recent years as a 
way of providing contextual and in-depth understanding of healthcare seeking and provision of 
care [117]. This research borrows from the tradition of social constructivism assuming that the 
social world and people’s behaviour are constructed socially, politically and psychologically, as 
are also humans’ understandings and explanations of the world [162]. This was applied, for 
example, when studying the interactions between health workers and the women and the men 
and women, and their different behaviours and point of views.   
 
The design of qualitative research is often characterized by emergent design: an openness to 
adapt the inquiry during the course of the research as the understanding deepens or situations 
change, and was also my understanding when carrying out the studies [162]. This was an 
important principle in the data collection process and one example of this was that in Study II 
the data were collected in two phases which made it possible to explore issues from the first 
phase more in details in the next set of FGDs, and also during the IDIs.  
 
One often used sampling strategy in qualitative research is purposive sampling [162]. This 
means that study subjects are selected because they are rich in information about the 
phenomena, that they have certain insights into or experience of the topic. For example only 
men who were fathers were included in Study II, since it was believed that they would have 
experience of pregnancy, and/or ANC and HIV testing.  
 
Trustworthiness is a concept used in qualitative research and achieved through the measures of 
credibility (e.g. selection of participants, methods etc.), dependability (e.g. how time-dependent 
the data are) and transferability (e.g. how well the results could be transferred to other settings) 
[120].  
 
Credibility was strived for through a careful selection of methods and participants relevant for 
the research questions. Several efforts were made to ensure credibility. Examples of such efforts 
were that participants with and without experiences of ANC and/or HIV testing were selected 
for the interviews (II), that rural/urban residents were represented to ensure that the results were 
applicable to both urban and rural areas (II), participants had various experiences of child 
bearing, and that the age of the participants were considered (I). Participants were also selected 
from different health facilities.  
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Triangulation was another measure used to create trustworthiness. Comparing findings from 
different methods such as semi-structured interviews and observations was one way of 
triangulation (I) [163]. Further, the combination of FDGs and in-depth interviews (II) gave a 
deeper understanding of the issues since the FGDs generated the general principles of couple 
HIV testing and the interviews gave the participants’ personal views and experiences [117]. 
 
Analyst triangulation was applied during the analysis process and was achieved by co-authors 
reading selected transcripts, by discussing codes, categorization of codes and development of 
themes. This was done at several time points and until consensus was achieved [162]. Further, 
in the articles categories (I) and quotations (I, II) are presented to improve credibility and 
illustrate how the results were generated [120]. Presenting the results in a feedback workshop in 
Iganga Town with community members, health workers and district health officials provided 
feedback on the interpretation of the preliminary findings and during the workshop feedback to 
the participants was also provided [117, 121]. 
 
Prolonged engagement in the field, one year in total, was another essential aspect that was 
employed to improve the quality of the data collected. I spent much time in Iganga and Mayuge 
districts where the studies were conducted both in the community and at the various health 
facilities. Dahlgren et al write about “persistent observations”, which are focused observations 
of the study subject during field work and this was employed by visiting almost all health 
facilities in the districts where the organization and quality of ANC and HIV testing was 
observed as well as the interactions between health workers and pregnant women [117].  
 
The lengthy fieldwork further enabled me to interact with community members and health 
workers at district level and at the health facilities and have formal and informal conversations 
during and after working hours. This enriched and deepened my understanding for the context 
and facilitated the interpretation of the results.  
 
Quantitative studies 
The quantitative analysis is based on data that were collected in an HDSS. The HDSS structure 
enabled the establishment of a population-based cohort with pregnant women, and to follow 
them up after giving birth. Further, since the HDSS keeps socio-demographic data, the variables 
for SES as well as for distance were readily available for the women enrolled in the cohort.  
 
Two broad types of errors can normally be identified in epidemiological studies: systematic or 
random. The aim of epidemiological studies is usually to produce an estimate for an unknown 
population value, and the study design and analysis should be carried out to reduce such errors 
in the estimates and make them as small as possible [164]. In this research I wanted to estimate 
the prevalence of HIV testing among pregnant women and risk factors for not being tested. The 
risk of random errors decline with size of the sample and the study populations addressed in 
Studies III and IV were quite large, reducing the risk of random error. However, the number of 
women identified as HIV-infected at ANC was quite small and therefore conclusions about the 
completeness of PMTCT in Iganga/Mayuge based on these women’s adherence patterns should 
therefore be interpreted with some caution.  
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Systematic errors, or bias, relate to the validity of a study. Bias could be defined as “error which 
applies unequally to comparison groups”, i.e. an error that affects one group more than another 
[165] and biases are often divided into selection bias, information bias and confounding. 
Validity of a study estimate may also be referred to as internal vs. external validity. External 
validity is how generalizable the study findings are to populations outside the study-base, while 
internal validity depends on existing biases and confounders. Below I will discuss possible 
errors, in particular systematic errors that this research might be subject to.  
 
Selection bias 
Selection bias in cohort studies might occur at enrolment or be due to non-response or dropout 
from a study. Enrolment of women into the HDSS cohort was based on self-reports on 
pregnancy and this way of recruitment could be subject to selection bias. Women who did not 
seek ANC during pregnancy might have been more likely to not report their pregnancy due to 
social desirability, since the majority of the population know that pregnant women should seek 
ANC. Since women who do not seek ANC are not HIV tested either, this might have led to an 
over-estimation of the proportion of women HIV tested in the HDSS cohort. However, during 
the regular HDSS data collection rounds in this setting under-reporting of pregnancies always 
occurs. About 2000 births but only 1200 pregnancies (700 pregnancies/data collection round) 
are identified yearly in the Iganga/Mayuge HDSS; thus we knew already before study start that 
only about 60% of all pregnancies are normally captured. This research actually identified a 
higher number of pregnant women (n=881) than usual, about 77% of the expected pregnancies.  
In a study looking at the discrepancies between the reporting of pregnancies and reporting of 
births in the Iganga/Mayuge HDSS a risk factor for not reporting pregnancy was the pregnant 
woman being below 18 years of age [166]. If women below 18 years had a different ANC 
attendance behaviour and different HIV testing uptake than the women enrolled it would have 
influenced the results in this thesis. Other suggested reasons for not reporting pregnancies is 
random error caused by the cultural belief that it would cause bad-luck to tell someone about a 
pregnancy until late pregnancy as well as difficulty for women to know if they are pregnant 
given the very high fertility rate with frequent pregnancies and continued breastfeeding 
affecting menstrual periods, as well as the lack of pregnancy tests. 
 
Due to the fact that pregnancies are generally missed during HDSS-data collection, and since 
this study captured more pregnancies than usual, this under-reporting is unlikely to have biased 
the results. Hence, the results are believed to be generalizable to the HDSS- and district’s 
population.  
 
Dropout occurred at several time-points in the cohort. First when women who had not gone for 
ANC at enrolment should have been interviewed after giving birth. This dropout was due to the 
fact that the women had moved, or were not at home during the several follow-up visits. 
Second, some women were not found in the registers, most likely due to poor-record-keeping. 
Neither of these two dropouts should have biased the results since the women who dropped out 
are unlikely to be different from the women who remained in the study with regard to ANC 
attendance, HIV testing and HIV infection. 
 
The women further self-selected into the different ANC facilities, and women who chose 
facilities without HIV testing equipment could have chosen these facilities because of their lack 
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of HIV testing services, and could have had higher- or lower HIV prevalence than what was 
observed among the women tested. However, a Zambian study compared the HIV prevalence 
among people who had undergone provider-initiated HIV testing with those who had undergone 
non-provider HIV testing and did not observe a difference between the groups [24]. Further, a 
study from Kenya found lower HIV prevalence among women who refused HIV testing during 
ANC [132]. Hence, there are no obvious reasons to believe that women attended certain ANC 
facilities based on HIV testing services being available or not.  
 
Information bias 
Information bias is often subdivided into recall bias and misclassification. Both exposure and 
outcome could be subject to misclassification. Misclassification might be of two different kinds: 
non-differential- (random) or differential (systematic). If misclassification has occurred, a person 
is classified into the wrong outcome or exposure category [165]. Non-differential 
misclassification means that measurement problems occur in all groups. Differential 
misclassification on the other hand occurs when either the exposure (e.g. socioeconomic status or 
distance to a health facility) is misclassified according to somebody’s outcome status (here not 
being HIV tested), or if the classification of the outcome would be influenced by exposure status, 
meaning that the measurement problems occurs in one group differently causing a systematic 
error [164]. The data for this research were collected through questionnaire-based, face-to-face 
interviews, and responses could have been subject to reporting bias from the respondents. 
However, in order to get as valid answers as possible the interviews were conducted in private, 
and by well-trained and experienced female interviewers. Further, the questions were also 
structured to cover the most sensitive questions in the end of the interview to pose them when 
the interviewee had had a chance to get to know and gained some trust for the interviewer [119]. 
Much of the exposure data was also derived from the pre-existing HDSS database e.g. data on 
socioeconomic status, age, marital status etc., and therefore not subject to self-reports. 
 
The record reviews at the health facilities were conducted by me and two experienced and 
trained assistants, and the HDSS information on woman’s name, male partner’s name, village, 
age and expected date of delivery were used to identify the “right” woman. If unsure about the 
identification, the woman was excluded. Data on the outcome “being tested for HIV” came 
from registers at the health facilities, and the quality of the outcome measure is dependant on 
whether the forms were filled in correctly. However, the research team spent much time at the 
various health facilities and observed the record keeping, and the quality of HIV testing 
registration seemed to work well, but there is a risk of a random error and non-differential 
misclassification of the outcome, in turn diluting the estimate towards the null hypothesis, 
making the estimated association weaker than the true population value [164]. 
 
Confounding 
Confounding occurs when the association between exposure and outcome is distorted due to the 
mix of the effect of the exposure with another factor associated with the outcome under study. 
A confounding factor is a third factor that is associated with both the exposure under study and 
the outcome, a factor that also is independently of the exposure associated with the outcome 
[165].  
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The distribution of a confounder needs to be uneven in the comparison groups.  If data has been 
collected for a confounder that could be controlled for in the analysis phase with the goal to 
eliminate or reduce variation in the level of the confounding factor between compared groups. 
 
In this research several potential risk factors associated with the outcome (not being HIV tested) 
were analysed, and the risk factors identified for not being tested were: being poor, having a 
distance longer than 3 km to a facility with HIV testing services and having more than four 
living children.  
 
A possible non-collected risk factor that might have confounded the estimate for the association 
between having more than four living children and not being HIV tested is education. It is likely 
that a less educated woman has a higher number of children and also has less knowledge about 
the importance of being HIV tested.  
 
Decision tree analysis (IV) 
The decision-tree analysis combined the empirical data from the HDSS cohort and assumptions 
on the most recent HIV transmission rates data used in the UNAIDS Spectrum modelling [48]. 
The transmission rates for the various ARV regimens, and the women’s CD4 cell count levels 
during pregnancy and during breastfeeding, are based on a review of the available literature. 
The studies included in the review are not always easily comparable since they differ with 
regard to exposure, population etc. Nevertheless, it is the best data available, and has been 
reviewed by some of the most experienced researchers in the field.  
 
In addition to what has been discussed above for the qualitative and quantitative research 
methods, the research in this thesis has also been triangulated by the use of different methods to 
study access to PMTCT services. The use of several research methods made the results and 
conclusions more reliable and trustworthy.  
 
Further, the data from this research were also triangulated with data collected by other 
researchers within the ARVMAC project. 
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CONCLUSIONS 
 
x Policy implementation of opt-out HIV testing and couple testing for HIV aiming to 
increase enrolment and completion of PMTCT has not been successful in this setting 
due both to health system weaknesses and failure to contextualize the programmes. (I, 
II, III, IV) 
 
x Very few of the women who sought ANC from facilities without HIV testing services 
carried through the testing referral, and this is a major reason for the low population 
uptake of HIV testing during pregnancy. (I, III) 
 
x The poorest women had the lowest access to HIV testing, primarily because of living 
further away from the health facilities with HIV testing services. (III) 
 
x The opt-out HIV testing was not accompanied with sufficient counselling to empower 
women to make informed decisions. (I) 
 
x Most of the HIV-infected women did not adhere to the PMTCT services, bring their 
babies for testing, practice safe feeding or were not referred to HIV care. This is a 
missed opportunity since diagnosing HIV is not the end-goal but the first and crucial 
step in PMTCT and the first step towards care and preventive measures. (I, IV) 
 
x The PMTCT coverage in this setting translated into an estimated MTCT rate of 13% at 
birth and 16% at six months. Strengthening the health system to enhance adherence to 
the PMTCT services could reduce MTCT. (IV) 
 
x Increasing access to HIV testing during pregnancy to 100% either through expanded 
onsite testing or better counselling and referral systems, was estimated to be the single 
most effective intervention to decrease MTCT in this rural setting. Yet, only combined 
PMTCT interventions together with perfect adherence to all PMTCT components would 
reduce MTCT rates to levels below the target of less than 5%. (IV) 
 
x The implementation of couple testing for HIV during pregnancy has failed in this 
setting. Neither pregnant women nor men felt comfortable to test together with their 
spouse. Local gender norms and behaviours have been neglected when HIV testing 
programmes were implemented and alternative methods of male partner recruitment are 
needed. (I, II, III) 
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RECOMMENDATIONS 
To improve access to PMTCT services, increased coverage of HIV testing during pregnancy is 
crucial. This thesis indicates that even though an opt-out HIV testing policy has been 
implemented, uptake of testing during pregnancy is far from universal. Based on the findings 
from this thesis, recommendations that could increase the access to PMTCT services are 
presented.  
 
To increase access to PMTCT services, interventions both in the health system and the 
community are needed to make the services more available and acceptable.  
 
By involving the community in policy implementation the acceptability of the policies might 
improve and increased access to PMTCT services attained.  
 
Strengthening the referral structure for HIV testing or implementing outreach testing could help 
to increase the availability and acceptability of testing services.  
 
Strengthened adherence support to HIV-infected women could decrease dropout from the 
PMTCT programmes, and structures should be established to link the woman and her infant 
from PMTCT- to ART and/or paediatric care.  
 
Since gender dynamics was identified as a main hindering factor to men’s acceptance of couple 
HIV testing, the recruitment for couple testing should be made more acceptable to men. 
Focusing the community messages to the men more explicitly, as well as introducing peer-
counsellors or role models at community-level might increase male involvement in PMTCT. In 
addition, adapting the otherwise female domain of the ANC facilities to make men feel 
welcome might increase the male involvement.  
 
Since couple HIV testing was not well-accepted by either men or women, increasing men’s 
access to individual HIV testing by acknowledging their own recommendations for how that 
could be achieved, might be even more crucial. 
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Appendix 2. Summary of ARVs 
Nucleoside analogues (NRTIs) Non-Nucleoside analogues (NNRTIs) Proteas Inhibitors (PIs) 
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Appendix 3. Question guide for semi-structured interviews (I) 
HIV pre-test counseling 
1. Mubulwalilo bye munwela eyidagala babawelewo mu engeli nningi nga okubabudabuda. 
Bakubudabuda mu kwekebeza akawuka kasilimu?  
ANC clinics provide many different services, among them counseling. Were you 
counseled/taught about HIV testing?  
 
2. Okilowozaku ki otya kubyo kubudabudibya? 
What do you think about the counseling? 
  
3. Nkoberaku ebyaliwo nga bamaze okukubudabuda/okukusomesa kubya akawuka kasilimu? 
Could you please describe what happened after being counseled for HIV testing? 
 
HIV testing 
4. Olowoza migasoki egili mukwekebeza akawuka ka silimu? 
What do you think are the benefits of being tested for HIV? 
 
5. Wasalawo otya okwekebeza akawuka? Waliwo eyakuwaamagezi oba waliwo ekyabawo? 
How did you decide to take the HIV test? Did someone recommend you to do it, was it a 
something that influenced your decision?  
6. Okilowozaku ki ekyo kukebera akawuka kasilimu nga eyiteka mubulwaliro obwokunwelamu 
eyidagala  ekyokuba nti abakyala abaida okunya eyidagala balinobakebeza akawuka ka 
silimu? 
What do you think about that HIV testing is done as routine during ANC? 
 
7. Okilowozaku ki ekyokwida wano okunwa eyidagala ate bamala bababudabuda kubyo 
okwekebeza akawuka kasilimu era olunaku lwene olwo babatolaku omusayi era 
bakuwelawo ebivilemu? 
What do you think about that women during ANC receive information about HIV testing, 
are tested and receive the test results on the same day? 
 
Effects of HIV testing 
8. Walowozaku kwebyo ebinava mukwekebeza? 
Did you think about the outcome of HIV test results when you were to be tested for HIV? 
 
9. Onayegeraku kwekyo kyoli? 
Would you disclose your HIV status to someone?  
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10. Mubuwaliro bwemunwelamu eyidagala ebayo okubudabuda omwami no mukyala ekyo 
ekilowozaku otya? 
At ANC, couples are encouraged to be counseled and tested together, what do you think 
about that? 
  
11. Owulira ofya kwekyo kyewasalawo okwekebeza? 
How do you feel about being tested for HIV? 
 
 
Effects if tested HIV positive 
12. Singa bakukebera nga olina akawuka, ekyo kikyusa kitya obulamu bwo? 
If you were to be tested HIV positive, how would that influence your life?    
 
13. Oyidi engeli omukyala alina akawuka dasobola okukozesa okuziyaza omwana okufuna 
akawuka? 
Do you know how a woman with HIV can protect her baby from acquiring the HIV virus?  
  
Male involvement 
14. Olina omwami?Obyi wandyenze yetabe mukwida okunwa eyidagla nga olinda? 
Do you have a partner?  
If yes, would you like your partner to be involved in ANC during pregnancy? 
 
15. Omwami wo yakuwaku amagezi okwekebeza akawuka oba be nga olinda? 
Did your partner influence your decision whether to be HIV tested or not during pregnancy?  
 
16. Olinayo ekindi kyona kyona kiwandyenze okwongera kubigemangana no okwekebeza 
akawuka kasilimu, nokkusiyiza akawuka obutagema mwana nga kava ku maamwe ku 
bulwaliro yemunwela eyidagala obo eliyo ekindi kyonakyona kwebyo byetwogeileku.
  
Is there anything you would like to add regarding HIV testing and PMTCT at ANC, or any 
other issues that we have discussed? 
 
Webale ino okwetaba mu musomo guno, kibaile kyamugaso ino okuwayamu nife kwebyo 
ebikugemaku 
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Appendix 4. Topic guide (II) 
1. First, what do you think are men’s roles for antenatal care during pregnancy? 
2. Are you aware of any services that can help parents to prevent HIV transmission to the 
unborn child?  
3. Would you like to receive those services?  
4. How do you see the benefits from the PMTCT services at ANC?  
5. Today, few men attend ANC health units, what do you think are the reasons for this? 
6. Today, few men are HIV tested at ANC health units, what do you think are the reasons 
for this? 
7. How do you think you and other men would like to be involved in the PMTCT 
programme?  
8. What would be the consequences for you and your partner if you came to know that 
your pregnant wife (partner) is HIV positive?  
9. What if one in a couple is tested positive and the other negative, what effect could that 
have for their lives? 
10. If your partner was tested HIV positive, how would you act after the result was given? 
11. If you were tested HIV positive, how would you act after the result was given? 
12. What do you think about the different places where women deliver from?  
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Appendix 5.  Questionnaire used in the HDSS survey (III, IV) 
 
Round Number   
FA Code 
Date of Interview 
Village Name & CODE…………………………………………… 
Structure No 
Location ID       
PREGNANT WOMAN’S ID 
PREGNANT WOMAN’S NAME ………………………………………………………………….….. 
1. Oli mabundha buti? 
Are you currently pregnant? (confpreg) Yes =1   No=2 Æ end the interview 
2. Amabundha ago gamyezi emeka buti? 
How many months old is the pregnancy? (oldpreg)     |__|__| months  Do not know = 98  
3. Mulimoki omukulu gwokola? 
What is your present main occupation? (choose one) (occup) 
1. Subsistence farming 
2. Commercial farming 
3. Small business  
4. Large business 
5. Formal employement  
6. Labourer 
7. Unemployed 
8. Other pls specify 
  
B. HEALTH CARE SEEKING DURING PREGNANCY  
4. a. Wafunaku obwidhandabi bwona-bwona kumabundha ganho nga otweireku okuja okunwa obulezi? During the time of pregnancy, 
have you sought any type of care EXCEPT ANC? (anycare)  
Yes = 1    Æ question 4, b and c, than question 5 No = 2    Æ question 8 
b. Waja emirundi emeka?  
 How many times have you sought care? (timesanycare) 
………………………………. times 
c.  Omulundi ogwasokeraila okuja okufuna obwidhandabi, amabundha ganho, gali gamyezi emeka? At what month of the 
pregnancy did you seek any care for the first time? (ageanycare)  
 
1.  Months 1-3 
2. Months 4-6 
3. Months 7 or later 
IGANGA/MAYUGE DEMOGRAPHIC SURVEILLANCE SYSTEM 
Pregnancy questionnaire 
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C. ANTENATAL CARE 
8. Kumabundha ganho, wali ogireku mukifo ekinwerwamu obulezi? 
During this pregnancy have you attended ANC health unit/s? (anccare)  
Yes = 1 Æ question 10   No= 2  Æ question 9 
9. Nsonga ki edhakulemessa okuja okunwa obulezi? What was the reason/s for not going for ANC? (reasonnoanccare)  
(Do not read out the alternatives, tick what is mentioned, SEVERAL REASONS COULD BE MENTIONED) 
 Yes=1 No=2 
1. Pregnancy is still young 
  
2. Was not feeling ill 
  
3. Lack of money 
  
4. Fear 
  
5. Distance to health facility 
  
6. Staff attitudes at health facility 
  
7. Weather conditions 
  
8. Partner did not agree on visit ANC 
  
9. Don’t know the importance/benefits of visiting ANC 
  
10. Other pls specify  
  
 After answering question 9 Æ question 27 (FIRST READ THE HIV PREAMBLE) 
10. Anhi eyakuwa amagezi okuja okunwa obulezi? 
When you sought ANC during this pregnancy, who advised you to do so? (whoadviceanccare) (do not read out, circle what is 
mentioned)  
1. You yourself  
2. Husband  
3. Your mother 
4. Mother in law 
5. Other pls specify 
 
11. Gha wotera okuja okunwa obulezi kumabudha ganho? During this pregnancy, where do you normally go for ANC? 
(whereanc)  
1. Hospital 
2. Health centre 
3. Private clinic 
4. Private midwife 
5. Traditional birth attendant 
6. Other, pls specify  
 
12. Musawo wangeriki atera okukolaku nga ogire okunwa obulezi? 
What type of health care staff do you normally see at ANC health unit? (whoseenanc)  
1. Medical doctor/Clinical officer 
2. Midwife 
3. Nurse 
4. TBA 
5. Other pls specify 
 
13. Nandyenze okunkoberaku erinha eryekifo kyonweramu obulezi niwe kyaganibwa? (ancfacility) 
Please tell me the name and place of the facility? 
……………………………………………………………………………………………………………………… 
For official use only;  
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14. Ntambulaki yotera okukozesa nga oja okunwa obulezi? What type of transport do you normally use to get to the 
ANC health unit? (transpanc) 
I Bus 
II By foot (walking) 
III Ambulance/facility vehicle 
IV Motorbike  
V Taxi 
VI Private Car 
VII Bicycle 
VIII Other (Specify): 
 
15. Kikutwalira kiseraki okuva wano okutuka wonwera obulezi? How long does it normally take to go from your home 
to the ANC health unit? (do not read ot the alternatives) (timetoanc) ? 
1. less than 1 hour 
2. 1-2 hours 
3. 3-4 hours 
4. 5 -12 hours 
5. 13-24 hours 
6. more than 1 day 
      98. Do not know 
 
16. a) Kumabudha ganho, mirundi emeka gyewakaja okunwa obulezi? (timesanc)  During this pregnancy, how many 
times have you attended ANC?  
 ................... times 
 
b) Amabudha ganho gali gamyezi emeka wewatandikira okunwa obulezi era wakajayo emirundi emeka?  
At what month of pregnancy did you attend ANC health unit and number of times? (ancvisittrim) 
 Number of ANC visits/trimester 
1. Months 1-3 |__|__| 
2. Months 4-6 |__|__| 
3. Months 7 or more |__|__| 
 
17a. Wasasulayo ekintu kyona kyona bwewaja yemunwela obulezi? Did you pay anything during the ANC visits? 
Yes = 1     No= 2    
Æ question 17b     Æ question 18 
 
17b. Osasula otya buli murundi gwaja okunwa obulezi? How much did you pay for ANC, including transport? 
(whatpayanc) 
 1. ANC visit (including official and 
non official payment) (USh) 
2.  Transport 
(Ush) 
3. Kind (specify) 
VISIT 1    
VISIT 2    
VISIT 3    
VISIT 4    
Total    
  
18. Kumabundha ghanho, mwajaku nomusadha wo ewomusawo gyonwera obulezi? 
During this pregnancy, has your partner ever attended ANC with you? (partnanc)  
Yes = 1  Æ question 20   No= 2  Æ question 19 
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19. Lwaki omusadhawo tiyaja nhiwe gyonwera obulezi? What was the main reason why your partner did not attend ANC with 
you? (whynotpartnanc)  
1. He is rarely at home 
2. He does not want to 
3. He fears 
4. I did not ask him to attend ANC 
5. He does not see the benefits/ importance of attending ANC 
7. Other pls specify 
 
D. HIV TESTING 
Twogeireku kubigemagana n’ofuna obwidhandhabi no’kunywa obulezi nga oli mabundha. Mu madwalilo agandi 
basomesaku kubya kawuka kasilimu no’kwekebeza. Buti ndiija kubuzaku kubigemagana no’kwekebeza 
akawuka.  
 
We have talked about health care during pregnancy and especially ANC. At some health facilities they carry out 
HIV counselling and testing at ANC, now I would like to ask you some questions about HIV testing.  
 
20. Kumabundha ganho, bakusomesaku ebigemagana nokwekebeza akawuka akasilimu yonwera obulezi?  
During this pregnancy, were you counselled for HIV testing at the ANC health unit? (womcounslanc)   
Yes = 1   No= 2     
 
21. Kumabundha ganho, bakukeberaku akawuka akaleta silimu?  
     Have you been tested for HIV during this pregnancy?(testpreg)   
  Yes = 1  Æ question 23 No=2  Æ question 22      Do not know = 98  Æ 
question 22 
 
22. Lwaki tiwekebezangaku akawuka ka silimu kumabundha ganho? Why have you not taken an HIV test during this 
pregnancy? (whynottest) (Do not read out the alternatives, tick what is mentioned, SEVERAL REASONS COULD BE 
MENTIONED) 
 Yes=1 No=2 
1. Fear/stigma 
  
2. Testing services were not available  
  
3. Transport costs  
  
4. Lack of transport  
  
5. Testing site is too far 
  
6. Don’t know where to get HIV tested  
  
7. Don’t need the results  
  
8. Need permission   
  
9. Weather  
  
10. Long waiting time  
  
11. Other pls specify 
 
  
 After answering this question Æ 27 
23.  Kumabundha ganho, wekebereza gha akawuka kasilimu? 
      Where did you take the HIV test during this pregnancy? (whrtest)  
(pls specify name and location of the health unit) 
…………………………………………………………………………………………………….. 
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For official use only;  
 
24. Mulundi ki wewekebereza akawuka kanho akasilimu? During which ANC visit/s did you take the HIV test/s? (visittest)  
 (several tests are possible, separate by using a comma)  
 
ANC visit number; ………….. 
25. Wafuna ebyava mukwekebeza kunho? Did you receive the test result? (recivrsult)  
Yes = 1   Æ question 27  No = 2   Æ question 26  
26. Nsongaki eyakulobera ofuna ebyava mukwekebeza kunho? What was the reason for not receiving the HIV test result? 
(resnnotrecivrslt)  
(Do not read out the alternatives, tick what is mentioned, SEVERAL REASONS COULD BE MENTIONED) 
 Yes=1 No=2 
1. Fear  
  
2. Transport costs  
  
3. Lack of transport  
  
4. Testing site is to far 
  
5. Don’t know where to get the results  
  
6. Don’t need the results  
  
7. Need permission   
  
8. Weather  
  
9. Long waiting time 
  
10. Lack of time  
  
11. Other pls specify  
  
 
27. Have you ever been tested for HIV? (evrhivtest)       
 Yes = 1 Æ question 28       No = 2  Æ question 32  
  
 Do not want to answer = 3   Æ question 32      Do not know = 98 Æ question 32             
 
28. How many times have you been HIV tested? (testtims) 
 …….. times 
 
29. Balo adhi bwoyemereire kubigemagana na kawuka kanho? Have you disclosed your HIV status to your partner? 
(disclospart) 
Yes = 1    No = 2     Do not 
want to answer = 3 
  
If answering no to question 8 and/or 18 Æ 32  
 If answering yes to question 18 Æ 30  
 
Mubitundi edindhi mwetunwera obulezi, abaami baiffe bakubirizibwa okwidhanga ni bakyala baibwe 
okusomesobwa nho kwekebeza akawuka kasilimu: 
At some ANC health units the partners to pregnant women are encouraged to attend ANC for HIV counselling 
and testing 
 
30. Kumabundha ganho, omusadhawo yafunaku okusomesebwa kubigemagana nakawuka kasilimu gyonwera obulezi? Has 
your partner been counselled for HIV testing at ANC health unit during this pregnancy? (partnconsl)  
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Yes = 1    No = 2  
  Do not know = 98  
  
31. Kumabundha ganho, omusadhawo yakeberwaku akawuka eyo gyonwera obulezi? Has your partner been HIV tested at 
ANC health unit during this pregnancy? (partntestanc) 
Yes = 1    No = 2   
  Do not know = 98  
 
32. Omusadhawo yakukoberaku engeri gyayemereremu kubigemegana nakawuka? Has your partner disclosed his HIV status 
to you? (mandisclo) 
Yes = 1    No = 2     
  Do not want to answer = 3 
 
33. Olina kakadha oba ekitabo kyonweraku obulezi? Do you have an ANC card or ANC book? (anccard) 
Yes = 1    No = 2    
If No, answer question 34 and then end the interview. If yes and an ANC card/book is available, ask to see it and fill in the 
answer to question 35-38 after the interview, do not ask the questions 
 
34. Lwaki ozira kadha eyo oba ekitabo kyonweraku obulezi? Why don’t you have an ANC card/ book? (whynoanccard) 
 
 
 
 
 
 
 
NB. BE VERY CAREFUL ABOUT TAKING DOWN THE RIGHT ANC CARD/BOOK NUMBER AND THE 
NAME OF THE HEALTH UNIT 
 
35. Write the ANC card/book number (crdnr) 
…………………………………………………………………………………………………………… 
36. Write down the name of the facility name and location where health care was sought (village or parish) (crdfac) 
___________________________________________________________________________________________ 
 
For official use only;  
 
37. How many times has the mother attended the ANC health unit? (count the number of visits, using the dates indicted in the 
book/card) (crdtimanc) 
………… times 
38. Is the following information written on the card/book? (crdinfo)  
(NB information can be found on the first page) (circle all appropriate) 
 Yes=1 No=2 
C   
T   
 
 
 
 
 
  
1. I have not gone for ANC  
2. I went for ANC but did not get a card/book 
3. I went for ANC but I lost the ANC card/book 
4. Other, pls specify  
 
I
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Two years after the introduction of provider-initiated, opt-out HIV counselling
and testing during antenatal care (ANC) in Uganda, HIV testing uptake is still
low. This study was carried out to explore pregnant women’s experiences of, and
views on, the policies for opt-out, and couple HIV testing, and to understand
how the policy implementation could be improved in order to increase access to
prevention of mother-to-child-transmission (PMTCT) services.
The study was conducted at three ANC health facilities at different levels of care
in rural eastern Uganda. Data were collected through sit-in observations during
ANC and 18 semi-structured interviews with pregnant women receiving ANC,
and thereafter analysed using latent content analysis.
Pregnant women who received ANC from facilities that provided HIV testing
on-site perceived HIV testing as compulsory without actually fully realizing the
benefits of HIV testing and PMTCT. No referral for HIV testing or information
about testing was given at ANC facilities that lacked HIV testing on-site. A major
challenge of couple HIV testing was that pregnant women were made
responsible for recruiting their spouses for testing, a precarious dilemma for
many women who tried to fulfil health workers’ requests without having the
power to do so.
In order to increase uptake of PMTCT services, the pre-test counselling in groups
that precedes the provider-initiated HIV testing should be adjusted to inform
women about the benefits of PMTCT. Further, if testing is perceived as
compulsory it could potentially deter some women from seeking ANC services.
In order to increase HIV testing of male partners new strategies are needed, for
example peer-sensitization and male clinics. Moreover, to achieve the desired
outcomes of the PMTCT programme, monitoring and evaluation should be built
into the programme.
Keywords Provider-initiated, HIV testing, gender, antenatal care, Uganda
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KEY MESSAGES
 Counselling preceding provider-initiated HIV testing during antenatal care should be improved to inform women about
the benefits of HIV testing and prevention of mother to child transmission services.
 In order to increase male partner HIV testing during antenatal care, recruitment strategies that are more gender-sensitive
are needed.
Introduction
In 2003, only 10% of Ugandan women giving birth were tested
for HIV, despite the fact that 94% attend antenatal care (ANC)
and that Uganda has an overall HIV prevalence of 6.4%
(Karamagi et al. 2006). Three years later, the proportion of
pregnant Ugandan women receiving pre-test counselling (40%)
and HIV testing (21%) had doubled but still remained
unacceptably low (Ministry of Health [Uganda] and ORC
Macro., 2006).
Consequently, the goal of 80% coverage of prevention-of-
mother-to-child-transmission (PMTCT) services and a reduction
of new paediatric infections by 50% by 2010 as stated in the
universal access declaration, does not seem to be within reach
(WHO et al. 2008). HIV testing during ANC is the entry point to
PMTCT services, and in order to increase coverage of PMTCT,
the Ugandan government launched new policy guidelines in
2006, moving from voluntary counselling and testing (VCT) to a
provider-initiated opt-out HIV testing model (Ministry of
Health 2006). The new policy states that all pregnant women
and their male partners should routinely be offered counselling
and testing for HIV during ANC, and that health facilities
without testing services should refer couples for testing to a
nearby facility with HIV testing.
In Uganda, HIV counselling and testing is organized similarly
at most government health facilities: all women who come for
ANC, receive pre-test counselling combined with general health
information, together in a group. Thereafter, a venous blood
sample for a rapid test for HIV antibodies is taken and analysed
while the pregnant woman receives a physical check-up. Test
results can be received the same day during individual post-test
counselling (Ministry of Health 2006).
The Ugandan policy is in line with the policy for provider-
initiated HIV testing recommended by the World Health
Organization (WHO) for countries with a generalized HIV
epidemic, aiming to integrate HIV testing in standard medical
care at all health facilities (WHO and UNAIDS 2007). The
rationale is that if more people get to know their HIV status,
the number of people linked to treatment and prevention
interventions would increase (De Cock et al. 2003; De Cock et al.
2006). Health facility-based studies from sub-Saharan Africa,
including Uganda, show that opt-out HIV testing during
pregnancy may increase the testing uptake by up to 80%
(Perez et al. 2006; Chandisarewa et al. 2007; Creek et al. 2007;
Homsy et al. 2007; Dahl et al. 2008; Mugore et al. 2008).
However, the latest UNGASS progress report from Uganda
shows that despite a substantial improvement in coverage
doubling the number of ANC sites offering PMTCT, only 30% of
all pregnant women estimated to be HIV infected received
prophylactic antiretroviral drugs (ARVs) for PMTCT in 2007
(Ministry of Health 2008). The policy of couple HIV testing
during pregnancy, i.e. offering joint HIV testing for pregnant
women and their spouses, has shown to increase women’s
access to and completion of PMTCT services, but the uptake of
couple HIV testing in Uganda and other sub-Saharan Africa
countries remains low at 5–12% (Farquhar et al. 2004; Homsy
et al. 2006; Elisabeth Glaser Pediatric AIDS Foundation 2008;
Msuya et al. 2008).
Changing policies is a complex process and the effect of the
opt-out HIV testing policy has mostly been evaluated quanti-
tatively; for example, in Zimbabwe it was shown to contribute
to high uptake of HIV testing (Walt 1994; Mugore et al. 2008).
The aim of this study was to explore how the intended target
group, i.e. pregnant women, experience the new HIV testing
policy since, to the best of our knowledge, this has never been
evaluated in-depth in sub-Saharan Africa (Gruskin et al. 2008;
Thorsen et al. 2008). Further, the aim was to understand how
the policy implementation could be improved in order to
increase access to PMTCT services.
Methods
Study setting
This study was carried out in the rural districts Iganga and
Mayuge, 120 km east of Uganda’s capital city Kampala,
between February and March 2008. In these rural districts all
health facilities provide ANC, ranging from level II up to
hospital level. Level II health facilities provide outpatient
services; level III health facilities include a general ward, a
laboratory and maternity services; and level IV health facilities
also have operation theatres.
HIV testing and PMTCT services were introduced at Iganga
district hospital in 2004 and soon thereafter expanded gradually
to lower-level health facilities. The policy for opt-out HIV
testing during ANC was introduced in the two districts in 2006,
and implemented similarly regardless of level of care. Pre-test
counselling is always provided in groups during the general
health education sessions. The number of women per counsel-
ling session varies with the level of care, ranging from five at
level II facilities to 40 at hospitals. The duration of a group
counselling session is about 15minutes regardless of facility
level. Most of the health facilities in the two districts are
government health facilities but a few are run by non-
governmental organizations. The majority of the facilities are
level II, and most of them cannot perform HIV testing. Instead,
according to the guidelines, these lower level facilities should
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provide HIV counselling to all pregnant women and their
partners, and then refer them for testing at higher level of care.
Study design
This study included both semi-structured interviews and sit-in
observations. The interviews aimed to investigate pregnant
women’s experiences of provider-initiated HIV testing, and
included questions about how women experienced the pre-test
counselling received; what information they had received
about HIV; whether they had understood the purpose of HIV
testing; and their view on couple HIV testing. In order to get
views from women who received ANC from different levels of
care, respondents were recruited from three purposely-selected
health facilities: one district hospital (n¼ 10), one health
facility III (n¼ 6) and one health facility II (n¼ 2). The
hospital and the health facility III provided HIV testing
during ANC, while the health facility II was supposed to refer
patients for HIV testing. All pregnant women visiting one of the
three facilities were eligible to participate.
In total 18 women were interviewed. Purposive sampling was
performed in order to obtain the views of both first-time
pregnant women (n¼ 4) and women who had been pregnant
before (n¼ 14), as well as women with unknown (n¼ 10) vs
confirmed HIV infection (n¼ 8). Women were approached at
registration for ANC in collaboration with a nurse working at
the health facility. The aim of the study was described to
eligible women, and they were invited to participate in an
interview while waiting for their HIV test results or other ANC
services. The interviews were conducted in a separate room at
the health facilities in order to ensure confidentiality. Each
interview was carried out in the local language Lusoga by one
of two Ugandan female sociologists with previous experience of
qualitative and HIV research, and the interviews lasted for
about 40minutes. Four women attending ANC at the hospital
declined participation since they had to attend to their children.
The interviews were audio-recorded, transcribed verbatim and
translated into English by one person, and thereafter checked
for errors by a second person.
Sit-in observations during ANC were also performed at all
three health facilities. The aim of the sit-in observations was to
explore the organization of PMTCT services and the content of
the pre-test counselling. The interviewer together with the first
author observed pre-test counselling sessions during the same
6 days as when the interviews were performed. Through
interviews and sit-in observations at the level II health facility
it was found that no information about HIV testing was given,
nor were women referred for testing. Since the aim of this
study was to explore women’s experiences of routine HIV
testing during ANC, no more respondents were included from
that facility for this reason.
Data analysis
We analysed the data using latent content analysis which aims
to analyse the underlying meaning of the respondents’ state-
ments (Graneheim and Lundman 2004). Analysis started
during data collection. Transcripts were read and discussed
within the research team after finishing an interview to identify
probes or follow-up questions to be included in the next
interview. These reviews also helped to decide when saturation
for the main research question had been reached. After data
collection, the transcripts were read several times to get a
feeling for the data. Thereafter so-called meaning units were
identified and labelled with codes (Graneheim and Lundman
2004). The codes were compared for similarities and differ-
ences, and grouped into categories on a manifest level. The
categories were subsequently interpreted for the latent meaning
and organized into themes on an abstract level. The first author
initially coded the data. Analyst triangulation was applied
during the process: co-authors read selected transcripts,
discussed codes, categorization of codes and development of
themes at several points, until consensus was achieved (Patton
2002). An additional source of triangulation regarding the
content of the pre-test counselling came from comparing the
findings with findings from another study in the same setting
exploring the quality of ANC (Patton 1990). This is described in
a forthcoming article from the same research consortium
(www.arvmac.eu) (Conrad, undated).
Ethics
Ethical approval was obtained from the Makerere University
School of Public Health Institutional Review Board and the
Uganda National Council of Science and Technology. All
participants received detailed information about the study,
and were informed that their participation was voluntary. It
was emphasized that they could decline participation without
any negative consequences for their ANC, that information
obtained would be kept confidential and that data would be
analysed after de-identification. All respondents gave written
informed consent before participation.
Results
Two main themes were identified during the analysis: ‘To test
or not is not a woman’s choice’ and ‘Absent partners: the
responsibility of women?’. Themes and categories are summar-
ized in Table 1. The themes are described and illustrated with
quotes below.
To test or not is not a woman’s choice
Respondents from the ANC clinics that provided HIV testing
generally thought that they could not receive any ANC services
unless they accepted being tested for HIV.
‘‘I am told that when you come for ANC, they have to take your
blood sample for testing: if you refuse they will not give you any
treatment (ANC) . . .No one (health worker) will care about you
when you’re pregnant, if you don’t accept to be tested for HIV.’’
(unknown HIV status, multi-gravida, health facility III)
On the other hand, sit-in observations and interviews in the
health facility that did not provide HIV testing on-site revealed
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that women there were neither informed about, nor referred for
HIV testing as the PMTCT guidelines prescribe.
Few of the women who received ANC from clinics that
provided HIV testing on-site had fully understood the reasons
for testing and the majority had little knowledge about PMTCT.
‘‘I also do not understand why they examine us and even go ahead
to take off blood . . . ’’ (unknown HIV status, primi-gravida,
hospital)
Women further commented that they felt inferior in relation
to the health workers and that they would never question
anything a health worker said, or ask questions for clarification.
‘‘What the health worker would decide upon is what I would go
with, because me I am just a patient . . . ’’ (HIV infected,
multi-gravida, health facility III)
Another example of the power imbalance described by the
pregnant women was the fact that staff often took blood samples
for testing without informing the women about why they did so.
The women themselves did not dare to question the rationale
behind it, but suspected that health workers did it in order
to test women who otherwise would not accept being tested.
‘‘That is why they take the blood before telling you, because if they
tell you before, you can dodge and tell them that I will come back
and fail to come, because not everybody is willing to test.’’
(unknown HIV status, multi-gravida, hospital)
The power asymmetry between the pregnant women and health
workers was further made clear by the fact that some women had
to pay informal payments to staff. Although women knew that
they should not have to pay for ANC services, they felt unable to
demand the services they were entitled to free of charge.
In contrast to the negative view of opt-out testing among
most respondents, there were women who viewed the new
testing policy during ANC as something positive that could
benefit both them and their children.
‘‘ . . . it was compulsory to test . . . It is good because I got to know
my status, and yet before I used to produce children without
knowing that I was positive. But now health workers counsel me
well, they carry my baby whenever I come and they give me
Septrin.’’ (HIV infected, multi-gravida, hospital)
Absent partners: the responsibility of women?
The PMTCT policy in Uganda states that all pregnant women
and their male partners should be offered HIV testing routinely
during ANC. However, since very few men spontaneously
accompanied their wives for ANC, health workers tried to
recruit men for testing through the pregnant women. This was
also confirmed by the sit-in observations.
‘‘. . . health workers asked if I could convince my husband to also
come for testing.’’ (HIV infected, multi-gravida, hospital)
Women felt obliged to accept the request to try and persuade
their partners to come for HIV testing. However, the majority
described it as a complicated mission and a major dilemma to
try to recruit their spouses while having very limited power to
influence their partner’s actions.
‘‘You can tell him but he will refuse to come. He will just tell
you that he is not coming. He does not give any reason why he
won’t come.’’ (unknown HIV status, multi-gravida, health
facility II)
Since the women rarely felt they could just ask their partners
directly, they talked about using alternative strategies, includ-
ing lies, to get their spouses to come to the health facilities,
hoping that once there, the health workers would help to
convince the men to be tested.
‘‘Maybe we can get somebody to go and deceive him that his wife is
stuck in the clinic, then I think he can come.’’ (unknown HIV
status, primi-gravida, hospital)
Some health workers offered HIV-infected women assisted
disclosure and recommended that the women should delay
partner disclosure until the man had joined them at the ANC
clinic.
‘‘She (health worker) also told me that when I go back home I
shouldn’t tell my husband directly. That I should tell him to come
along with me to the health centre such that they can test both of
us.’’ (HIV infected, multi-gravida, hospital)
Some women with a confirmed HIV infection revealed that
they felt forced by the ANC staff to unwillingly disclose their
HIV status. Their fear of abandonment made some refuse to
bring their partner for testing.
‘‘He told me that he tested and was negative though it was some
time back and he is faithful, he does not cheat on me. If we test
positive it will be me who infected him. That’s why I cannot come
along with him to let him know that we are positive . . .He will
chase me away . . .’’ (HIV infected, multi-gravida, hospital)
Table 1 Summary of themes and categories
Themes To test or not is not a woman’s choice Absent partners: the responsibility of women?
Categories  HIV testing is mandatory
 Poor knowledge of HIV
 Health workers decide for me
 Not possible to ask questions
 Health workers know what is best for me
 Health workers request that we bring our partners
 Male partners refuse to come to antenatal care clinics
 Bringing the message causes anxiety
 Risk of discordance—a challenge
 Partner would not disclose
 Health workers should teach partners
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There were a few women who felt ready for couple testing
and realized that the assisted disclosure would release them
from the burden of being the messenger.
‘‘When we come here together, it would be easy for the health
worker to explain to him all the details of my sickness unlike
me who would not tell him everything that I was told at the
health centre.’’ (unknown HIV status, multi-gravida, health
facility III)
In general, couple testing was not appreciated, and for the
women, bringing home the message of HIV testing to the
spouse was associated with great anxiety due to fear of negative
reactions, and severe consequences.
‘‘Because there is a time I jokingly told him that if the test results
show that we are infected, what do you do? And he said that he can
kill himself.’’ (unknown HIV status, primi-gravida, hospital)
The fear of HIV sero-discordance within the couple, especially
if the woman would be infected and the man not, was a
common concern and a major barrier to couple testing. Many
feared being accused of infecting their partners, something that
could lead to relationship problems and separation.
‘‘When you test as a couple, you may turn out to be discordant;
when one of us is positive and the other is negative this may lead to
separation and misunderstanding, and the man will claim that it’s
the woman who brought the infection. Men will never accept their
mistakes. They are normally rude.’’ (unknown HIV status,
multi-gravida, hospital)
When the male partner was known to have concurrent sexual
relationships, the value of couple testing was described as limited,
and the women asked the health workers for advice on how to
protect themselves against being infected during pregnancy.
‘‘For my husband, I don’t know whether he would take my advice.
So I don’t know how I would protect myself, maybe I can consult a
health worker. For instance if the husband has got other sexual
partners, it is easy to infect me, yet I might not have the virus [now].’’
(unknown HIV status, multi-gravida, health facility III)
Men’s freedom of choice, having the possibility to decline an
HIV test was often mentioned. It was seen as unfair that men,
as opposite to women, could choose to opt-out of testing during
ANC, to test alone without informing their partners, or even
receive antiretroviral treatment without disclosing this to their
partners.
‘‘. . . for example there was a couple that was infected but the
husband used to take care of himself alone, even treatment, without
taking care of the wife. The wife passed away last year . . .’’
(unknown HIV status, multi-gravida, hospital)
Discussion
This study found that women who received ANC from health
facilities that provided HIV testing on-site generally perceived
testing as mandatory, and rarely fully understood the benefits
of HIV testing or PMTCT. Women who received ANC from
health facilities that lacked on-site testing were neither
informed about nor referred for testing. Couple-testing was
generally not appreciated and put women in a precarious di-
lemma where they felt forced to comply with health workers’
requests to recruit their husbands for HIV testing while
fearing negative consequences at home. Below, these findings
are discussed in relation to how implementation of provider-
initiated HIV testing during ANC in Uganda could be improved.
The fact that HIV testing was viewed as compulsory is in line
with recent concerns that the global policy change from VCT to
provider-initiated HIV testing could make patients feel obliged
to test (Maman and King 2008). Despite the fact that we
interviewed women who had just attended a group pre-test
counselling session, many did not fully understand the benefits
of HIV testing and PMTCT, and since they felt submissive in
relation to the ANC staff, they avoided asking questions. In
order to improve the outcome of counselling, it is crucial that
women feel comfortable to ask questions, and that the
power-imbalance between health workers and pregnant
women is taken into account during ANC. Requests for
informal payment during ANC were reported, and further
emphasized the power hierarchy between health staff and
pregnant women.
HIV testing of pregnant women is the first step in the PMTCT
programme and the entry point for HIV-infected women to
receive other PMTCT services. The new opt-out HIV testing
policy aims to achieve higher coverage of PMTCT and to reduce
HIV transmission, but since women did not fully understand
why HIV testing was carried out, the current pre-test counsel-
ling seems to be insufficient for reaching these goals (WHO and
UNAIDS 2007; WHO et al. 2008). Similarly, since existing data
on provider-initiated HIV testing show that this testing model
results in an increased workload and less time for counselling,
new strategies for counselling need to be considered. One
option is sensitization campaigns about PMTCT at the commu-
nity level to raise awareness among both women and men
before they come to the health facilities (Evans and Ndirangu
2009).
The reported lack of counselling and referral from health
facilities without HIV testing capacity on-site has confirmed our
observations from the same district, that referral systems for
PMTCT need further review (Larsson et al. 2009). Since the
majority of health facilities that provide ANC belong to this
category, the failure to counsel and refer pregnant women for
HIV testing means that these women miss the opportunity to
receive other PMTCT services as well. One strategy to improve
both quality and access to pre-test counselling would be to
monitor and evaluate pre-test counselling at all health facilities,
including level II, as well as monitoring the referral system on a
regular basis. Further, a more robust referral system should be
introduced to follow up those who have been referred for
testing. For example, women who receive ANC where testing is
not available could be given a referral note to present at the
testing facility that should then be fed back to the first ANC
facility. Another option could be to introduce HIV testing at
lower level health facilities, perhaps through outreach activities
from a higher level of care or by diverting more resources for
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testing equipment and staff training to lower level health
facilities. Independently of where pregnant women receive
ANC, they should be empowered with information about the
importance of HIV testing during pregnancy.
Being asked to recruit male partners for HIV testing was
associated with anxiety due to perceived risk of intimate
partner violence among our respondents. These findings appear
to be supported by studies in similar settings in Botswana,
Kenya and Tanzania (Taegtmeyer et al. 2006; Weiser et al. 2006;
Msuya et al. 2008). The Ugandan PMTCT policy is based on
evidence that male partner involvement is associated with
women’s completion of PMTCT in sub-Saharan Africa
(Farquhar et al. 2004; Ministry of Health 2006; Homsy et al.
2007; Sarker et al. 2007; Kasenga et al. 2010; Msuya et al. 2008).
However, our findings raise the question of whether using
women to recruit their unwilling male partners for HIV testing
is the best way to get men involved. WHO emphasizes
that gender patterns need to be considered in order to
successfully implement policy, but gender aspects in terms of
decision-making power and women’s financial dependency on
their male partners is rarely integrated in policy development
and implementation, and few countries have followed the call
from the United Nations to integrate gender dimensions into
HIV plans (Vlassoff and Garcia Moreno 2002; WHO 2002; WHO
2003; Greig et al. 2008; WHO 2009). Though the Ministry of
Health in Uganda has incorporated gender into the Health
Sector Strategic Plan, our findings suggest that a more gender-
sensitive implementation of the PMTCT policy could improve
community effectiveness of couple testing during ANC
(Theobald et al. 2005). Instead of targeting men through their
pregnant wives, more men could be reached by using gender-
sensitive interventions at community level, i.e. community
health workers or male peers informing men about the
potential benefits of HIV testing and PMTCT. Another
solution might be to have male clinics in connection with
ANC, where men could receive counselling and HIV testing and
meet other men.
The current study focused on the pregnant women’s experi-
ences; no self-reported experiences of health workers and
men are included, nor have we interviewed women visiting
private ANC providers. However, our respondents were selected
to represent various levels of care, different HIV statuses and
different previous pregnancy experience, and we found con-
sistency in the findings among these different groups, and
concordance between interviews and sit-in observations.
Since the ANC offered at different health facilities in the
districts is rather similar, we believe that our findings are
applicable also to other ANC facilities in Uganda. We used
analyst triangulation within the research team, and in add-
ition triangulated our findings with data from another study
on the quality of ANC in the same setting. The two women
interviewed at a health facility that did not provide testing
were included in the analysis since quantitative studies
from the same district confirm that despite PMTCT guidelines,
few women are referred for, or carry through, any referral
for HIV testing (Larsson et al. 2009; Larsson et al. 2010). The
fact that interviews were conducted at the health facilities
could have hampered some potential criticism about health
workers or care received, but the interviews were always
conducted in a private space separate from the health workers.
To create trustworthiness, both the first and the fourth
author had prolonged engagements in the field at the health
facilities.
Four women, all from the hospital, declined participation for
the reason that their children needed their attention and as we
observed them taking care of their children, we have no reason
to doubt their reasons for declining.
In conclusion, provider-initiated HIV testing during ANC is
crucial to increase the coverage of testing and PMTCT.
Moreover, the preceding counselling needs to be improved so
that women are properly informed about the benefits of HIV
testing and PMTCT. However, this cannot be achieved unless
pregnant women are empowered with information to make
informed choices, and if testing is perceived as compulsory this
could potentially deter some women from seeking ANC
services. As health workers often are overburdened, one
possible solution might be to use community health workers
or peers to counsel women about HIV testing in the community
before the women come for ANC. Moreover, alternative ways to
recruit male partners for HIV testing during ANC are needed,
for example through peer-sensitization and male-friendly clin-
ics. Lastly, improved monitoring and evaluation should be built
into the PMTCT programme to improve pre-test counselling as
well as the referral system, in order to improve on the desired
outcomes of the PMTCT programme.
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Mistrust in marriage-Reasons why men do not
accept couple HIV testing during antenatal
care- a qualitative study in eastern Uganda
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Abstract
Background: A policy for couple HIV counseling and testing was introduced in 2006 in Uganda, urging pregnant
women and their spouses to be HIV tested together during antenatal care (ANC). The policy aims to identify HIV-
infected pregnant women to prevent mother-to-child transmission of HIV through prophylactic antiretroviral
treatment, to provide counseling, and to link HIV-infected persons to care. However, the uptake of couple testing
remains low. This study explores men’s views on, and experiences of couple HIV testing during ANC.
Methods: The study was conducted at two time points, in 2008 and 2009, in the rural Iganga and Mayuge districts
of eastern Uganda. We carried out nine focus group discussions, about 10 participants in each, and in-depth
interviews with 13 men, all of whom were fathers. Data were collected in the local language, Lusoga, audio-
recorded and thereafter translated and transcribed into English and analyzed using content analysis.
Results: Men were fully aware of the availability of couple HIV testing, but cited several barriers to their use of
these services. The men perceived their marriages as unstable and distrustful, making the idea of couple testing
unappealing because of the conflicts it could give rise to. Further, they did not understand why they should be
tested if they did not have symptoms. Finally, the perceived stigmatizing nature of HIV care and rude attitudes
among health workers at the health facilities led them to view the health facilities providing ANC as unwelcoming.
The men in our study had several suggestions for how to improve the current policy: peer sensitization of men,
make health facilities less stigmatizing and more male-friendly, train health workers to meet men’s needs, and hold
discussions between health workers and community members.
Conclusions: In summary, pursuing couple HIV testing as a main avenue for making men more willing to test and
support PMTCT for their wives, does not seem to work in its current form in this region. HIV services must be
better adapted to local gender systems taking into account that incentives, health-seeking behavior and health
system barriers differ between men and women.
Background
In 2002 the World Health Organization (WHO) formu-
lated recommendations advising couple HIV testing in
settings with high HIV prevalence [1,2]. The policy
guidelines are based on the assumption that couple test-
ing would help increase spousal support for women to
use prevention of mother to child transmission
(PMTCT) services, create opportunities for secondary
prevention by counseling both men and women about
HIV, and increase the uptake of testing and identifica-
tion HIV infected persons [3-5].
In 2006, following the WHO policy, Uganda’s Ministry
of Health formulated PMTCT guidelines that promoted
couple HIV testing [4,6]. Mother to child transmission
(MTCT) accounted for 16% of new HIV infections in
Uganda in 2008, despite a reported coverage of PMTCT
services of 50% [7]. PMTCT is a short-term and rela-
tively inexpensive intervention that can reduce MTCT
rates to just over 1%, and therefore it is vital to find
effective ways to increase women’s access to and com-
pletion of PMTCT services [7].
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However, the uptake of couple HIV testing during
ANC in SSA, including Uganda, has so far been very
low, only 5-12% of pregnant women are HIV tested with
their spouses [8-12]. Studies from SSA have shown an
association between male partner involvement in their
wives’ ANC, couple HIV testing, and, pregnant women’s
likelihood of accessing and completing PMTCT services
[9,10,13,14]. These associations led to the assumption
that couple testing would be key for increasing male
partners’ involvement in PMTCT. Instead, it seems
more likely that preexisting male partner involvement is
what leads some men to accompany their wives to ANC
and to support them during PMTCT, and it is possible
that the few men who accompany their wives to ANC
are not representative of most men.
Men’s uptake of HIV testing is lower than women’s in
most low and middle-income countries since women
are tested more often when pregnant, and as a conse-
quence men also have less access to antiretroviral treat-
ment [5,6,15,16]. In Uganda, virtually all adult men
(99%) have heard of HIV, but only 11% have ever tested
for HIV, while 57% of all pregnant women have been
HIV tested [17-22]. The low testing rate among men in
Uganda is disappointing since HIV was first acknowl-
edged by the Ugandan government already in the late
1980’s, and large-scale information campaigns about
HIV and prevention, including HIV testing, have been
carried out at all levels of society [17,23].
A recent study of pregnant women’s experiences of
the implementation of the couple HIV testing policy in
the same population, revealed that many women felt
subordinate to their partners and burdened by health
workers’ demand to bring their male partners in for
HIV testing[24].
Couple HIV testing during ANC has obvious potential
benefits. However, the poor uptake of couple testing
and the difficulties of reaching men suggest that the
current approach needs to be reevaluated. The present
study examines men’s own perspectives by exploring
fathers’ views on, and experiences of couple HIV testing
in two rural Ugandan districts.
Methods
Study setting
The study was conducted in Iganga and Mayuge Dis-
tricts, Busoga region, eastern Uganda. More than 80% of
the population in the two districts lives in rural areas
and only Iganga town is semi-urban. The majority of
the population are subsistence farmers, but in Iganga
town many are also involved in small businesses such as
selling vegetables and fruits in the market (mostly
women) or working as bicycle taxi drivers (only men).
The literacy rate among men in the region is in
line with Uganda’s national rate of nearly 90%.
Approximately half of the population is Muslim and half
is Christian. Polygamy is common irrespective of reli-
gion. In most families, men are the breadwinners and
the decision-makers [25]. Although “zero-grazing” and
“Western” norms of monogamy have been communi-
cated through the media, and are seemingly becoming
the norm, many men still adhere to the traditional prac-
tice of having several concurrent partners [23,25].
The total fertility rate is high at 6.7 and is similar to
the Ugandan average. About 70% of the population lives
within of 5 km from a health unit. The HIV prevalence
in Busoga region is about 6.2% among women and 4.4%
among men [17]. Free HIV testing, including couple
HIV testing during ANC should be offered at hospitals
and most health centers in the districts. The lowest level
health facilities without onsite HIV testing are supposed
to refer couples for testing [6]. A number of non-
governmental organizations occasionally provide HIV
testing through outreach activities in the communities.
According to national guidelines, counseling that
addresses people’s concerns and fears should precede all
HIV testing.
Study participants and data collection
Study participants were fathers from both rural and
semi-urban locations who had had a child in the past
year. Data were collected through nine focus groups
with about 10 participants each, four held in April 2008
and five held in April 2009, as well as through 13 in-
depth interviews held in April 2009, until saturation was
achieved. An iterative process was used whereby the
data from 2008 were reviewed and preliminary analysis
carried out before the next data collection. This preli-
minary analysis enabled the team to explore emerging
themes and issues more in detail.
Participants in the 2008 FGDs were homogenous with
regard to place of living (two in rural and two in semi-
urban settings) and then sub-divided based on number
of children (one child vs. two or more children) in order
to capture views from men with similar potential ANC
exposure. Both in 2008 and 2009, all FGDs included
both men who had and who had not been HIV tested.
FGDs were held at times and venues considered conve-
nient by the participants, usually under a big tree in the
middle of the village. Study participants were in each
data collection location recruited by a Ugandan research
assistant together with a local leader (local council
chairperson). The two together found eligible men at
peoples’ homes and at places where people normally
gather. Recruitment took place at different times of the
day to get both those who worked outside the home
and farmers working at home. The study specifics were
explained to eligible men and they were invited to
participate.
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For the FGDs in 2009 we used the same recruitment
procedures and similar inclusion criteria as in 2008
except for the criteria of the number of children, where
we instead used years in stable relationship with partner
(less than vs. more than five years). The in-depth inter-
views were conducted after the FGDs in order to
explore personal experiences around HIV and HIV-
testing and to follow up on issues identified in the
FGDs. As with the recruitment of FGD participants
the aim was to include both rural and semi-urban men
who had had a child within the last year. We also
sought men with a range of experiences of HIV-
testing: HIV tested during ANC, HIV tested but not
during ANC, and never HIV tested. Interviews were
carried out at times and places that ensured privacy
and that were convenient for the respondents, typically
at their home or work place.
The data collection instruments were topic guides
modified according to each data collection method, as
well as to the type of respondents in the interviews. The
topic guides comprised key areas such as views and
experiences of couple HIV testing during ANC and HIV
testing in general, experiences with and perceptions of
ANC attendance, and factors hindering or facilitating
couple testing and ANC attendance. One male and one
female sociologist collected data in the local language,
Lusoga. FGDs and interviews were audio-recorded, and
thereafter translated and transcribed in English. A note-
taker participated in the FGDs to capture the group
dynamics, gestures, and emotions of participants.
The atmosphere during the FGDs was open and men
seemed to enjoy discussing this topic. They were inter-
ested in knowing more and the research team often
stayed after the discussion to answer questions about
various issues related to HIV. Men commonly asked
questions about how they could obtain condoms, how
one use them, if they could use the same condom only
once, and why they should be HIV tested before devel-
oping symptoms.
Analysis
Data were analyzed using latent content analysis as
described by Graneheim and Lundman [26]. All through
the data collection periods the author ECL was present
in the field. For the first phase of data collection she
joined the discussion before and after the formal FGDs,
and during the second phase she and author XN
observed all FGDs. FGDs were discussed in detail by the
research team immediately after each session to guide
subsequent FGDs, and to identify issues that should be
followed up in the interviews. This initial discussion also
helped establish when saturation had been reached.
After data collection, ECL read all transcripts repeatedly,
and written comments were made on the texts. All
authors then read selected transcripts. Within the texts
meaning units (i.e. individual sentences related to a cer-
tain concept) were identified. Meaning units were then
condensed and assigned codes. Initial coding was done
manually on paper copies of transcripts, and thereafter
handled and organized using Nvivo software 8.0. The
codes were compared and grouped into categories with
similar topics, which were in turn grouped into themes.
The themes developed were developed based on the
interpretation of underlying meaning on a higher analy-
tical level as compared to the more descriptive cate-
gories. All steps of the analysis were discussed among
the co-authors.
Triangulation in the analysis of the data was achieved
by having researchers with many different backgrounds
analyze the data separately (pharmacist, epidemiologist,
M.D., anthropologist, sociologist). Another source of
validation was through presenting the results on a feed-
back workshop to people living in the study area.
Ethics
Ethical approval was sought and obtained from Maker-
ere University School of Public Health Institutional
Review Board and the Uganda National Council of
Science and Technology. Eligible men were informed
that their participation was entirely voluntary and all
signed an informed consent form when they agreed to
participate in the study.
Results
We identified a number of reasons for the low uptake of
couple HIV testing, including lack of understanding of
why testing was important, the perceived stigmatizing
nature of HIV care, and perceived rude attitudes among
health workers. Most prominent, however, was men’s
descriptions of their marriages as fundamentally
unstable and distrustful, making the idea of couple test-
ing unappealing because of the conflicts it could lead to
in marriages. Secondary prevention of HIV or partner
support was not stated reasons to test. The men’s
answers did not differ by place of residence or age.
Mistrust in marriages hinders men from accepting couple
HIV testing
During the discussions and interviews, the men often
talked about the nature of their marriages. They rarely
portrayed marriages built on love and understanding,
instead they described relationships where mistrust was
widespread, and extramarital affairs were common, espe-
cially among men. Extramarital affairs were in general
tacitly accepted within a marriage, and rarely discussed
between spouses. However, the ever-present suspicion,
that one’s partner would be unfaithful, created a perva-
sive atmosphere of mistrust between husbands and
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wives. It was nevertheless evident that the men valued
family harmony and were unwilling to do anything that
could provoke outright family conflict.
The men had a generally negative view of couple HIV
testing and the “promise” of couple HIV testing at ANC
health facilities actually discouraged men from accompa-
nying their wives on antenatal visits. In fact, the men
saw the situation where one might receive HIV-test
results in the presence of one’s spouse as a disadvantage
rather than as an advantage:
You know in most cases, we men don’t like to accom-
pany our wives because we know about this program
whereby once you go with your wife, then you must
be tested for HIV. So we are very worried about
escorting our wives (for ANC).
In-depth interview participant, henceforth “IDI”
We are told that when you go for ANC, they screen
you for HIV, syphilis and other diseases. So this
makes one fear.
Focus group discussant, henceforth “FGD”
Instead men felt that voluntary individual testing was
preferable, because it would enable them to keep a posi-
tive test result from their wives, if they felt it necessary.
We do not want to disclose our status to our part-
ners; when you go for HIV testing you even never tell
your wife that you went. So you and your wife test in
different places. (FGD)
Since trust and love were uncommon ingredients in a
marriage, disclosure that one or the other spouse was
HIV positive would not elicit supportiveness in the
other spouse, men explained, but rather would risk
creating a lot of arguing and could easily disturb a fra-
gile family harmony.
It is because we don’t tell our wives the truth; you lie
to her that she is the only one yet her friends see you
with other women. So if we go for testing and find
out that we are infected she will immediately start
quarrelling since already there is no love that we
show each other. (FGD)
The ever-present possibility that either member of the
couple was having an extramarital affair only made the
“offer” of couple HIV testing and the risk of discordance
more unappealing, as the following men explained:
This issue is big, the root cause of all these problems
is the issue of adultery, couples are not open to each
other and therefore fear to discuss those things
together/.../(FGD)
It affects us negatively; for example if you have been
together for 10 years and they tell you that she is
infected and you are not, it causes misunderstanding
in the home/.../.
It brings a lot of thoughts in a home, you really get
strong thoughts...you start wondering where this person
got the infection. You really live in total/.../You won-
der a lot where she got this infection and you may
even develop diseases like high blood pressure. (FGD)
Since men were, by general agreement, the ones who
were more likely to be having sexual relationships out-
side of the marriage, the risk of testing, getting a posi-
tive result, and having it made known to their spouses
was perceived as especially threatening.
It is because men have so many extramarital relation-
ships. They lie to their wives that they are faithful, but
actually they have many women, not wives but
women with whom they have sexual relationships. So
when they think about the women they have had
intercourse with, they choose to rather stay in the dark
without finding out their HIV status. (FGD)
The wife feels so bad because in everyday life women
know that it is we men who are promiscuous, so she
would straight away know that I got infected from the
places I visit, and from that moment my wife never stays.
She would say that I am going to infect her with HIV.
Men’s portrayed tendency to deceive their wives was
supported by the power structure of marriages in which
men are decision-makers and have the power over their
wives’ actions. Men resisted women’s efforts to influence
them, including when it came to HIV-testing:
We men have a despising heart; a woman will tell
you to go to the health center with her, but when you
get up in the morning you tell her not to disturb you
claiming that you are going to look for money. In
that way you avoid her. (FGD)
As to why some men did go for couple HIV testing, the
men we interviewed speculated that these were men who
had a good relationship with their wives, and had mar-
riages marked by mutual love, trust, and understanding.
Few men go for testing, and only those who are close
to one another get tested (together with their wife),
because they encourage each other/.../
It depends on the way you believe/live in the home, a
man may say that if you are willing to go, you go,
but as for me I won’t. But it should be that there is a
good relationship between wife and husband, that’s
when she tells you to go and you go. (FGD)
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In other cases the men emphasized a sense of respon-
sibility to their wives and families, along with love:
To me what forces me is my responsibility. I fear to
spoil my love, a problem to come and it is a result of
my failure to escort my wife, so it gives me the
responsibility to go with her when she starts to go for
antenatal care, and they tell us, and I do what they
have told us. And also because of the love, I have
with her. (FGD)
Men can recite HIV testing messages but this does not
induce them to test
When speaking in the abstract about HIV testing, men
recognized its importance. However, despite the ability to
recite the HIV testing messages broadcasted in their
communities, they did not see any reason to get tested
themselves. Most of the men in the study had not been
tested and only very few had been tested during ANC.
Among the men who had never tested, some went so far
as to agree that it would be good to get tested, but most
reasoned firmly that they did not want to get tested at all.
How was it that they could recite the messages about
HIV testing but not see any reason why they themselves
should actually go for testing? A topic that came up in
all FGDs and interviews was that men wanted more
convincing arguments for why they should be tested.
The men described again and again how they had been
informed that they should be tested but not why it
would be advantageous to identify a possible HIV infec-
tion before symptoms arise.
I could say that people need to be informed thor-
oughly, rather than telling them, friends “come for
blood testing, come for blood testing”. But we have to
sit down and teach people that a person should have
his/her blood tested when he/she is still healthy
(meaning without symptoms). (IDI)
That men lacked the kind of information they needed
to motivate HIV testing was further reinforced by the
men’s questions and curiosity around HIV-related issues
in the discussions that immediately followed the inter-
views and FGDs.
The media, especially the radio, which was the men’s
main source of information about HIV, had conveyed the
message that one should get tested, but the campaigns had
apparently failed to motivate the men to do so. The men
suggested that live information campaigns at the commu-
nity level instead of frequent media messages would be a
more effective strategy for getting them to test, in part
because it would enable them to ask questions.
These programs are mostly on radio, but it would be
better if you organized meetings on the LC level (i.e.
in the community), rather than putting programs on
the radio/.../then I would come there and I will
understand everything better. (IDI)
Men also suggested that men who had been HIV tested
should serve as role models, talking about their experi-
ence to other men. This strategy, men felt, would have a
greater impact on their willingness to get tested than
radio messages. Along the same lines, they also suggested
they might be more motivated to test if men who where
HIV positive came and talked to them about their lives.
Like in our village, there is no person who has ever
been ill to the extent of dying as a result of HIV/
AIDS. So it is needful for you to get somebody who
had suffered a lot from HIV/AIDS and you walk
with him as a testimony for the people, to let them
understand that this (HIV) cannot kill a person if he
gets good medicine and care. (FGD)
Interestingly, none of the respondents mentioned sec-
ondary prevention, neither to the wife nor to extramarital
partners, as a motive for HIV testing. This is in line with
their description of their marriages where concern for
their wives’ well being did not seem to dissuade many
men from having unprotected sex outside the marriage.
The expressed need for more information and differ-
ent kinds of information to motivate testing in the com-
munity was reinforced by the story one focus group
participant told of finally being convinced to get tested:
I had never been tested, but we were taught and we
finally went for testing after 2 days. So the issue is
having people taught first so as to be strong in heart
in that they give you time with some examples given
to you and after which you are tested, that even if
you are found infected, you have a look at your sick
colleague and get encouraged because I took some
given days being taught and as a result I become
strong and went for testing. (FGD)
Perceived deficiencies and problems in the health care
system discouraged the men from testing
The problems men raised with the health care facilities
were many, but can be divided into four overarching
categories: the distance and cost of getting there, organi-
zational problems at the facilities, the perceived rude-
ness of many health care workers, and the perception
that informal payment was required to obtain medicine
and good care.
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Health facilities were often far away from where the
men lived, and going there was not only costly, but took
time away from work and other activities:
Now, this becomes a long distance/.../in order for the
person to go and have a blood test/.../it is just a long
distance. (IDI)
Furthermore, when one finally got to the health facility,
organizational problems made it cumbersome to actually
get the care one needed. Men reported having been
forced to wait an entire day for care, a heavy sacrifice for
someone who needs to work to support his family:
Even the long line at the hospital (chorus answer
yes....) women can be there from 08.00 a.m. in the
morning up to evening, and waste all the time you
would have spent looking for posho [food]. (FGD)
Another health system weakness pointed out as a bar-
rier for HIV testing, was the lack of integration between
HIV care and other health services. By singling out and
exposing patients seeking HIV care through special
clinics or opening hours, men were further discouraged
from getting tested.
People start noticing your (HIV) status, because of
the specific days you go for check up. (FGD)
While HIV care put patients too much in the lime-
light, at the ANC the problem was the opposite. Men
were excluded from the sessions where their wives were
examined, and had to wait outside without any informa-
tion about what was happening to their pregnant wives.
A number of men therefore questioned the rationale for
their presence during ANC.
Now the problem with the medical staff is, you as a
man, they cannot tell you what exactly they are
doing inside there (during ANC), instead I can sit on
the verandah and they get on with whatever check-
ups and you only take your spouse back home. (IDI)
We are not allowed to go in, it is only the Doctor
and the woman, so we are left outside, helpless until
the woman comes out/.../. (FGD)
Lack of drugs at the health facilities and general low
confidence in the care provided further eroded men’s
feeling that it was worth their time to go there:
/.../most of the times when you go to the hospital they
tell you that there are no drugs they tell you to go to
such and such a clinic and buy the drugs/.../. (FGD)
The organizational issues the men cited at the health
facilities were compounded by their experience that,
in the end, payment was required to really get any
medicine. Although most men knew that antiretroviral
treatment (ART) was provided for free by several orga-
nizations, many feared not having access to care if they
tested HIV positive. Even if the drugs were free, some
noted, there were additional costs such as transport to
treatment sites, leading them to argue that in reality,
HIV treatment is only for the rich.
When you join TASO (The AIDS Support Organiza-
tion, which provides ART for free), you may even fail
to get transport to go for medication. So such issues
discourage people from going for HIV testing. (FGD)
Even when men did accompany their wives to ANC or
attend the health facilities, most men had experienced
the demanding of informal payments from health care
workers.
The doctors normally demand money for “Sumbusa”
literally meaning paying them for their services (all
the men in the group laugh since they recognize the
scenario). (FGD)
Above and beyond waiting times, lack of drugs, costs,
and the demanding for money, however, perhaps the
most unpleasant aspect of accompanying their wives to
ANC that men discussed was enduring the rude treat-
ment their wives often received at the hands of some
health care workers.
Sometimes nurses abuse our wives in our presence
saying, “whoever owns this one might be having pro-
blems.” If a nurse abuses your wife in your presence,
you can’t go back to that place again. In fact going to
the hospital for ANC is not easy but we just endure.
In fact most times we are just forced to go the health
units but it is not easy. (FGD)
The health workers’ mistreatment of the spouses made
the men feels uncomfortable and embarrassed. The
men’s feeling of embarrassment actually seemed to be
more important than the fact that women were abused.
You may go with your wife but on reaching there and
looking at the way they are treating your wife is
unkind, it is not good for the man to be there. These
nurses, there is a way these women are treated/.../she
is abused and embarrassed. So for us men, we just
choose not to accompany our wives to avoid such
things. (FGD)
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Some men had experienced nurses at ANC speaking
disrespectfully also to them directly:
/.../sometimes when you get there (to the ANC clinic)
the nurse wants to talk to you in a dominating way
just like she talks to the pregnant women. So we
sometimes feel like not going there because the nurse
will be rude to us yet it is not we men who are preg-
nant. They use harsh language, the same kind they
use with women in labor, so sometimes they want to
use that same harsh language with us. Yet we men
are easily provoked and could even become harsher
than the nurses, so you rather stay away (many par-
ticipants laugh and give signals of approval). (FGD)
Given all of the above, it is not surprising that seeking
health care in general seemed to be rare among these
men.
/.../but they will get a few patients because there are
people who have take even 40 years without going to
the hospital so it’s so hard because if someone buys
Panadol (pain killers) and feels better... (FGD)
Respondents’ reasons for not accepting couple HIV
testing, and factors that would make them accept couple
testing, are summarized in Table 1.
Discussion
According to our study, couple HIV testing during ANC
is unpopular among rural Ugandan men primarily
because they fear relationship conflicts in case of HIV
sero-discordance. The men lack incentives to be tested,
partner support, or secondary prevention of HIV is not
considered as important reasons for testing. Further-
more, the men feel unwelcomed and disrespected at
antenatal care facilities.
Set against the background of the actual marriage
relationships described by men in our study, the widely
implemented policy of couple HIV-testing appears to be
based on an unrealistic view of the nature of marriage
in rural Uganda. The “promise” of couple HIV testing
seemed to make the men less likely, not more likely, to
test. The risk of one partner turning up infected and the
other not, could easily create suspicion that one or the
other partner had been unfaithful, and was thought to
threaten marriage stability and family harmony. Previous
research in Uganda has shown that marriages can also
be easily destabilized by fertility issues such as lack of a
male child [27].
On a theoretical level, our study supports previous
research that has pointed out how traditional gender
norms in themselves can constitute significant barriers
to health care seeking among men across the world[28].
The norm that men should not show weakness, for
example by seeking health care, dictates against men
being HIV tested, especially alongside their wives [28].
Social structures, cultural norms, and implicitly gender-
biased health systems stand in complex relationships to
one another, and influence health outcomes for men
and women differently [29]. Former research has shown
that HIV-infected men find it more difficult than HIV-
infected women do to disclose their infection directly to
their spouse, and that men prefer to use a third party as
a mediator [30]. The results from our study provide a
robust example of gender as a social determinant of
health since men are expected to enter the female
domain of the ANC clinic to be tested and counseled
alongside their wives. The couple HIV-testing policy
runs up against the more common pattern in Uganda of
a clear division between male and female domains [25].
Another way in which the interaction of gender and
health systems plays out in our research is in the rheto-
ric of couple HIV testing. The ANC is perceived as lar-
gely catering to women, failing to take men’s needs into
account. The couple HIV testing policy mimics the dis-
course common when discussing male involvement in
sexual and reproductive health programs in general,
where men’s involvement is introduced to enable
women to access health care services, rather than for
the men’s own good [31-35].
According to men in our study, and also shown in
other research, separating HIV testing, care and treat-
ment from other kinds of health care only increases the
stigma of living with HIV [36]. Integrating HIV care
Table 1 The men’s reasons for not accepting couple HIV
testing, and suggestions for how to increase men’s
acceptance of couple HIV testing
A. The men’s reasons for not accepting couple HIV testing
• Worries and fear related to relationship problems
• Lack of fully understanding of why they should be tested
• Distance to health facilities and waiting time
• HIV is treated as a special disease at health facilities and this is
stigmatizing
• Health facilities are not male friendly
• Health workers treat the men and their wives badly
B. Suggestions for how to increase men’s acceptance of couple HIV
testing
• Community based information campaigns
• Peer influence and role models
• Avoid treating HIV as a special disease at health facilities
• Make HIV testing easier through:
a. More flexible opening hours for testing at health facilities
b. Provide testing from non-governmental organizations
c. Provision of transport to testing site
d. Provision of home-based testing
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into general health care would not only make testing,
monitoring and ART provision more sustainable, but
would also reduce the stigma that research has already
related to the vertical organization of HIV care [37].
Alternative HIV testing methods such as mobile clinics,
work-place testing opportunities, and door-to-door test-
ing, suggested by our study participants, have also been
shown to increase uptake of services and reduce stigma
[38,39]. A further factor in men’s reluctance to go for
testing was the perceived rude behavior among health
workers’, a factor also found in studies in Tanzania
[40,41]. Therefore interventions targeting health workers
also seem to be crucial.
The WHO recommends that the implementation of
policies encouraging male involvement during ANC
should always be accompanied by awareness campaigns
in the community, to help men - and women- to under-
stand why the policies are put in place[42]. The policy
for couple HIV testing might have created awareness
about couple testing among these Ugandan men, but
the policy did not make them act and get tested. The
men pointed out, for example, that the mass media
were their main source of information about HIV, but
that they would prefer live sensitization programs in
their communities. Several studies in Uganda, and else-
where in SSA, have found that both sexual health
awareness as well as increased testing, more use of
condoms, more use of family planning, and less sexual
risk-taking, all can be successfully achieved by “live”
community, and peer-to-peer interventions [43-45]. One
study found that exposure to radio programs about
family planning in Uganda did not increase actual con-
traception except for individuals who also received “live”
interpersonal communication[44]. Thus, one-way com-
munication through media can create awareness, but
live, personal communication may be needed to deepen
men’s understanding of the benefits associated with HIV
testing and make them act.
The men in our study had several suggestions for how
to improve the current couple HIV testing policy: peer
sensitization of men, make health facilities less stigma-
tizing and more male-friendly, train health workers to
meet men’s needs, and hold discussions between health
workers and community members.
A potential weakness of our study was that a female car-
ried out the interviews and some of the FGDs. However,
when comparing FGD responses, no differences attributa-
ble to the moderator’s gender were found. Instead, the
men talked very freely and often asked sensitive questions
about safe sex, discordance and condom use. Since many
answers were neither expected nor socially desirable, we
believe that this study offers a fair description of actual
attitudes and practices in this population.
Conclusion
Pursuing couple HIV testing as a main avenue for get-
ting men to be tested and supportive of PMTCT for
their wives, seems not to work in its current form. In
order to implement a successful, culturally adapted cou-
ple testing policy in this setting, our research suggests
that gender differences in health-seeking behavior,
health systems’ different effects on men and women,
and gender structures in society at large must be taken
into account.
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The aim of this study was to assess population-level HIV-testing uptake among pregnant Ugan-
dan women, key for access to prevention-of mother to child transmission (PMTCT) services, and 
to identify risk factors for not being tested for HIV, 
The study was conducted May 2008- May 2010 in the Iganga/Mayuge Health and Demo-
graphic Surveillance Site (HDSS), Eastern rural Uganda, during regular surveillance of 68,000 
individuals. All pregnant women identified to be pregnant May-July 2008 (n=881) were included, 
interviewed about pregnancy-related issues and linked to the HDSS database for socio-
demographic data. Women were followed-up via antenatal care (ANC) register reviews at the 
health facilities to collect data related to ANC services received, including HIV testing. Adjusted 
relative risk (aRR), and 95% confidence intervals (CI) for not being HIV tested were calculated 
using multivariable binomial regression among the 544 women who remained after follow up and 
record review. 
Despite high ANC attendance (96%), the coverage of HIV testing was 64%. Only 6% of 
pregnant women who sought ANC at a facility without HIV testing services were tested for HIV 
and only an additional 14% received any type of counseling regarding HIV. At ANC facilities 
with onsite HIV testing, 85% were tested. Less than 13% of the women reported ever being ac-
companied by their male partners to ANC, and only 4% of the women tested had been couple 
tested for HIV. Living more than three kilometers away from a health facility with HIV testing 
services was associated with not being tested both among the poorest (aRR,CI; 1.44,1.02-2.04) 
and the least poor women (aRR,CI;1.72,1.12-2.63),  but the poorest generally lived farther away 
from HIV testing services (t-test p<0.01). 
In summary, the lack of onsite HIV testing services and distant ANC facilities leads to 
missed opportunities for PMTCT in rural Uganda, especially for the poorest women. Referral 
systems for HIV testing need to be improved and testing should also be expanded to include 
lower level health facilities through targeted capacity 
strengthening. This in order to ensure that the poli-
cy of HIV testing during pregnancy is implemented 
more effectively and that testing is available and 
accessible for all. 
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An estimated 17,000 children in Uganda were infect-
ed with HIV through mother-to-child transmission 
(MTCT) in 2009, despite a stable HIV prevalence of 
7.5% among women of reproductive age (15-49 
years) and high (94%) uptake of antenatal care 
(ANC)[1, 2]. HIV testing is the first and crucial 
step in prevention of MTCT (PMTCT); however, 
only 63% of pregnant Ugandan women were test-
ed in 2010 [3].  A reduction in MTCT rate from 
roughly 40% to around 1% is possible through 
the provision of prophylactic therapy with three 
antiretroviral medicines (ARVs) administered to 
HIV infected women before, during and after deliv-
ery, cesarean section, and provision of prophylactic 
ARVs to newborns and replacement infant 
feeding[4].  In low-income countries with limited 
access to combination ARV regimens or the capacity 
to provide cesarean section and replacement feeding, 
the rate of MTCT can still be reduced to around 5%, 
provided that women are tested, enrolled in and 
complete the PMTCT program [5-7]. 
Long waiting times at health facilities and lack 
of comprehensive information about HIV and 
PMTCT, spousal disapproval and stigma, are gen-
erally suggested as barriers to the uptake and 
completion of PMTCT [8-11]. The World Health 
Organization (WHO) recommends that countries 
with generalized HIV epidemics implement opt-
out or provider-initiated HIV testing during ANC 
to increase likelihood of HIV testing among preg-
nant women [12]. Health facility-based studies 
have indicated an increase in HIV testing rates 
during pregnancy and thus support utilization of 
these recommendations [13-18].  Accordingly, the 
Ugandan national policy guidelines for PMTCT 
recommends that all pregnant women are coun-
seled and tested for HIV during ANC, provided 
they do not actively opt-out, or referred for test-
ing if onsite services are not available [19].  Addi-
tionally, but so far with limited success in practice, 
joint couple HIV testing including the pregnant 
woman and her spouse has also been introduced in 
Uganda, hoping to expand the coverage of HIV 
testing and to reduce barriers to accessing PMTCT 
services [20-24]. 
Despite these efforts at the national level, evi-
dence on the effectiveness of policy implementa-
tion at population-level is still lacking. This study 
examines barriers to HIV testing in the context of 
the national opt-out HIV testing policy and as-
sesses population-based coverage of HIV testing 
during pregnancy in a prospective cohort of preg-
nant women identified through a health and de-
mographic surveillance site in Uganda.  
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Study setting 
This population-based cohort study was conduct-
ed between May 2008 and May 2010 at the Igan-
ga/Mayuge Health & Demographic Surveillance 
Site (HDSS), a designated area across parts of the 
Iganga and Mayuge districts in eastern Uganda.  
The HDSS is predominantly rural, but also partly 
semi-urban (Iganga Town).  The main source of 
income in the area is subsistence farming[25]Ǥ  In 
2008, the HDSS population was 68,000 individu-
als among 12,000 households. HDSS activities 
include data collection on births, deaths, pregnan-
cies, and migration three times per year and have 
been described elsewhere [26].  Add-on surveys 
for special studies, such as part of this study, are 
also conducted between or during regular data 
collection rounds. 
The estimated HIV prevalence among Busoga 
women aged 15-49 years is 5.6%, which, for this 
regionally dominant ethnic group, is lower than 
the Ugandan average for women of reproductive 
age (7.5%)[27].  Ugandan health facilities range 
from the lowest level II health centres (midwife 
available) to hospital level (level V). ANC is pro-
vided at all levels and should include a physical 
examination, the provision of necessary medi-
cines, health education, and HIV counseling and 
testing, or HIV testing referral.  The Ugandan 
national guidelines recommend at least four ANC 
visits per pregnancy[28]. In the HDSS area, 13 
health facilities provided ANC, and one-third of 
these offered PMTCT services, a proportion cor-
responding to the overall accessibility to PMTCT 
services across the two districts. Very few other 
options for HIV testing existed in this area at the 
  ͵
time of study and to our knowledge, no home-based 
HIV testing or out-reach testing was carried out. 
At the time of enrolment for this study, WHO 
recommended the use of dual ARV prophylaxis of 
zidovudine (AZT) and lamivudine (3TC) from 
pregnancy week 28[29].  The ARV regimen used 
at lower level health facilities in the two districts 
was single dose nevirapine (sd-NVP), while the 
hospital provided either sd-NVP or the dual ARV 
regimen, or triple ARVs for women eligible for 
that for her own health.  Most of the HIV-
infected women in this setting received a dual 
combination ARV prophylaxis.  
 
Study design and data collection 
Ethical approval was obtained from Makerere 
University School of Public Health Institutional 
Review Board and the Uganda National Council 
for Science and Technology (Ref.nr. HDREC, 
052). The HDSS setup was used to determine the 
population coverage of HIV testing.  All women 
in the 12 000 households who were pregnant 
(n=881) at the time of study enrollment May-July 
2008 were identified through self-reports as part 
of routine data collection on pregnancies in the 
HDSS.  Within 2-6 weeks after this screening, 
field-assistants visited these women at their homes 
and after describing the purpose and specifics of 
study, invited the women to participate in an in-
terview. All women agreed.  Written informed 
consent was obtained from all participants at this 
point of enrolment, which included consent to 
link women’s interview data to health facility and 
core HDSS data.   
Four field-assistants (females due to the sensi-
tive nature of some questions related to women’s 
health and pregnancy) were trained for three days.  
The training focused on how to ask questions 
about pregnancy and HIV and how to use the 
questionnaire, which included questions about 
personal characteristics, ANC attendance and care 
received. The questionnaire was translated into 
the local language, Lusoga, piloted and adjusted to 
clarify some minor issues.  During data collection, 
a field-supervisor held daily meetings with the 
field-assistants to deal with any problems arising. 
At enrolment, 412 (47%) of the 881 women 
had not yet attended ANC during the current 
pregnancy, most of them because they were in an 
early gestational stage. These 412 women were 
therefore followed up for second interview after 
their expected delivery (interviewed May-August 
2009) to capture any information regarding ANC 
attendance.  The follow up interviews covered the 
same questions as those put to the women who 
had sought ANC already at enrolment in 2008.  
Out of these 412 women, 279 (68%) could be 
followed up and of these 41 women had not 
sought ANC at all (31 because they had had a 
miscarriage and l0 declined to give any reason). 
The 133 women that could not be followed up 
had either moved or were otherwise unavailable 
(some were not at home during any of the three 
study visits) and therefore excluded from the 
study. Hence, a total of 707 women (881-41-133) 
were followed up through ANC record reviews at 
the health facilities where they had sought ANC, 
to collect data on type of ANC received, including 
HIV testing. The first author and two trained 
field-assistants with ANC experience carried out 
the record reviews (in February- May 2010).  
Identification was confirmed by the use of 
available HDSS information on name, age, ex-
pected time of delivery, home village and name of 
spouse. Interview and record data were thereafter 
linked to core HDSS socio-demographic data and 
distances to health facilities for each respondent. 
Data   
Data were double entered in separate entry forms 
in SPSS software[30], merged using STATA soft-
ware[31], and linked to demographic data from 
the HDSS database using the women’s HDSS 
identity numbers. 
The outcome under study was: “not being test-
ed for HIV during current pregnancy” (obtained 
from record reviews). Based on existing literature, 
various potential risk factors for not being tested 
for HIV were then identified, and preliminarily 
divided: (i) socio-demographic characteristics (ii) 
health-seeking behavior (iii) health facility-related 
factors and (iv) distance to health facilities (GPS 
data).  
 Ͷ
Socio-demographic characteristics included 
age, occupation, household size, number of living 
children, spousal support and socioeconomic sta-
tus (SES). The HDSS keeps asset-based SES data 
on each household as wealth quartiles generated 
from principal components analysis [32, 33] and 
asset variables identified by the Uganda Bureau of 
Statistics, which have been described in detail 
elsewhere[26]. We first examined wealth quartiles 
and the two lowest quartiles were then grouped 
into “poorest women”, and the highest two into 
“least poor women”, due to similar associations 
with the main outcome for these categories. Age 
was grouped into <21, 21-34, and >34 years, since 
young and older women would have different 
childbirth experiences. Occupation was catego-
rized into ‘farmers versus other’ and number of 
living children into 0-4 children versus >4, based 
on a median number of 4 children. 
Data on health-seeking behavior were defined 
as adherence to national guidelines for ANC, type 
of facility where women sought ANC, whether 
anyone advised the woman to seek ANC. Seeking 
ANC late was defined as attending ANC after the 
sixth gestational month.  
The shortest distance from home to the near-
est ANC health facility and to the nearest facility 
with onsite HIV testing, was estimated using GPS 
coordinates [34]. Distance was first categorized 
into three equally large groups; 0-1; 2-3, and >3 
kilometers, but the first two categories were later 
merged when analyzing “distance to nearest facili-
ty with onsite HIV testing”, due to their similar 
associations with the main outcome. 
During an initial descriptive analysis, chi-
square statistics were used to compare the rela-
tionship between the risk factors and not being 
tested for HIV). Though we grouped the factors 
as described above, their association with the out-
come was independently assessed, first by calcu-
lating bivariate relative risk estimates, using bino-
mial regression models with link log. Independent 
variables with a p-value <0.25 in bivariate analysis 
were tested in the multivariable model. By using a 
backward selection procedure we came up with a 
final multivariable model that included SES, num-
ber of children and distance to a health facility 
with onsite HIV testing.  In the multivariable 
models variables were considered statistically sig-
nificant if the adjusted p-value was <0.05.  
The initial analysis showed a statistically signif-
icant interaction between the variables “number 
of children” and SES for the main outcome. 
Therefore we stratified the data analysis by SES to 
account for effect modification. The association 
between the distance to a health facility with vs. 
without HIV testing services (t-test), for the poor-
est vs. the least poor, differed by SES. We there-
fore thought it would be interesting to show strat-
ified analysis also for this variables even though the 
interaction was not as statistically significant the 
interaction between SES and number of children.  

4GUWNVU
Uptake of ANC and HIV testing  
Figures 1 and 2 depict the flow of study partici-
pants and show the percentages of those women 
who sought ANC and received HIV testing. Of the 
707 women who reported they sought ANC 25 
(4%) attended ANC from a traditional birth at-
tendant (TBA) or at a drug-shop, hereinafter 
termed “informal facility”, hence 682 women 
(96%) sought ANC at least once. Four hundred 
and twenty-six (78%) out of 682 received ANC at a 
health facility that offered onsite HIV testing, while 
118 women (22%) attended a health facility that did 
not offer onsite HIV testing.  The majority (n=544; 
80%) of the women reporting ANC visits could 
also be traced back to the ANC registers. Overall, 
only 64% (371/579) of the women were HIV test-
ed during the current pregnancy (the denominator 
of 579 includes 544 found in registers +10 who did 
not seek any ANC at all+25 who sought ANC at 
informal facilities, Fig 1).  
ANC and HIV testing by health facility 
Figure 3 shows the proportion of women tested 
for HIV by the type of health facility. The majori-
ty of the women who attended a health facility 
that offered onsite HIV testing, 85%, were coun-
seled and HIV tested. However, only 20% vs. 
  ͷ
17% of women who attended health facilities that 
did not have HIV testing onsite vs. informal facili-
ties, respectively, were counseled about or 
counseled and tested for HIV. Only 6% of preg-
nant women who initially went for ANC at a 
health facility that did not have onsite HIV testing 
were HIV tested, either because they were not 
referred by the staff or because they had not fol-
lowed-up on the recommendation to test else-
where. 
Figure 1. Flow of study participants: pregnant women enrolled, seeking ANC and being tested for HIV  
Figure 2. Type of health facility where the women sought ANC 
Enrolled allpregnantwomen
intheHDSS(n=881)
Women whodid not
seek ANC(n=41)
Women identified inhealth
facility registers(n=544)
Women whosought
ANC(n=707)
Losttofollowup
133women
132women
Healthfacility withonsite HIV
testing78%(n=426)
Healthfacility without onsite
HIVtesting 22%(n=118)
HIVtested
85%(n=364)
HIVtested
6%(n=7)
NotHIVtested
15%(n=62)
NotHIVtested
94%(n=111)
Allhouseholds (12000)intheHDSS
screened forpregnantwomen
Sought ANCfrom
TBAs/drug shops
(n=25)
Women incohort attheendof HDSS
datacollection (n=748)
Sought ANC
outside the
districts (n=6)
Losttofollowup
Misscarriage
(n=31)
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Sample characteristics and health-seeking 
behavior and distances to health facilities 
Table 1 presents the sample characteristics and 
health-seeking behaviors among the women. 
About half of the women who sought ANC did 
so at hospital-level (50.1%). Although 96% did at 
least one ANC visit, only 28% fulfilled the three 
ANC visits. Using GPS coordinates, about one-
third (30.7%) had to travel four kilometers or 
more to access a facility that offered onsite HIV 
testing. Very few male partners attended ANC 
with their wives (12.7%). The record reviews per-
formed at the ANC health facilities that provided 
HIV testing showed that the uptake of couple 
testing was only 4% among women who tested 
for HIV. 
Women who had not been HIV tested had an 
average distance of 3.5 kilometers to the nearest 
testing facility, compared to 2.8 kilometers among 
women who had been tested (t-test, p<0.01).  
Moreover, the poorest women had 3.5 kilome-
ters to a health facility with testing services as com-
pared to 2.7 km for the least poor (t-test, p<0.01) 
 
 
Table 1. Socio-demographic factors, health-seeking behavior and likelihood of not testing for HIV 
during pregnancy among women seeking ANC  (n=707) 
Characteristic All women, n (%) Not tested for HIV, n* (%) 
Tested for HIV, 
n* (%) 
Crude RR** 
(95%CI) 
Demographic information  Column % Row % Row %  
 Median: 25.5 Range: 14-50 Median: 25.7 Median: 24.7  
Age 14-20 140 (19.2) 34 (34.7) 64 (65.3)  
Age 21-34 510 (70.1) 115 (31.8) 247 (68.2)  
Age 35+ 78 (10.7) 18 (39.1) 28(60.9)  
Number of people living 
in the household      
1-5  199 (30.9) 69 (32.9) 141 (67.1)  
6-9 324 (50.2) 53 (35.0) 96 (64.4)  
10+  122 (18.9) 29 (35.4) 53 (64.6)  
Occupation     
Subsistent farmer 511 (73.0) 146 (37.2) 247 (62.8) 1 
All other 189 (27.0) 27 (17.9) 124 (82.1) 2.08 (1.36-3.18) 
 
     
Figure 2. Type of health facility where the women sought ANC 
  ͹
Characteristic All women, n (%) Not tested for HIV, n* (%) 
Tested for HIV, 
n* (%) 
Crude RR** 
(95%CI) 
Demographic information  Column % Row % Row %  
 Median: 25.5 Range: 14-50 Median: 25.7 Median: 24.7  
Socio-economic  
statusa      
Least poor 283 (49.7) 57 (29.2) 138 (70.8) 1 
Poorest 287 (50.3) 81 (40.7) 118 (59.3) 1.39 (1.05-1.84) 
Number of living children  Median 4.0 Range: 1-11    
0-4 433 (80.2) 122 (28.2) 311 (71.8) 1 
5+ 107 (19.8) 47 (43.9) 60 (56.1) 1.56 (1.21-2.00) 
Mean of transport to ANC      
By foot 304 (43.0) 98 (42.1) 135 (57.9)  
Other means 403 (57.0) 75 (24.1) 236 (75.9)  
Travel time from home to 
ANC health facility     
< 1 hr 320 (45.3) 88 (34.8) 165 (65.2)  
1-2 hrs  363 (51.3) 81 (29.5) 194 (70.6)  
3-4 hrs  23 (3.3) 4 (26.7) 11 (73.3)  
5-12 hrs  1 (0.1) 0 1 (100)  
Partner attended ANC 
during current pregnancy      
Yes 90 (12.7) 15 (23.1) 50 (76.9) 1.22 (0.74-2.01) 
No 617 (87.3) 158 (33.0) 321 (67.0) 1 
Health-seeking  
behavior     
Person advising woman 
to seek ANC     
Nobody 587 (83.0) 139 (30.3) 320 (69.7) 1 
Spouse 62 (8.8) 18 (40.9) 26 (59.1) 1.35 (0.94-1.94) 
Mother/ Mother in-law 43 (6.1) 8 (26.7) 22 (73.3) 0.88 (0.47-1.66) 
Other 15 (2.1) 8 (72.7) 3 (27.3) 2.40 (1.60-3.59) 
Number of ANC visits 
during current pregnancy  
Median: 2 Range: 
1-6    
1 206 (38.1) 56 (27.2) 150 (72.8) 1 
2 181 (33.4) 60 (33.1) 121 (66.9) 1.22 (0.90-1.66) 
3+  154 (28.5) 54 (35.1) 100 (64.9) 1.29 (0.94-1.76) 
Seeking ANC the first 
time after month 6      
Yes 219 (44.2) 67 (30.6) 152 (69.4) 1 
No 276 (55.8) 67 (24.3) 209 (75.7) 1.39 (1.00-1.94) 
Level of care where ANC 
was sought     
Hospital 350 (50.1) 33 (12.1) 239 (87.9) 1 
Level III/ Level IV 184 (26.3) 49 (32.0) 104 (68.0) 2.64 (1.71-4.06) 
Private clinic/Level II 165 (23.6) 91 (76.5) 28 (23.5) 6.30 (4.24-9.37) 
Seeking ANC from a 
health facility without 
onsite HIV testing  
services  
    
Yes 173 (24.7) 111 (94.1) 7 (5.9) 6.46 (5.16-8.10) 
 No 527 (75.3) 62 (14.6) 364 (85.4) 1 
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Characteristic All women, n (%) Not tested for HIV, n* (%) 
Tested for HIV, 
n* (%) 
Crude RR** 
(95%CI) 
Demographic information  Column % Row % Row %  
 Median: 25.5 Range: 14-50 Median: 25.7 Median: 24.7  
Amount paid for ANC 
(USD)  
    
0 253 (31.2) 42 (39.2) 65 (60.8)  
0.1-1 340 (41.9) 86 (31.2) 190 (68.8)  
1-max (11.7) 219 (27.0) 45 (27.9) 116 (72.1)  
Received counseling for 
HIV testing (self-
reported) 
    
Yes 484 (68.6) 60 (15.2) 334 (84.8)  
No 222 (31.4) 113 (75.3) 37 (24.7)  
Ever HIV tested before 
this pregnancy (n=812) 
    
Yes 569 (70.1) 75 (17.6) 351 (82.4)  
No 243 (29.9) 98 (83.0) 20 (17.0)  
Distance     
Distance to health facility 
where woman sought 
ANC  
Range: 0-4 km    
0-1 km 216 (37.2) 60 (33.2) 121 (66.8) 1.65 (1.13-2.41) 
2-3 km 171 (29.4) 27 (19.7) 110 (80.3) 0.887 (0.63-1.26) 
4+ km 194 (33.4) 39 (26.9) 106 (73.1) 1 
Distance to nearest 
health facility with HIV 
testing 
Range: 0.12-6.7 
km    
0-3 km 461 (69.3) 94(25.9) 269 (74.1) 1 
4+ km 204 (30.7) 69 (45.4) 83 (54.6) 2.57 (1.36-4.86) 
a Calculated using principle component analysis on household assets divided into two groups b Adjusting for age 
*n=544 with information on HIV testing ** Crude RRs shown only for variables with p-value <0.25  
 
Risk factors for not being tested for HIV 
during pregnancy 
The bivariate analysis identified several risk 
factors (p<0.25) for not being tested for HIV: 
being a farmer, being poor, having more than 
four living children, living more than 3 kilo-
meters from a facility with onsite HIV testing, 
not seeking ANC at one’s own initiative, 
seeking ANC late (first visit later than gesta-
tional month six) and, somewhat surprisingly 
but inversely related to seeking ANC late 
(Table 1). Table 1 also presents other poten-
tial risk factors that were analyzed but that 
was shown to be non-significant (p>0.25) and 
not analyzed in the multivariable model.  
The risk factors (p<0.25) were then ana-
lyzed in a multivariable model using a back-
wards selection procedure. The multivariable 
analysis showed that when stratifying by in-
come level, the only significant risk factor for 
not being tested for HIV among the poorest 
women was living more than three kilometers 
away from a health facility with testing ser-
vices (aRR 1.44, 95% CI 1.02-2.04), adjusting 
for age. Among the least poor, having more 
than four children (aRR 1.77, 95% CI 1.00-
3.16), and living more than three kilometers 
from a health facility with testing services 
(aRR 1.72, 95% CI 1.12-2.63), came out sig-
nificant after adjusting for age.  
For the women who attended ANC at a 
facility without HIV testing, but who report-
ed that they had been counseled for HIV test-
ing, 13% were HIV tested, as compared to 
  ͻ
4% among women who said they had not 
been counseled.   
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This population-based study from two rural 
Ugandan districts found that the uptake of 
HIV testing among pregnant women was 
64%, i.e. very similar to the WHO 2010 esti-
mate of 63%  testing coverage at national 
level [3]. The study also provides further in-
sight into why less than two-thirds of preg-
nant women ever pass the key entry-point to 
access PMTCT. Apparently, non-referral for 
HIV testing from more distant health facili-
ties that lack HIV testing onsite poses a major 
bottleneck for increased PMTCT coverage, 
especially for the poorest women and despite 
higher than national average levels of ANC 
attendance in this setting 96% vs. 94%[2]. 
The opt-out testing policy seems to work 
fairly well in facilities where HIV testing is 
available onsite since 85% of the women who 
attended such facilities were tested. This find-
ing is also supported by previous re-
search[37]. However, very few women, only 
6% who attended ANC at health facilities 
without testing onsite, were referred or car-
ried out referral for testing. Moreover, only 
20% of the women seeking ANC at facilities 
without testing had been counseled about or 
counseled and tested for HIV; and yet, the 
Ugandan PMTCT guidelines state that all 
pregnant women should be counseled[19]. 
This finding is consistent with a recent quali-
tative study conducted from the same area 
which suggested inadequate HIV counseling 
and a lack of testing referral from this type of 
facility[10]. Our analysis further reports that 
male partner support was low, only 13% of 
the pregnant women reported being accom-
panied to the ANC facility by their spouse, 
and 4% of the women had had couple HIV 
testing. 
Previous findings from the same setting 
suggest a combination of health system fail-
ures and traditional gender structures as im-
portant barriers to male partner involvement 
[11, 34]. Firstly, men are recruited for couple 
HIV testing through their pregnant spouse 
who are told by the midwife to fulfill the 
challenging, and often impossible task to 
convince the male family decision-maker to 
go for couple testing[34], especially for wom-
en in unstable relationships.  Secondly, men 
are less likely in general to seek any type of 
health care and especially ANC, which is 
viewed as a female domain [11]. For more suc-
cessful policy-implementation and involvement 
of male partners in ANC and PMTCT, 
knowledge about local gender structures are 
needed, including a direct targeting of men at 
their own conditions.  
Poverty has also previously been reported 
as an important barrier to PMTCT services in 
Uganda [41]. Thus, although inequity in ac-
cess to health care has improved dramatically 
since the 1970s, when it was acknowledged at 
global level, much remains to be done in 
terms of poor people’s right to basic health 
care and before universal access could be-
come more realistic [36, 40].  
The increased risk for not being HIV test-
ed among women with many children corre-
sponds to a previous finding in the same set-
ting indicating that women who are tested 
during a previous pregnancy feel less moti-
vated to test again[38]. Nevertheless, failure 
to test for HIV during all pregnancies could 
have important implications for MTCT in 
Uganda, which has one of the highest fertility 
rates in the world (6.7) as well as a high preva-
lence of concurrent partnerships[39]. Our pop-
ulation-based findings differ from those from 
a hospital-based study, also in eastern Ugan-
da, where having more children was associat-
ed with a positive attitude towards testing 
during ANC [33]. Having many children 
might also be confounded by educational 
level or staff attitudes towards the benefit of 
PMTCT, factors not analyzed here.  
The known inverse relationship between 
distance to a health facility and health care 
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seeking played an important role also for 
HIV-testing in this setting where a previous 
study also showed that living three kilometers 
or more from a health facility decreased the 
likelihood of seeking facility care for febrile 
children [40]. The Ugandan National Health 
Policy recommends that all people should 
have a maximum distance of five kilometers 
to a health facility, and reducing that distance 
to three kilometers, the cutoff barrier identi-
fied in our study for seeking adequate care, 
appears unrealistic [41]. Thus, to improve 
effective PMTCT coverage in Uganda, refer-
ral systems for HIV testing must improve, in 
parallel with an expansion of onsite and/or 
out-reach HIV testing to lower level facilities 
as part of routine care. Scaled-up out-reach 
testing may be preferable due to human re-
source shortages in Uganda and the risk of 
insufficient quality of counseling as PMTCT 
services are expanded to lower levels of care 
with inadequately trained staff [42]. However, 
the feasibility of testing at lower-level facilities 
may be enhanced if accompanied by commu-
nity-based peer-counseling [43].  
The low coverage of HIV testing and the 
above discussion clearly illustrates the Millen-
nium Development Goal Countdown dis-
course on the importance of well-functioning 
health systems to successfully implement large-
scale interventions, such as PMTCT [36].  
None of the eligible women declined par-
ticipation, possibly due to the fact that the 
HDSS collect data regularly, making women 
used to responding to questions and possibly 
more keen to participate in research. The 
women lost to follow-up did not differ signif-
icantly from the responders in terms of socio-
demographic baseline information. The loss 
of respondents at health facility level was due 
to random mistakes by the midwives and 
evenly distributed among the facilities, thus 
should not have biased the results. For the 
record reviews we used the HDSS information 
described in the method section and when 
uncertain about identification, the woman 
was excluded.  We relied on register data for 
some variables, and must therefore contend 
with the possibility that what is defined as 
lacking in receipt of certain care aspects, 
might in some cases be due to mis- or unreg-
istered information. However, most registers 
appeared to be completed appropriately for 
the selected variables, especially for HIV test-
ing. 
Conclusion  
High ANC attendance, yet low HIV testing 
coverage, demonstrates missed opportunities 
to enroll women into PMTCT services. This 
study shows, at population-level, that lack of 
onsite HIV testing services, poverty, failure to 
adjust to existing gender norms and distance 
to health facilities are clear barriers to effec-
tive policy implementation and high HIV 
testing uptake.  The health system in terms of 
policies, funds, and human resources, needs 
to be mobilized to ensure that HIV testing is 
available and accessible for all pregnant wom-
en during ANC.  Without increasing the up-
take of this first and crucial component of the 
PMTCT program, the UNAIDS call for “Vir-
tual elimination of HIV infections due to 
MTCT” is unachievable.  

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+PVTQFWEVKQP
The reported coverage of antiretroviral 
prophylactic therapy for prevention of mother-to-
child transmission (PMTCT) services has 
increased in in the sub-Saharan African region in 
recent years, but was still limited to 60% in 
2010.[1] The estimated coverage of PMTCT 
services in many low-income countries however 
are subject to overestimations since they only 
consider enrolment into the programmes, but 
does not include whether the individual PMTCT 
components are fulfilled or not.[2] PMTCT is a 
complex intervention and built on sequential 
interventions taking place in order to reduce 
mother-to-child transmission (MTCT) of HIV, 
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starting with antenatal care (ANC), HIV testing, 
and ending with antiretroviral medicines (ARVs), 
and breast feeding advice.[3] Without any 
intervention, MTCT is 35-40% but may be 
brought down to around 1% in high-income 
settings with optimal resources available, and has 
been reported at 5% in trial settings in low- and 
middle-income countries.[4-6] However, health 
systems’ shortcomings, such as poor referral 
systems for HIV testing, inadequate PMTCT 
counseling, and dropouts from the programme, 
hamper the effectiveness of PMTCT services and 
lead to HIV infections among children that could 
have been prevented.[7-9] Barker et al. have 
modelled that an 80% uptake in each of the 
PMTCT programme-components of: ANC 
access, HIV- and CD4 testing, and ARV 
prophylaxis, would translate into a situation where 
only 51% of women in need in the end would 
receive ARV prophylaxis.[8]  
In Uganda, the estimated proportion of HIV 
positive pregnant women that receive any kind of 
ARVs for PMTCT has increased from 34% in 
2007 to 53% in 2009.[2, 10] Most estimates, as 
well as research on coverage, and effectiveness of 
PMTCT programmes, like the Barker study, use 
national, aggregated data, or are health facility-
based.[8, 11-13] Hence, the actual effectiveness of 
PMTCT programmes at population level has not 
been assessed. 
This study is based on a population-based cohort 
of pregnant women recruited in a Health and 
Demographic Surveillance Site (HDSS) in rural 
Uganda. The aim of the study is to estimate the 
number of children infected with HIV at birth, 
and at six months post-partum in a district 
population, by using recent empirical cohort data 
on uptake of PMTCT programme components in 
combination with the latest data available on 
MTCT rates. Further, we modelled different 
scenarios assuming increased coverage of 
individual PMTCT programme components, in 
order to estimate the impact on HIV infections 
among children for each scenario.  
/GVJQFU
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The empirical data on PMTCT programme 
coverage derives from a population-based cohort 
study carried out between 2008 and 2010 in the 
Iganga-Mayuge HDSS in rural Uganda. Data were 
collected on ANC attendance, HIV testing, ARV 
prophylaxis, type of ARV prophylaxis provided to 
the mother and mode of infant feeding, and dropout 
at each step was analysed. 
The Iganga-Mayuge HDSS population consists of 
an estimated 68,000 individuals living in 12,000 
households that are followed-up regularly and 
data on vital events such as births, deaths, and 
migration are collected. The HDSS area is 
predominantly rural (80%), apart from Iganga 
town which is semi-urban, and the main source of 
income is subsistence farming. The adult HIV 
prevalence in Eastern Uganda is estimated at 
5%.[14]  ANC is available at health facilities at all 
levels with an estimated ANC attendance of 96% 
in this setting.[15]  At the time of study, about 
half of the health facilities also provided HIV 
testing services and one third accredited to have 
ARV prophylaxis for PMTCT. According to the 
national PMTCT guidelines, women visiting 
facilities without testing services should be 
referred to neighbouring health facilities for HIV 
testing. The ARV prophylactic regimens at the time 
of study were based on the WHO 2006 
recommendations and were for the mother either 
dual ARVs with zidovudine (AZT) and lamivudine 
up to one week after delivery, or single dose 
nevirapine. Babies received AZT for one week or 
sd-NVP. Triple ARVs (ART) was only provided to 
women eligible for that for her own health.  
$CUGECUG*&55EQJQTVUVWF[
During the regular HDSS data collection in May-
July 2008, all households were screened for 
pregnant women and all of these women (n=881) 
were followed throughout their pregnancy (Figure 
1).  In addition, record reviews were performed at 
the health facilities where the enrolled women had 
sought ANC. The data collection process has 
been described in detail elsewhere.[15] Data on 
PMTCT-dropout among HIV infected women 
(n=13) was collected from the ANC records for 
everyone, and through semi-structured interviews 
for about half of them (n=7). Five of the HIV 
infected women could not be interviewed; one 
because she was not found, three women had 
moved out of the HDSS area, and two denied 
being HIV infected. The interviews were home-
based, semi-structured using both closed, and 
open-ended questions and conducted 12-20 
months after delivery by a Ugandan midwife with 
long experience of PMTCT work.  
&GEKUKQPVTGGCPCN[UKU
We performed a decision tree analysis with the 
main outcome being the estimated number of 
children infected with HIV at birth and at six 
months post-partum in the Iganga and Mayuge 
districts. In the analysis, the population-based data 
for the HDSS-cohort were analysed using 
frequency tables to define the proportion of 
women covered by each stage of the PMTCT  
͵ 
  
Figure 1. Iganga-Mayuge Health and Demographic Surveillance site- cohort of pregnant women 
Table 1. Decision tree analysis input 
Data from the base-case (HDSS-cohort) on probability of coverage for individual PMTCT 
programme components  
Components Probabilities 
ANC attendance 0.96 
Attending ANC at a facility with HIV testing services  0.78 
HIV tested (at facility with HIV testing services) 0.85 
HIV tested (at ANC without HIV testing services) 0.06 
HIV prevalence 0.035 
HIV infected women/baby pair receiving any ARV prophylaxis  0.83 
       Mother ARV prophylaxis -sd-NVPa 
       Mother ARV prophylaxis -dual prophylaxis AZTb and 3TCc 
       Mother ARV prophylaxis –ART (for her own health) 
0.33 
0.57 
0.10 
Women practicing safe feeding  0 
HIV mother to child transmission ratesd 
Peripartum transmission rates for different ARV regimens 
No ARV prophylaxis 0.22 
sd-NVP 0.12 
Dual prophylaxis of AZT and 3TC 0.04 
ART for her own health  0.02 
Postpartum transmission rates per month of any breastfeeding (mixed or exclusive) 
Mother’s CD4 cell count 350 mm3 0.0157 
Mother’s CD4 cell count >350 mm3 0.0051 
If mother receive ART for her own health  0.002 
Ͷ 
programme, referred to as the base-case PMTCT 
coverage. These data were combined with the 
most recent UNAIDS estimates of MTCT rates 
for different ARV prophylactic regimens, for 
different feeding practices, and for different CD4 
cell count levels among the women. The 
combined data were subsequently entered as 
probabilities in a decision tree model created in 
Microsoft Excel and the model inputs are 
presented in Table 1. [16] The HIV prevalence of 
3.5% used in the analysis is derived from the 
number of pregnant women that tested positive 
for HIV in the HDSS cohort. Blood samples for 
CD4 cell count are not routine in the two districts, 
therefore the number HIV infected children at six 
months is presented for both MTCT rates below 
and above 350 mm3 CD4 cell counts.  
a single dose nevirapine b zidovudine c lamivudine d 
UNAIDS Reference Group on Estimates 
Modelling and Projections, Working Paper on 
MTCT transmission rates for use in Spectrum, 
2011, UNAIDS: Geneva. 
Inference to Iganga and Mayuge district 
population 
In order to estimate the number of HIV infected 
children in the whole of the Iganga and Mayuge 
districts, we inferred the base-case probabilities in 
Table 1 to the districts population of about 
1 140 000 individuals in 2008. [17] Based on the 
Ugandan crude birth rate of 45/1000 and the HIV 
prevalence of 3.5%, there was an expected 51 
300 pregnant women in the two districts in 2008 
of which 1796 were estimated to be HIV infected.  
Estimated effectiveness for scenarios with an 
assumed increased coverage of PMTCT 
components  
Different scenarios were modelled where the 
base-case PMTCT coverage was used and then an 
increased coverage of individual PMTCT 
programme components was assumed. This was 
done to estimate how an increased coverage of 
individual PMTCT components would impact the 
number of HIV infected children at birth and at 
six months.  
The effectiveness was estimated for the following 
scenarios, assuming the base-case PMTCT 
coverage but additionally with:  
x an ANC attendance of 100% 
x an uptake of HIV testing of 100%  
x provision of ART throughout pregnancy 
and the breastfeeding period to the HIV 
infected women who received ARV 
prophylaxis 
x an Optimal scenario, combining all the 
above  
x an OptimalPlus scenario, same as 
Optimal scenario but where uptake of 
ART was increased to 100% instead of 
the base-case uptake of 83%  
In the above presented scenarios, the coverage of 
all other PMTCT components were kept at the 
base-case coverage level presented in table 1.  
To estimate the effectiveness of the base-case 
PMTCT coverage as compared to a situation 
without any PMTCT services at all, a scenario that 
assumed that no one would receive any PMTCT 
service at all was also modelled.  
Further, for the scenarios presented above the 
number of children infected with HIV at six 
months was calculated for two different 
situations; one with the mothers CD4 cell count 
levels set to > 350 mm3 and one with CD4 cell 
count levels set to 350 mm3. 
To estimate the relative effect on the number of 
HIV infected children for each scenario, all 
scenarios were compared to the estimated number 
of HIV infected children with the base-case 
PMTCT coverage. For those comparisons, the 
postnatal transmission rate for CD 4 cell count of 
>350 mm3 was used.  
In the scenarios modelled, adherence to the ARV 
prophylaxis is assumed to be 100%, if medicines 
were disbursed. Since perfect adherence to ARV 
prophylaxis is rare, we also created alternative 
models for all the scenarios described above but 
assuming 50% adherence to ARV prophylaxis.  
'VJKEU
All women participating in the study gave their 
informed consent. The home-based interviews 
with HIV infected women after birth were 
carefully planned in order not to reveal the 
women’s HIV status to anyone. Ethical approval 
for the study was obtained from Makerere 
University School of Public Health Institutional 
Review Board, and the Uganda National Council 
of Science, and Technology in 2008 (Ref.nr. 
HDREC, 052).  
4GUWNVU
HIV infected children at birth and at six months 
with the base-case PMTCT coverage  
Given an HIV prevalence in the HDSS cohort of 
3.5%, 1796 HIV infected pregnant women and 
the base-case PMTCT coverage, an estimated 240 
children would be HIV infected at birth in the 
ͷ 
Iganga and Mayuge districts (Table 2). At six 
months of age, this number would have increased 
to 284 or 369 depending on maternal CD 4 cell 
count levels being or > 350 mm3, respectively. 
This corresponds to an MTCT rate of 13% at 
birth, and 16% or 20% at six months (Table 2). If 
comparing to a situation without any PMTCT 
programme, the base-case PMTCT coverage did  
prevent 155 (39%) child HIV infections at birth 
and 152 (35%) or 149 (29%) child HIV infections 
at six month of age, again depending on the 
mothers immune status.  
83% uptake of ARV prophylaxis, empirical 
finding, b100% uptake of ARV prophylaxis.
/6%6TCVGUHQTVJGFKHHGTGPVUEGPCTKQU
The MTCT rates for the different scenarios range 
from above 13% for the base-case PMTCT 
coverage to just above 2% for the OptimalPlus 
(Table 2). Interestingly, the Optimal scenario using 
the base-case ARV prophylaxis coverage of 83%, 
which is rather high, would give an MTCT rate of 
5.4% at birth, which is still above the WHO target 
of MTCT rates below 5%. For the OptimalPlus 
scenario assuming 100% adherence both during 
pregnancy and during the breastfeeding period the 
MTCT rates are 2.0% and 3.1% at birth and six 
month respectively. Hence, adherence levels are 
crucial, especially during the breastfeeding period 
Table 2. Scenarios with different coverage of PMTCT components, number of children infected with HIV and MTCT rates
Scenario Description At birth At six months- 
CD 4 cell count >350 
mm3 
At six months-  
CD 4 cell count  
350 mm3 
Number of 
children 
MTCT 
rate (%) 
Number of 
children 
MTCT rate 
(%) 
Number of 
children 
MTCT 
rate (%)
Base-case  
PMTCT 
coverage 
Number of HIV 
infected children 
the Iganga-
Mayuge district 
population based 
on the empirical 
HDSS cohort 
data  
240 13.4 284 15.8 369 20.5 
100% ANC Base-case 
scenario but 
100% ANC 
attendance 
234 13.0 278 15.5 363 20.2 
100% HIV 
testing 
Base-case 
scenario but 
100% HIV testing  
172 9.6 217 12.1 303 16.9 
100% ART Base-case 
scenario but ART 
provided to 
100% of women 
receiving ARV 
prophylaxis 
197 11.0 227 12.6 265 14.8 
Optimal 
scenario 
A combination of 
Scenario 2, 3 
and 4 (uptake 
83%)a  
97 5.4 121 6.7 135 7.5 
OptimalPlus
scenario  
A combination of 
Scenario 2, 3 
and 4 (uptake 
100%)b 
36 2.0 56 3.1 56 3.1 
No PMTCT No ARV 
prophylaxis given 
to HIV infected 
women/babies 
395 13.4 436 15.8 518 28.8 
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Effects of base-case PMTCT coverage together 
with an assumed increased coverage of PMTCT 
components with 100% adherence to ARV 
prophylactic drugs 
Since ANC attendance in this setting is as high as 
96%, the effect on MTCT of increasing ANC 
attendance to 100%, is limited (Figure 2 a and b). 
Instead, the low coverage of HIV testing appears to 
be the major bottleneck for PMTCT in Iganga-
Mayuge districts. An assumed increase of HIV 
testing coverage to 100% among pregnant women 
attending ANC could reduce the number of HIV 
infections among children at birth by 28%, or by 
24% at six months (Figure 2 a and b).  
Increasing ART coverage to all women receiving 
ARV prophylaxis, while keeping all other 
components constant, would comparably only 
give an 18% reduction of infections at birth and 
20% at six months.  
The Optimal scenario with 100% ANC 
attendance, 100% HIV testing and ART to all 
women receiving ARV prophylaxis (uptake 83%), 
translates into a 60% decrease of infections at 
birth, and a 57% decrease at six months compared 
b) at 6 months
a) at birth
Figure 2. Estimated relative effects of an assumed increase in coverage of individual PMTCT programme components 
as compared to the base-case PMTCT coverage 
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to the number of children HIV infected with the 
base-case coverage (Figure 2 and b). 
The OptimalPlus scenario, with 100% ANC 
attendance, 100% HIV testing, and providing 
ART to all HIV infected women (100% vs 83% in 
the Optimal scenario) would gives the best results 
and translate into an estimated reduction of 85% 
at birth and 80% at six months.  
Effects of base-case PMTCT coverage together 
with an assumed increased coverage of PMTCT 
components with 100% adherence to ARV 
prophylactic drugs 
Assuming a lower adherence level of 50%, and 
assuming 100% HIV testing uptake, the number 
of HIV infections among children would be 
reduced by 10% at birth, and 9% at six months 
compared to the estimated MTCT rate for the 
base-case PMTCT coverage (Figure 2 c, d).  
In this case the Optimal scenario with ANC, HIV 
testing, and ART set to 100%, would only provide 
a total reduction of 22% of infections at birth and 
at six months compared to number of children 
estimated to be HIV infected with the base-case 
PMTCT coverage (Figure 2 c, d). 
d) at 6 months
c) at birth
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To our knowledge, this is the first study to use 
population-based data on coverage of PMTCT 
components to model the effectiveness of a 
PMTCT programme in a Sub-Saharan African 
population.  Our results show that in this 
Ugandan setting, with a poorly resourced health 
system, the existing PMTCT programme is 
estimated to have averted up to 35% of HIV 
infections among six-month-old children yearly 
depending on maternal CD 4 cell count levels, 
when comparing to a situation without any 
PMTCT programme.   
The estimated MTCT rate is still considerable, 
13% at birth, and 16% at six months, which is far 
from the MTCT elimination targets to reduce 
global child HIV infections by 90% by 2015.[18] 
In addition, 80% of HIV infected children have a 
high probability of dying before five years of age 
due to poor access to HIV treatment for 
children.[19, 20]  
Our study highlights the fact that single, or multi-
component health system interventions aimed at 
increasing the uptake of HIV testing, and/or 
increased access to ART, could significantly 
reduce MTCT of HIV.  The possibility to reach 
significantly better results by increasing HIV 
testing is especially interesting. We found in an 
earlier study from the same area that the main 
determinant of being HIV tested among women 
seeking ANC, was whether the facility could offer 
onsite HIV testing or not since referral from rural 
peripheral ANC clinics for HIV testing did not 
work.[7] Hence, by upgrading facilities to supply 
rapid HIV testing, refer women for testing, or 
otherwise increase HIV testing uptake, keeping all 
other components constant, the PMTCT 
programme effectiveness could according to our 
results be significantly increased.  
The challenges associated with large-scale 
implementation of PMTCT programmes have 
generally been underestimated, partly because of 
the assumption that it may piggyback on an 
already established intervention with high 
coverage, ANC.[21] However, our study 
emphasises the complexity of the PMTCT 
programme, and that the effectiveness of the 
programme is dependent on the uptake of each of 
the PMTCT programme components. Almost all 
HIV infected women (96%) have been in contact 
with the health care system during ANC, and 
should have received PMTCT programme 
components according to the PMTCT 
guidelines,[22] thus the failure to motivate women 
to test for HIV, and to deliver a complete 
PMTCT programme reflects missed opportunities 
and a health system weakness. With the base-case 
PMTCT coverage , 13% of the HIV exposed 
children were estimated being infected at birth. 
This could be compared to Barker et al’s 
modelling showing that 80% ANC attendance, 
80% HIV testing, and 80% access to ARV 
prophylaxis would translate into a 16% versus 
12% MTCT if women with CD4>350 received 
sd-NVP versus AZT/3TC.[8] Our results 
support, but do also complement the Barker study 
since we used population-based cohort data, and 
included all PMTCT programme components, 
including the crucial step of feeding practices. We 
reach similar conclusions on the urgent need for 
health system strengthening and to make already 
known efficient PMTCT interventions more 
effective in order to reduce the MTCT in sub-
Saharan Africa, while we also point at striking 
effects of increasing e.g. HIV testing in this 
specific context.  
Hence, a well-functioning health system is crucial 
to deliver the interventions that build the PMTCT 
programme, something that has also been 
described in previous studies.[7, 15, 21] A 
Rwandan study demonstrated that women 
attending ANC clinics where PMTCT, and ART 
had been integrated were almost twice as likely to 
enrol in ART care as compared to women 
attending stand-alone clinics for ANC.[23] The 
authors attribute this to comprehensive support to 
HIV infected pregnant women, and stress that 
integration of HIV care is crucial.[23] In addition 
to health systems interventions to increase access 
to the PMTCT programme components, our 
earlier studies highlight how HIV prevention, and 
care is still threatened by stigma, and lack of 
knowledge among the pregnant women.[7] 
Increased awareness at community level, and 
general de-stigmatising interventions will be of 
benefit to staff handling HIV testing, for pregnant 
women as well as for women in need of the full 
PMTCT programme.[7, 24, 25] 
The “100% HIV testing” Scenario reduced HIV 
infections by 28% at birth and by 24% at six 
months, as compared to the “OptimalPlus”- 
scenario, that reduced the number of infections by 
85%, and 80% at birth and six months of age, 
respectively.  These results highlight the necessity 
of increasing capacity for HIV testing at ANC 
facilities but also the need to implement the 
newest PMTCT guidelines from the WHO, 
stating that HIV infected women should receive 
ART throughout the breastfeeding period to 
reduce MTCT of HIV. The interventions needed 
ͻ 
to increase the effectiveness of PMTCT 
programmes differ between context, and 
countries. As shown previously, in a country with 
poor ANC attendance, increasing ANC 
attendance could be the best intervention to 
increase PMTCT effectiveness.[13]  
Our results show that uptake and adherence to 
ART, especially throughout the breastfeeding 
period is crucial in order to decrease the MTCT. 
If keeping uptake and adherence at 100% 
throughout the breastfeeding period MTCT rates 
would be 3.1%, and for the base-case coverage of 
83%, which might be more realistic in real-life, 
MTCT rates at the same time would be 6.7% or 
7.5 depending on maternal immune statuse while 
breastfeeding. Thus, support to both midwives at 
ANC, and pregnant women to get a solid 
understanding of the importance of taking drugs 
as prescribed, and following feeding advise, is 
equally necessary.  
/GVJQFQNQIKECNEQPUKFGTCVKQPU
visiting the households twice during the study 
we hope to have minimised the risk of missed 
pregnancies. If pregnant women with HIV were 
more likely to avoid the data collection, MTCT 
rates have been underestimated. Studies have 
shown that HIV infected women may be less 
likely to be HIV tested.[9]  
Open-ended questions on PMTCT adherence to 
women enrolled in the Iganga-Mayuge PMTCT 
programme revealed that our assumption of 100% 
adherence to any ARV regimen provided was 
unrealistically optimistic, therefore we also 
modelled all scenarios assuming 50% adherence. 
A study from Zambia found that only 68% of 
women that had received the simplest ARV 
prophylactic regimen, NVP, had actually taken it 
as prescribed.[26]
%QPENWUKQPU
In this setting, HIV infections could be reduced 
by 28% by increasing HIV testing capacity at 
health facilities to ensure 100% testing among 
women seeking ANC. Importantly, more 
infections would be averted by increasing HIV 
testing as compared to increasing the supply of 
the ART prophylactic drugs used in this context, 
however both interventions are obviously needed 
and highly cost-effective means of prevention.  
Our analyses further highlight gains in following 
the latest guidelines on ART prophylactic drug 
regimens, as well as enforcing the urgency in 
scaling-up delivery of HIV testing at all ANC 
facilities, and ensuring high adherence.  Further, in 
order to determine the effectiveness of PMTCT 
programmes in different settings, it is crucial to 
analyse at what stages of the PMTCT programme 
dropouts occur and target interventions 
accordingly.  
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